norethindrone has been researched along with norethindrone acetate in 625 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 172 (27.52) | 18.7374 |
| 1990's | 135 (21.60) | 18.2507 |
| 2000's | 227 (36.32) | 29.6817 |
| 2010's | 82 (13.12) | 24.3611 |
| 2020's | 9 (1.44) | 2.80 |
| Authors | Studies |
|---|---|
| Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Joshi, JV; Joshi, UM; Naik, VK | 1 |
| Di Pietro, S; Mauri, M; Tancini, G; Varini, M | 1 |
| Berg, G; Hammar, M; Larsson-Cohn, U; Lindgren, R; Olsson, AG | 1 |
| Fahy, UM; Foster, PA; Hartog, M; Hull, MG; Torode, HW | 1 |
| Fraser, DI; Hillard, TC; Pryse-Davies, J; Siddle, NC; Whitehead, MI | 1 |
| Hotz, E; Imthurn, B; Keller, PJ | 1 |
| Pouilles, JM; Ribot, C; Tremollieres, F | 1 |
| Berg, G; Hammar, M; Karlberg, J; Lindgren, R; Sandin, K; Wiklund, I | 1 |
| Berg, G; Hammar, M; Lindgren, R; Pryse-Davies, J; Risberg, B | 1 |
| Hotz, E; Imthurn, B; Keller, PJ; Macas, E | 1 |
| Christiansen, C; Haarbo, J; Svendsen, OL | 1 |
| Higashi, S; Mizumoto, R; Yamagiwa, K | 1 |
| Carol, W; Etzrodt, R; Klinger, G | 1 |
| Farooq, A; Jha, P; Murugesan, K | 1 |
| Bottazzo, GF; Ghiggi, MR; Lombardi, G; Rossi, R; Savastano, S; Tommaselli, AP; Valentino, R | 1 |
| Barja, P; Bocaz, JA; Bonnar, J; Carrol, A; Coutinho, E; Daly, L; Goncalves, M; Leck, I; Thomson, JM; Tsakok, M | 1 |
| Fu, GM; Li, DZ; Wang, GP; Wei, ZN; Zhao, XL; Zhou, MY; Zuo, MD | 1 |
| Kellokumpu-Lehtinen, P; Pelliniemi, LJ; Pulkkinen, MO; Schweikert, HU | 1 |
| Kuhl, H; Pietzsch, V | 1 |
| LaRosa, JC; Miller, VT; Muesing, RA; Phillips, EA; Stillman, RJ; Stoy, DB | 1 |
| Allen, PW; Lai, FM; Wong, FW | 1 |
| Christiansen, C; Haarbo, J; Leth-Espensen, P; Stender, S | 1 |
| Garza-Flores, J; Hall, PE; Perez-Palacios, G | 1 |
| Crook, D; Fraser, D; Schenkel, L; Stevenson, JC; Whitehead, MI | 1 |
| Cust, MP; Gangar, KF; Hillard, TC; Lees, B; Stevenson, JC; Whitehead, MI | 1 |
| Christiansen, C; Riis, BJ | 2 |
| Meyer, JE; Ravnikar, VA; Stomper, PC; Van Voorhis, BJ | 1 |
| Brückmann, D; König, EM; Krafft, W; Schirmer, A; Schmeisser, G; Steuckardt, R | 1 |
| Christiansen, C; Jensen, SB; Johansen, JS; Riis, BJ | 1 |
| Christiansen, C; Hassager, C; Jensen, LT; Pødenphant, J; Riis, BJ | 1 |
| Byrjalsen, I; Christiansen, C; Riis, BJ | 2 |
| Frenchek, B; Speroff, L; Speroff, T; Williams, SR | 1 |
| Nguyen, HT; Shiu, GK; Skelly, JP; Worsley, WN | 1 |
| Krexner, E; Pietschmann, P; Resch, H; Willvonseder, R; Woloszczuk, W | 1 |
| Fraser, DI; Parsons, A; Pryse-Davies, J; Stuart, G; Whitehead, MI; Wordsworth, J | 1 |
| Asai, M; Masahashi, T; Narita, O; Ohsawa, M; Wu, MC | 1 |
| Hemp, O; Löttge, M; Seifert, B; Spieler, W | 1 |
| Krafft, W | 1 |
| Pietschmann, P; Resch, H; Willvonseder, R | 1 |
| Dören, M; Montag, M; Schneider, HP | 1 |
| Florio, V; Morini, A; Mossa, B; Roscetti, C | 1 |
| Mishell, DR | 1 |
| Christiansen, C; Jensen, J; Riis, BJ; Strøm, V | 2 |
| Farooq, A; Lal, B; Murugesan, K; Vij, U | 1 |
| Azuma, T; Mizumoto, R | 1 |
| Gold, E; Goulding, A | 2 |
| Florio, V; Mossa, B; Pelle, R; Tocci, B | 1 |
| da Luz, RJ; Rubens, RD | 1 |
| Gürtler, R; Schmidt, UM; Stier, G | 1 |
| Andreasen, EE; Jensen, HK; Madsen, LG | 1 |
| Milwidsky, A; Rahav, G; Shalev, O | 1 |
| Amatayakul, K; Suriyanon, V | 1 |
| Carpenter, JT | 1 |
| Alexander, WJ; Austin, H; Louv, WC; Perlman, J | 1 |
| Ashton, RE; Dowd, PM; Griffiths, WA; Jacobs, HS; Miller, JA; O'Brien, TJ; Wojnarowska, FT | 1 |
| Griesinger, R; Schindler, AE | 1 |
| Bonnar, J | 1 |
| Guerin, JF; Rollet, J | 1 |
| Belsey, EM | 1 |
| Christiansen, C; Johansen, J; Riis, BJ | 1 |
| Hellgren, M; Mattsson, LA; Samsioe, G; Sporrong, T | 1 |
| Annus, J; Apró, G; Bartfai, G; Belsey, E; Bulpitt, C; Kovacs, L; Pinol, A | 1 |
| Anderson, C; Karambolova, KK; Snow, GR | 1 |
| Joshi, JV; Joshi, UM; Sankolli, GM; Shah, RS | 1 |
| Cleary, PA; Gilbert, PR; LaRosa, JC; Lipson, A; Miller, VT; Muesing, RA; Stadel, B; Stoy, DB | 1 |
| Hoffmann, G; Pollow, K; Schommer, M; von der Ohe, M | 1 |
| Achard, B; Boujenah, A; Cohen, J; Debache, C; Loffredo, V; Paris, X; Pez, JP; Robert, J; Serkine, AM; Solal, P | 1 |
| Anklesaria, PS; Gupta, KC; Joshi, JV; Satoskar, RS; Shah, RS | 1 |
| Boonsiri, B; Chutivongse, S; Crona, N; Garza-Flores, J; Gundersen, G; Juarez-Ayala, J; Kolkijkovinda, S; Medberg, M; Samsioe, G; Valles de Bourges, V | 1 |
| Lobo, RA | 1 |
| Fraser, D; Whitehead, MI | 1 |
| Frenchek, B; Gordon, EM; Mazur, CA; Speroff, L; Williams, SR | 1 |
| Hempel, E; Illessy, G; Schubert, KH | 1 |
| Ma, XH; Qin, ZL | 1 |
| Gambrell, RD | 2 |
| Loikkanen, M; Luotola, H; Pyörälä, T | 1 |
| Binkerd, PE; Günzel, P; Hendrickx, AG; Korte, R; Leuschner, F; Neumann, BW; Poggel, A; Prahalada, S | 1 |
| Bauer, J; Kratochvíl, B; Kulovaný, E; Minajev, G; Strnad, P | 1 |
| Allen, WE; Porter, DJ | 1 |
| Kreutner, AK | 1 |
| Cullberg, G; Mattsson, LA; Samsioe, G | 3 |
| Christiansen, C; Jensen, J; Nilas, L | 1 |
| Baird, PJ; Crandon, AJ; Eastman, CJ; Fay, R; Hudson, CN; Toppila, M; Tyler, JP | 1 |
| Staland, B | 2 |
| Mattsson, LA; Samsioe, G | 1 |
| Einen, MA; Kamel, M; Saleh, F; Sallam, H; Souka, AR | 1 |
| Brachmann, K; Göretzlehner, G; Männchen, E; Nikschick, S | 2 |
| Winton, F | 1 |
| Kunkel, S; Meissner, J; Rudolf, K; Rüting, M | 1 |
| Blödow, K; Kunkel, S; Rudolf, K | 1 |
| Kunkel, S; Rudolf, K; Woltanski, KP | 1 |
| Kunkel, S; Rudolf, H; Rudolf, K | 1 |
| Edwards, CA; Hughes, LE; Kumar, S; Mansel, RE; Scanlon, MF | 1 |
| Corbishley, TP; Iqbal, MJ; Wilkinson, ML; Williams, R | 1 |
| Howell, A; Ribeiro, G | 1 |
| Caprasse, J; Casanas-Roux, F; Donnez, J; Ferin, J; Thomas, K | 1 |
| Bailey, CJ; Carrington, LJ | 1 |
| Endacott, J; Padwick, ML; Pryse-Davies, J; Whitehead, MI | 1 |
| Calabria, AA; D'Amato, MS; Fioravanti, A; Morozzi, G; Parrini, E; Renieri, A; Taddeo, A | 1 |
| Emms, H; Lewis, GP | 1 |
| Brincat, M; Magos, AL; O'Dowd, T; Schlesinger, P; Studd, JW; Wardle, PJ | 1 |
| Morsman, J; Varma, TR | 1 |
| Andersch, B | 1 |
| Duke, A; Henderson, BE; Krailo, MD; Pike, MC; Roy, S | 1 |
| Dammé, J; Schulte-Hermann, R; Schuppler, J | 1 |
| Fraser, IS | 1 |
| Spona, J; Zeillinger, R | 1 |
| Baraghini, F; Barbieri, C; Dalla Vecchia, E; Di Renzo, GC; Grasso, A; Previdi, AM; Volpe, A | 1 |
| De Moor, P; Koninckx, P; Verhoeven, G | 1 |
| Flowers, CE; Hyde, BM; Wilborn, WH | 1 |
| Flosdorff, W; Hust, W | 1 |
| Grimes, EM; Taymor, ME; Thompson, IE | 1 |
| Altmann, G; Bernaschek, G; Feichtinger, W; Kemeter, P | 1 |
| Hellberg, D; Nilsson, S | 1 |
| Düsterberg, B; Hasan, H; Kivikoski, A; Laajoki, V; Pulkkinen, MO | 1 |
| Guillebaud, J | 1 |
| Cruickshank, J; McMaster, M; Weir, RJ; Wilson, ES | 1 |
| Catherwood, BD; Christiansen, C; Deftos, LJ; Pødenphant, J | 1 |
| Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM | 1 |
| Gustafson, A; Samsioe, G; Silfverstolpe, G; Svanborg, A | 2 |
| Chitalange, S; Chowdhary, VN; Desai, NK; Gupta, KC; Joshi, JV; Joshi, UM; Sankolli, GM; Satoskar, RS | 1 |
| Hümpel, M; Täuber, U | 1 |
| Chen, W; Qiu, LK | 1 |
| Quinn, MA | 1 |
| Czeizel, A; Nagy, M; Pázsy, A; Pusztai, J | 1 |
| Boonsiri, B; Channiyom, K; Virutamasen, P; Wongsrichanalai, C | 1 |
| Christiansen, C; Rødbro, P | 1 |
| Rodriguez, L; Schindler, C | 1 |
| Earl, HM; Hayward, JL; Knight, RK; Rubens, RD | 1 |
| Bhatki, S; Joshi, JV; Joshi, UM; Maitra, A; Sankolli, G | 1 |
| Christensen, MS; Christiansen, C; Hagen, C; Transbøl, I | 2 |
| Böhm, W; Börner, A; Carol, W; Greinke, C; Klinger, G; Lauterbach, H | 1 |
| Andino, N | 1 |
| Hingorani, V; Jain, AK; Jha, P; Kumar, D; Laumas, KR; Laumas, V; Malik, BK; Rahman, SA; Sarkar, NN; Takkar, D | 1 |
| Christensen, MS; Christiansen, C; Hagen, C; Rødbro, P; Transbøl, I | 1 |
| Dworken, HJ; Leseman, RF | 1 |
| Börner, A; Carol, W; Klinger, G | 1 |
| Kay, CR | 2 |
| Niththyananthan, R; Wynn, V | 1 |
| Meade, TW | 1 |
| Wingrave, SJ | 1 |
| Christensen, MS; Christiansen, C; Hagen, C; Stocklund, KE; Transbøl, I | 1 |
| Hardt, W; Nevinny-Stickel, J; Schmidt-Gollwitzer, K; Schmidt-Gollwitzer, M | 1 |
| Chauffour, J; Dhumeaux, D; Larde, D; Prigent, A; Saint-Marc Girardin, MF; Zafrani, ES | 1 |
| Edelman, DA; Kelly, SE; Kothenbeutel, R; Levinski, MJ | 1 |
| Agarwal, N; Hingorani, V; Laumas, KR; Laumas, V; Sarkar, NN | 1 |
| Dimov, I; Dzhebarov, S; Tokin, R | 1 |
| Christenson, RK; Lunstra, DD | 2 |
| Werner, D; Werner, M | 1 |
| Brøns, M; Jacobsen, JG; Kristoffersen, K | 1 |
| Buchsbaum, HJ; Gal, D; MacDonald, PC; Porter, JC; Simpson, ER | 1 |
| Lox, CD; Messiha, FS; Sproat, HF | 1 |
| Hull, MG | 1 |
| Christiansen, C; Jensen, GF; Transbøl, I | 1 |
| Roberts, JM | 1 |
| Hingorani, V; Jha, P; Laumas, KR; Murguesan, K; Singh, H; Takker, D; Uniyal, JP | 1 |
| Dickerson, JW; Ellis, FR; Fehily, AM; Meade, BW | 1 |
| Bach, JF; Dougados, M; Jungers, P; Kuttenn, F; Lesavre, P; Pélissier, C; Tron, F | 1 |
| Swyer, GI | 1 |
| Russowsky, M; Sartoretto, JN | 1 |
| Collins, A; Eneroth, P; Frankenhaeuser, M; Hagenfeldt, K; Hanson, U; Lundberg, U | 1 |
| Back, DJ; Breckenridge, AM; Crawford, FE; Hall, JM; MacIver, M; Orme, ML; Rowe, PH; Smith, E; Watts, MJ | 1 |
| Johansson, ED; Odlind, V; Victor, A | 1 |
| Allen, WE | 1 |
| Farooq, A; Kumar, D; Laumas, KR | 1 |
| Laumas, KR; Laumas, V; Sarkar, NN | 1 |
| Claessens, EA; Cowell, CA | 1 |
| Kasid, A; Laumas, KR | 2 |
| Møller, SE | 1 |
| Brandt, M; Hofmann, KD; Sommer, J | 1 |
| Schindler, C; Schober, J | 1 |
| Datta, PK; Saha, S; Samaddar, S; Sengupta, D | 1 |
| Maiti, BR; Sahu, A | 1 |
| Pal, I; Pal, MN | 1 |
| Saito, K; Tsubo, I; Yabumoto, N; Yasuzumi, G | 1 |
| Fotherby, K; Khan, FS | 1 |
| Mück, AO; Rabe, T; Runnebaum, B; Salbach, B; von Holst, T | 1 |
| Barbosa-Coutinho, LM; Dahlem, N; Orsi, V; Poy, M; Silva, IS; Spritzer, PM | 1 |
| Hagman, E; Kiilholma, P; Kivinen, S; Korhonen, M; Tuimala, R | 1 |
| Taskinen, MR | 1 |
| Bard, JM; Djøseland, O; Fruchart, JC; Gørbitz, C; Ose, L; Tonstad, S | 1 |
| Paskowitz, RA | 1 |
| Beyer, GP; Oosterbaan, HP; Schram, JH; Ubachs, JM; van Buuren, AH; van Kempen, PJ; van Leusden, HA | 1 |
| Klehr-Bathmann, I; Kuhl, H | 1 |
| Sitruk-Ware, R | 1 |
| Berg, G; Hammar, M; Lindgren, R; Risberg, B | 1 |
| Kauppila, AJ; Laatikainen, TJ; Paakkari, IA; Raudaskoski, TH; Tomás, EI | 1 |
| Ballagh, SA; Eggena, P; Jackanicz, TM; Lacarra, M; Mishell, DR; Shoupe, D | 1 |
| Ballagh, SA; Eggena, P; Jackanicz, TM; Lacarra, M; Mishell, DR | 1 |
| Dubey, RK; Imthurn, B; Jackson, EK; Keller, PJ; Rosselli, M | 1 |
| Christiansen, C; Marslew, U; Munk-Nielsen, N; Nilas, L; Riis, BJ | 1 |
| Asch, RH; Balmaceda, JP; Ciuffardi, I; Frederick, JL; Gonzalez, P; Maloul, S | 1 |
| Frenkel, Y; Kopernik, G; Lazer, S; Oettinger, M; Serr, DM; Tendler, R; Tugendreich, D; Zmira, N | 1 |
| Biglia, N; Campagnoli, C; Lanza, MG; Lesca, L; Peris, C; Sismondi, P | 1 |
| Barbuto, DA; Judd, HL; Karlan, BY; Lagasse, LD; Leuchter, RS; McGonigle, KF | 1 |
| Higashi, S; Ishida, N; Kato, H; Mizumoto, R; Tanaka, M; Tanigawa, K; Tomida, T; Uehara, S; Yamagiwa, K | 1 |
| Edwards, D; Meinertz, H; Munk-Jensen, N; Nielsen, SP; Obel, EB; Ulrich, LG | 1 |
| Rachev, E | 1 |
| Crook, D; Ellerington, MC; Marsh, MS; Stevenson, JC; Whitcroft, SI; Whitehead, MI | 1 |
| Doğan, P; Köse, K; Ozesmi, C | 2 |
| Gard, PR; Hanlon, GW; Malhi, JS | 1 |
| Bhargava, AS; Freihube, G; Günzel, P; Kuhnz, W; Lehmann, R | 1 |
| Bärenholdt, O; Hermansen, F; Munk-Jensen, N; Pors Nielsen, S | 1 |
| Ellerington, MC; Hillard, TC; Lees, B; Stevenson, JC; Whitcroft, SI; Whitehead, MI | 1 |
| Riggs, BL | 1 |
| Barbosa-Coutinho, LM; Coronel, AX; Dahlem, N; Moraes, JT; Oliveira, MC; Poy, M; Spritzer, P | 1 |
| Schoenemann, J | 1 |
| Boyd, ME; Colgan, TJ; Ferenczy, A; Fugere, P; Lorrain, J; Ross, AH | 1 |
| Bennett, P; Gydesen, H; Henrik-Nielsen, R; Jensen, BM; Micic, S; Munk-Jensen, N; Nielsen, SP; Obel, EB; Svenstrup, B | 1 |
| Fraser, D; Pryse-Davies, J; Schenkel, L; Whitehead, M | 1 |
| Bailey, MC; Bain, SD; Celino, DL; Edwards, MW; Jensen, E; Lantry, MM | 1 |
| Bakos, T; Lökös, M; Vincze, I; Volford, J | 1 |
| Crook, D; Godsland, IF; Lees, B; Stevenson, JC; Whitehead, MI | 1 |
| Pohlenz, J; Schönberger, W; Wemme, H | 1 |
| Eiken, P; Kolthoff, N | 1 |
| Hansson, L; Jern, S; Manhem, K; Milsom, I; Pilhall, M | 1 |
| Andreassen, TT; Eschen, C | 1 |
| Ditkoff, EC; Sauer, MV | 1 |
| Eriksson, K; Naessén, T; Rune, C; Wide, L | 1 |
| Christensen, A; Damber, MG; Hirvonen, E; Milsom, I; Saure, A | 1 |
| Dal Magro, L; Dal Pozzo, M; Ferroni, E; Maggino, T; Marchesoni, D; Mozzanega, B; Paternoster, DM; Romagnolo, C | 1 |
| Bjäörn, M; Ehnholm, C; Kääriänen, J; Lahdenperä, S; Luotola, H; Puolakka, J; Pyörälä, T; Taskinen, MR | 1 |
| Dören, M; Schneider, HP | 1 |
| Edmonds, DK | 1 |
| Godbillon, J; Pommier, F; Sioufi, A | 1 |
| Imthurn, B; Keller, PJ; Macas, E; Rosselli, M | 1 |
| Brailly, S; Chanson, P; Couzinet, B; Schaison, G; Thomas, JL; Young, J | 1 |
| Kasspohl-Butz, S; Lippert, TH; Mueck, AO; Seeger, H; Teichmann, AT | 2 |
| Orpana, A; Puolakka, J; Pyörälä, T; Viinikka, L; Ylikorkala, O | 1 |
| Adler, M; Cremer, M; Gay, F; Schmit, A; Van Gossum, A | 1 |
| Ditkoff, EC; Lindheim, S; Prosser, R; Sauer, MV; Zimmermann, RC | 1 |
| Kahri, J; Lahdenperä, S; Lappi, M; Luotola, H; Puolakka, J; Pyörälä, T; Taskinen, MR; Tilly-Kiesi, M | 1 |
| Slaveĭkov, S; Tanchev, S | 1 |
| Amadori, A; Ceccarelli, C; D'Anna, R; Jasonni, VM; Leonardi, J; Naldi, S; Possati, G; Santini, D | 1 |
| Arrenbrecht, S; Rozenberg, S; Ylikorkala, O | 1 |
| Arrenbrecht, S; Holinka, CF; Johannisson, E | 1 |
| Fraser, IS; Jackanicz, T; Lacarra, M; Mishell, DR; Weisberg, E | 1 |
| Heuner, A; Hümpel, M; Kuhnz, W; Michaelis, K; Seifert, W | 1 |
| Demacker, PD; Knapen, MF; Mulder, TP; Peters, WH; Roes, EM; Steegers, EA; van der Mooren, MJ | 1 |
| Lübbert, H; Nauert, C | 1 |
| Marik, JJ | 1 |
| Cacciatore, B; Paakkari, I; Tikkanen, MJ; Toivonen, J; Viinikka, L; Ylikorkala, O | 1 |
| Surrey, ES | 1 |
| Alexandersen, P; Christiansen, C; Haarbo, J; Lawaetz, H; Sandholdt, I; Shalmi, M | 1 |
| Stadberg, E | 1 |
| Felix, JC; Moyer, DL | 1 |
| Laird, SM; Lee, S; Li, TC; Okon, MA | 1 |
| Cacciatore, B; Paakkari, I; Tikkanen, MJ; Toivonen, J; Ylikorkala, O | 1 |
| Lippert, TH; Mueck, AO; Seeger, H | 1 |
| Bakos, O; Darj, E; Naessen, T; Persson, I | 1 |
| Armbruster, FP; Lippert, TH; Mueck, AO; Seeger, H | 1 |
| Bender, R; Berger, M; Heinemann, L; Heise, T; Hirschberger, S; Kimmerle, R; Weyer, C | 1 |
| Hampton, AL; Nie, G; Salamonsen, LA | 1 |
| Bajo, J; Folgueira, G; Haya, J; Ortega, P; Pérez-Medina, T | 1 |
| Gruber, DM; Huber, JC; Kurz, C; Sator, MO; Wagner, G | 1 |
| Godwin, A; Lippman, J; Massaro, J; Siu, C; Sulak, P | 1 |
| Bohnet, HG; Gredmark, T; Hornig, F; Hüls, G; Mattsson, LA; Torhorst, J | 1 |
| Cubrilo-Turek, M; Duraković, Z; Kusec, V; Stavljenić-Rukavina, A; Turek, S | 1 |
| Eriksen, EF; Kassem, M; Langdahl, B; Rungby, J; Vesterby, A | 1 |
| Hermann, AP; Mosekilde, L; Orskov, H; Vestergaard, P | 1 |
| Benraad, TJ; Merkus, JM; Sweep, CG; Swinkels, LM; van der Mooren, MJ; van Hoof, HJ | 1 |
| Arce, JC; Archer, DF; Dorin, MH; Heine, W; Nanavati, N | 1 |
| Alexandersen, P; Christiansen, C; Riis, BJ | 1 |
| Cooper, A; Crook, D; Ross, D; Spencer, C; Stevenson, J; Whitehead, M | 1 |
| Darney, P; Fraser, IS; Jackanicz, TM; Lacarra, M; Mishell, DR; Weisberg, E | 1 |
| Alvarez, F; Brache, V; Fraser, IS; Lacarra, M; Mishell, DR; Nash, HA; Weisberg, E | 1 |
| Archer, DF; Dain, MP; Furst, K; Tipping, D; Vandepol, C | 1 |
| Bjarnason, K; Cerin, A; Lindgren, R; Weber, T | 1 |
| Bilodeau, M; Fenyves, D; Marleau, D; Parent, R; Pomier-Layrargues, G; Tran, A; Villeneuve, JP; Willems, B | 1 |
| Aedo, AR; Cekan, SZ; Landgren, BM; Mattsson, LA; Stadberg, E; Westlund, P | 1 |
| Belch, JJ; Kennedy, G; McLaren, M; Seed, M | 1 |
| Ursic-Vrscaj, M | 1 |
| Agrawal, R; Conway, GS; Ginsburg, J; Jacobs, HS; Payne, NN; Prelevic, G | 1 |
| Mikkola, T; Viinikka, L; Ylikorkala, O | 1 |
| Cassel, D; Dain, MP; Furst, KW; Hille, D; Notelovitz, M; Skarinsky, D; VandePol, C | 1 |
| Benhamou, Y; Cacoub, P; Godeau, P; Piette, JC; Sbaï, A | 1 |
| Ballagh, SA; Bradshaw, KD; Nichols, M; Stanczyk, FZ; Thorneycroft, IH; Weber, ME | 1 |
| Ciszkowa, V; Czekaj, P; Nowaczyk-Dura, G | 1 |
| Lippert, TH; Mueck, AO; Seeger, H; Teichmann, AT | 1 |
| Kotsopoulos, D; Liang, YL; Malan, E; McGrath, BP; Peverill, RE; Smolich, JJ; Teede, HJ | 1 |
| Collins, PB; Johnson, A; Owens, D; Tomkin, GH | 1 |
| Brun, JF; El Bouhmadi, A; Laffargue, F; Raspal, N | 1 |
| Caubel, P; Lim, P; Ylikorkala, O | 1 |
| Cooper, AJ; Godsland, IF; Ross, D; Spencer, CP; Stevenson, JC; Whitehead, MI | 1 |
| Arth, C; Boddé, HE; Junginger, HE; Neelissen, JA; Schrijvers, AH; Wolff, M | 1 |
| Gonzalo-Lumbreras, R; Izquierdo-Hornillos, R | 1 |
| Altkemper, R; Coelingh Bennink, HJ; Helmond, FA; Kwee, B; Winkler, UH | 1 |
| Kempfert, N; Speroff, L; Symons, J | 1 |
| Arce, J; Archer, DF; Félix, JC; Kurman, RJ; Moyer, DL; Nanavati, N | 1 |
| Coelingh Bennink, HJ; Dören, M; Holzgreve, W; Rübig, A | 2 |
| Agardh, CD; Li, C; Lidfelt, J; Nerbrand, C; Samsioe, G; Schersten, B; Wilaman, K | 1 |
| Farquharson, RG; Gazvani, MR; Pierce, SJ | 1 |
| Fábián, G; Kovács, T; Nagy, J; Szigeti, N | 1 |
| Arce, JC; Cyrowski, MS; Davidson, MH; Maki, AC; Maki, KC; Marx, P; Nanavati, N | 1 |
| Betkowska-Korpała, B; Czarnecka, D; Jankowski, P; Kawecka-Jaszcz, K; Klocek, M; Olszanecka, A | 1 |
| Anderson, MC; Barlow, DH; Bragg, AJ; Campbell, MJ; Nielsen, B; Sturdee, DW; Ulrich, LG; Vessey, MP; Wells, M | 1 |
| Eviö, S; Tiitinen, A; Turpeinen, U; Ylikorkala, O | 1 |
| Bäckström, T; Bixo, M; Björn, I; Nöjd, KS; Nyberg, S | 1 |
| Bajart, L; Berthezène, F; Boissel, JP; Bully, C; Cornu, C; Cousin, P; Darsy, P; Ffrench, P; Mercier, C; Orgiazzi, J; Pommet-Nicot, C; Pugeat, M; Riou, JP | 1 |
| Elomaa, K; Lähteenmäki, P; Ranta, S; Tuominen, J | 1 |
| Guest, JF; Plumb, JM | 1 |
| Alexandersen, P; Christiansen, C; Delmas, PD; Riis, BJ; Stakkestad, JA | 1 |
| Fritz-Hansen, T; Højgaard, L; Jensen, HH; Ottesen, B; Pedersen, AT; Sørensen, MB | 1 |
| Degenkolb, J; Larsen, S; Müller, M; Pabst, G; Zdravkovic, M | 1 |
| Koch, P | 1 |
| Mueck, AO; Seeger, H; Wallwiener, D | 2 |
| Puolakka, J; Saltevo, J; Ylikorkala, O | 1 |
| Caubel, P; Lim, PC; Rozenberg, S | 1 |
| Boyd, RA; Flack, MR; Posvar, EL; Zegarac, EA | 1 |
| Bäckström, T; Jonsson, B; Odmark, IS | 1 |
| Andersen, TO; Høibraaten, E; Mowinckel, MC; Qvigstad, E; Sandset, PM | 1 |
| Bäckström, T; Nyberg, S; Sundström-Poromaa, I; Wihlbäck, AC | 1 |
| Cacciatore, B; Karonen, SL; Koistinen, HA; Laivuori, H; Ylikorkala, O | 1 |
| Haines, CJ; Jorgensen, LN; Sanderson, JE; Tang, K; Woo, J; Yeung, L; Yim, SF; Yip, GW | 1 |
| Herman, JR; Maier, WE | 1 |
| Bilgen, I; Bilgin, O; Coşan Terek, M; Memiş, A; Ozşener, S; Oztekin, K; Sendağ, F | 1 |
| Meczekalski, B; Słopień, R; Warenik-Szymankiewicz, A | 1 |
| Bernard-Poenaru, O; Blanqué, R; Cohen-Solal, ME; de Vemejoul, MC; Gardner, C; Roux, C | 1 |
| Bertina, RM; de Ronde, H; Høibraaten, E; Mowinckel, MC; Sandset, PM | 1 |
| Harwood, B; Mishell, DR | 1 |
| Haines, CJ; Sanderson, JE; Yim, SF | 1 |
| Bruhat, M; Kainulainen, P; Rudolf, K; Timonen, U; Vaheri, R; Viitanen, A | 1 |
| Gräser, T; Lippert, TH; Mueck, AO; Oettel, M; Seeger, H | 1 |
| Bilgin, O; Karadadaş, N; Sendağ, F; Terek, MC | 1 |
| Arndt, T; Bonnar, J; Creatsas, G; Depypere, H; Erenus, M; Nickelsen, T; Quail, D; Rechberger, T | 1 |
| al-Azzawi, F; Dillon, J; Hirvonen, E; Magaril, C; Pornel, B; Thompson, J; van der Mooren, MJ; Wahab, M; Ylikorkala, O | 1 |
| Chakravarthi, P; Fall, PM; Hansen, A; Onobrakpeya, OA; Raisz, LG; Willard, A | 1 |
| Basta, A; Bogdanowicz, M; Peszek, W; Sempka, A; Szczudrawa, A | 1 |
| Chen, LH; Jorgensen, LN; Loh, FH; Yu, SL | 1 |
| Clipper, S; Colson, C; Ekhato, IV; Guo, L; Huang, Y; Hurley, T; Lovdahl, M; Revitte, TJ | 1 |
| Arnesen, H; Guzic-Salobir, B; Keber, I; Seljeflot, I; Vrabic, L | 1 |
| Arce, JC; Baerug, U; Faber-Swensson, E; Heldaas, K; Larsen, S; Nordland, G; Norling, B; Winge, T | 1 |
| Chondros, C; Christodoulakos, G; Creatsas, G; Dendrinos, S; Kouskouni, E; Panoulis, C | 1 |
| Alexandersen, P; Bjarnason, NH; Christiansen, C | 1 |
| Azavedo, E; Barkfeldt, J; Christow, A; Kersemaekers, W; Lundström, E; Mol-Arts, M; Söderqvist, G; Svane, G; von Schoultz, B | 1 |
| Hornstein, MD; Surrey, ES | 1 |
| Bilgin, O; Karadadas, N; Ozsener, S; Sendag, F | 1 |
| Andersen, LF; Gram, J; Jespersen, J; Petersen, KR; Sidelmann, J; Skouby, SO | 1 |
| Cohen, SB; Lidor, AL; Lipitz, S; Mashiach, S; Novikov, I; Rabinovici, J; Seidman, DS | 1 |
| Botsis, D; Christodoulacos, G; Creatsas, G; Kassanos, D; Panoulis, C; Rizos, D | 1 |
| Campagnoli, C; Colombo, P; De Aloysio, D; Gambacciani, M; Genazzani, AR; Grazioli, I; Nappi, C; Serra, GB | 1 |
| Cheng, S; Puolakka, J; Sipilä, S; Suominen, H; Taaffe, DR | 1 |
| Abrahamsen, B; Bladbjerg, EM; Jespersen, J; Klitgaard, NA; Kristensen, SR; Madsen, JS; Stilgren, L | 1 |
| Barlow, DH; Bragg, AJ; Campbell, MJ; O'Brien, K; Sturdee, DW; Ulrich, LG; Vessey, MP; Wells, M | 1 |
| Karakus, C; Simsek, T; Trak, B | 1 |
| Bicknell, R; MacKenzie, IZ; Oehler, MK; Rees, MC; Wallwiener, D | 1 |
| Arrenbrecht, S; Oksanen, H; Ranta, V; Ylikorkala, O | 1 |
| Altekin, E; Altunyurt, S; Islekel, H; Onvural, A; Onvural, B; Posaci, C; Saygili, U | 1 |
| Honjo, H; Hosoda, T; Kitawaki, J; Tanaka, K; Tatsumi, H | 1 |
| Gücer, F; Kaplan, PB; Sayin, NC; Yardim, T; Yüce, MA | 1 |
| Georgiev, DB; Goudev, A; Koycheva, N; Kyurkchiev, S; Manasiev, N | 1 |
| Benhamou, CL; Garnero, P; Jamin, C; Pelissier, C; Roux, C | 1 |
| Jamin, C; Madelenat, P; Poncelet, C | 1 |
| Altavilla, D; Cincotta, M; Corrado, F; Crisafulli, A; D'Anna, R; Frisina, N; Gaudio, A; Ientile, R; Lasco, A; Morabito, N; Pizzoleo, MA; Squadrito, F; Vergara, C | 1 |
| Abrahamsen, B; Beck-Nielsen, H; Bonnevie-Nielsen, V; Rettmer, E; Stilgren, LS | 1 |
| Bonnar, J; Joyce, M; Norris, LA; O'Keeffe, N; Sheppard, BL | 1 |
| Christiansen, C; Lehmann, HJ; Riis, BJ | 1 |
| Falkeborn, M; Lithell, H; Naessén, T; Persson, I; Vessby, B | 1 |
| Kretschmar, S; Rakov, V; Von Holst, T | 1 |
| Skarda, J | 2 |
| Andersen, LF; Bladbjerg, EM; Jespersen, J; Skouby, SO | 1 |
| Keil, D; Lang, E; von Holst, T; Winkler, U | 1 |
| Keber, I; Salobir, BG; Vrabic, L | 1 |
| Russo, P; Trimarchi, CP | 1 |
| Liu, JH; Shumel, BS; Simon, JA; Speroff, L; Symons, JP | 1 |
| Benussi, C; Bevilacqua, G; Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR; Monteleone, P | 1 |
| Kempfert, NJ; Portman, DJ; Symons, JP; Wilborn, W | 1 |
| Aberg, A; Bendahl, PO; Borgfeldt, C; Li, C; Samsioe, G; Wilawan, K | 1 |
| Celik, S; Dagdeviren, B; Eren, M; Gorgulu, S; Suer, N; Tezel, T; Uslu, N | 1 |
| Berry, K; Burger, HG; Davis, SR; Goldstat, R; Koch, K; Meredith, I; Newman, A | 1 |
| Altavilla, D; Corrado, F; Crisafulli, A; Cucinotta, D; D'Anna, R; Frisina, N; Morabito, N; Ruggeri, P; Saitta, A; Squadrito, F; Squadrito, G | 1 |
| Anthony, MS; Cline, JM; Fox, JL; Suparto, IH; Williams, JK | 1 |
| Lynge, E; Ottesen, B; Pederson, AT; Stahlberg, C | 1 |
| Alpaslan, M; Fenkci, S; Fenkci, V; Onrat, E; Yilmazer, M | 1 |
| Arabi, A; Benhamou, CL; Garnero, P; Pelissier, C; Porcher, R; Roux, C | 1 |
| Ambroggio, S; Biglia, N; Dato, FA; Ponzone, R; Sgro, L; Sismondi, P; Ujcic, E | 1 |
| Bladbjerg, EM; Christensen, K; Gram, J; Henriksen, FL; Jespersen, J; Kristensen, SR; Madsen, JS | 1 |
| Boubli, L; Carpentier-Meunier, S; Charpin, C; Dales, JP; Garcia, S; Illouz, S; Lavaut, MN; Sferlazzo, K | 1 |
| Eviö, S; Tiitinen, A; Välimäki, M; Ylikorkala, O | 1 |
| FOSS, GL | 1 |
| PEREZ-MERA, RA; SHIELDS, CE | 1 |
| BETZ, G; WARREN, JC | 1 |
| FINE, E; LEVIN, HM; MCCONNELL, EL | 1 |
| CURWEN, S | 1 |
| BRADFORD, I; GENERINI, G; GOMEZ, RE | 1 |
| BRISCOE, CC | 1 |
| CARDOSO, T; GERARD, G; RODRIGUEZ, R; VIGNOLO-PUGLIA, WH | 1 |
| GERARD, G; POLETTI, H; VIGNOLO, WH | 1 |
| RIZKALLAH, T; TAYMOR, ML | 1 |
| ARANDA ROSELL, A; FERRER, S; GONZALEZ, O; MAQUEO, M; MUNGUIA, H; RICE WRAY, E | 1 |
| ARGUELLES, AE; SALABER, JB | 1 |
| Calaf, J; Cano, A; Molina, J | 1 |
| Aban, M; Atiş, S; Camdeviren, H; Kiliç, F; Pata, C; Pata, O; Tok, E; Utku Oz, A; Yazici, G | 1 |
| Alatas, E; Demir, S; Kaleli, B; Yildirim, B | 1 |
| Aktepe, O; Altindis, M; Fenkci, S; Fenkci, V; Kurtay, G; Sonmezer, M; Yilmazer, M | 1 |
| Atabekoglu, C; Cengiz, B; Cengiz, SD; Cetinkaya, E | 1 |
| Franke, HR; Vermes, I | 1 |
| Dhindsa, P; Forsyth, J; Mansell, P; Scott, AR | 1 |
| Adamo, EB; Altavilla, D; Bartolone, S; Bitto, A; Corrado, F; Crisafulli, A; D'Anna, R; Frisina, N; Inferrera, MA; Marini, H; Marini, R; Romeo, A; Squadrito, F; Squadrito, G | 1 |
| Ailawadi, RK; Bulun, SE; Gurates, B; Jobanputra, S; Kataria, M | 1 |
| Antoniadis, S; Iatrakis, G; Kourounis, G; Tsionis, C | 1 |
| Guilford, S; Manassiev, N; Oladipo, A; Proudler, AJ; Stevenson, JC; Whitehead, MI | 1 |
| Fink, L; Kreuter, J; Latsch, S; Selzer, T | 1 |
| Fink, L; Horstmann, M; Kreuter, J; Latsch, S; Selzer, T | 1 |
| Aguas, F; Beck, H; Bosio-LeGoux, B; De Geyter, C; Glant, MD; Hottgenroth, A; Lévrier, M; Neven, P; Nickelsen, T; Quail, D; Schmitt, H; Thé, HS | 1 |
| Bäckström, T; Bixo, M; Haeger, M; Jonsson, B; Odmark, IS | 1 |
| Azavedo, E; Carlström, K; Conner, P; Gräser, T; Söderqvist, G; Svane, G; von Schoultz, B; Walter, F | 1 |
| Dalsgaard, T; Lund, CO; Nilas, L; Ottesen, B; Pedersen, NG; Pedersen, SH | 2 |
| Engelstein, M; Kuhl, H; Mäenpää, J; Mattila, L; Mustonen, M; Rees, MC | 1 |
| Carlström, K; Christow, A; Conner, P; Kersemaekers, W; Mol-Arts, M; Skoog, L; Söderqvist, G; Tani, E; von Schoultz, B | 1 |
| Heikkinen, J; Mäenpää, J; Mattsson, LA; Skouby, SO; Timonen, U; Vaheri, R | 1 |
| Borgfeldt, C; Li, C; Samsioe, G | 1 |
| Bäckström, T; Bixo, M; Jonsson, B; Odmark, IS | 2 |
| Alessandrini, C; Arangino, S; Baldassari, F; Cagnacci, A; Landi, S; Volpe, A | 1 |
| Costa-Paiva, L; Lazar, F; Martinez, EZ; Pinto-Neto, AM | 1 |
| Fritz-Hansen, T; Jensen, HH; Ottesen, B; Pedersen, AT; Sørensen, MB | 1 |
| Bäckström, T; Dahmoun, M; Karlsson, MG; Odmark, IS; Pavlenko, T; Risberg, B | 1 |
| Athayde, C; Coutinho, EM; Maia, H; Maltez, A; Studard, E | 1 |
| Junkermann, H; Lang, E; Rakov, V; von Holst, T | 1 |
| Al-Azzawi, F; Proudler, AJ; Sami, S; Stevenson, J; Thompson, J; Wahab, M | 1 |
| Adaro, L; Albrecht, G; Baracat, EC; Bassol, S; Bayo, J; Blanco, S; Boccanera, R; Camargos, AF; Carranza-Lira, S; Celis-Gonzalez, C; da Fonseca, AM; da Sá, MF; de la Loza, FR; Gomez, G; Gurucharri, C; Llaca, V; Martinez, N; Murga, M; Murillo, A; Naranjo, C; Reyes-Marquez, R; Rios, PC; Sanchez, F; Santos, J; Santoyo, S; Sayegh, F; Siseles, N; Tempone, A; Tempone, LM; Tozzini, RI; Zarain, J | 1 |
| Adler, G; Galant, R; Maki, KC; Quinn, L; Witchger, MS; Young, D | 1 |
| Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V | 1 |
| Brynhildsen, J; Hammar, M | 1 |
| Liu, MC; Suiko, M; Yasuda, S | 1 |
| Azavedo, E; Carlström, K; Hofling, M; Kloosterboer, H; Svane, G; Von Schoultz, B | 1 |
| Baviera, G; Cancellieri, F; Corrado, F; Crisafulli, A; D'Anna, R; Squadrito, F | 1 |
| Shirk, RA; Winneker, RC; Zhang, Z | 1 |
| Drosdzol, A; Kowalczyk, R; Nowosielski, K; Piela, B; Rozmus-Warcholińska, W; Skrzypulec, V; Walaszek, A | 1 |
| Cline, JM; Cosman, F; Gardner, TR; Lindsay, R; Mikhail, MS; Preiss-Bloom, AO; Scotti, RJ; Vardy, MD; Williams, JK | 1 |
| Griva, BL; Luca, LA; Morceli, J; Moriguchi, SM; Nahas, EA; Nahas-Neto, J; Traiman, P; Uemura, G | 1 |
| Gursel, T; Gursoy, R; Himmetoglu, O; Karabulut, E; Onan, MA; Ozpolat, E; Taner, MZ; Taskiran, C | 1 |
| Fox, JL; Koudy Williams, J; Suparto, IH; Vinten-Johansen, J | 1 |
| Bernardi, F; Casarosa, E; Gabbanini, M; Genazzani, AD; Genazzani, AR; Luisi, M; Palumbo, M; Picciarelli, G; Pieri, M; Pluchino, N | 1 |
| Franke, HR; Smit, WM; Vermes, I | 1 |
| Bozkaya, H; Okumuş, B; Osmanağaoğlu, MA; Osmanağaoğlu, S; Osmanağaoğlu, T | 1 |
| Hapgood, JP; Koubovec, D; Louw, A; Ronacher, K; Stubsrud, E | 1 |
| Andersson, B; Glassell, M; Mattsson, LA; Thunell, L | 1 |
| Botsis, D; Christodoulakos, GE; Creatsa, M; Lambrinoudaki, IV; Panoulis, KP; Vlachou, S; Vourtsi, AD | 1 |
| Chiodini, A; Crosignani, PG; De Giorgi, O; Pasin, R; Pietropaolo, G; Vercellini, P | 1 |
| Gambacciani, M; Genazzani, AR; Spielmann, D | 1 |
| Pornel, B; Spielmann, D | 1 |
| Koninckx, PR; Spielmann, D | 1 |
| Eren, S; Pekin, O; Tugrul, S; Uslu, H; Yildirim, G | 1 |
| Erguder, I; Kurtay, G; Ozmen, B | 1 |
| Bouchard, P; De Cicco-Nardone, F; Garcea, N; Spielmann, D | 1 |
| Birkhaeuser, MH; Bodmer, C; Fuchs, G; Kraenzlin, ME; Lippuner, K; Popp, AW; Senn, C; Wyss, H | 1 |
| Honkanen, R; Kröger, H; Pentti, K; Saarikoski, S; Sandini, L; Tuppurainen, MT | 1 |
| Franke, HR; Vermes, I; Werner, HM | 1 |
| Ceylan, E; Inan, S; Koyuncu, FM; Kuscu, NK; Ozbilgin, K; Vatansever, S | 1 |
| Eviö, S; Furuholm, J; Meurman, JH; Sorsa, T; Tarkkila, L; Tiitinen, A; Välimäki, MJ; Ylikorkala, O | 1 |
| Bacchi Modena, A; Baldini, M; Benassi, L; Dei Cas, A; Luciana Barilli, A; Manotti, C; Rinaldi, M; Sgarabotto, M | 1 |
| Bergstrøm, H; Tonstad, S | 1 |
| Andersen, TO; Eilertsen, AL; Qvigstad, E; Sandset, PM; Sandvik, L | 1 |
| Arangino, S; Cagnacci, A; Cannoletta, M; Pirillo, D; Renzi, A; Volpe, A | 1 |
| Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Vitoratos, N; Vlachou, SA | 1 |
| Ellman, H; Rowan, JP; Simon, JA; Speroff, L | 1 |
| Başak, O; Demircan, S; Karul, A; Kizilkaya, K; Köseoğlu, K; Kozaci, LD; Odabaşi, AR; Yüksel, H | 1 |
| Boone, RH; Cheung, AM; Girlan, LM; Heathcote, EJ | 1 |
| Collins, P; Flather, M; Lees, B; Mister, R; Proudler, AJ; Stevenson, JC | 1 |
| Love, T; Nichols, TE; Persad, CC; Smith, YR; Tkaczyk, A; Zubieta, JK | 1 |
| Eren, S; Kutlu, T; Pekin, O; Tugrul, S; Uslu, H; Yildirim, G | 1 |
| Arguinzoniz, M; Boschitsch, E; Concin, H; De Geyter, C; Ehrenborg, A; Heikkinen, J; Hobson, R; Ibarra de Palacios, P; Samsioe, G; Scheurer, C; Schmidt, G | 1 |
| Hemelaar, M; Kenemans, P; Teerlink, T; van der Mooren, MJ; Verhoeven, MO | 1 |
| Aldrighi, JM; Alecrin, IN; Arruda, CG; Bortolotto, LA; Ramires, JA | 1 |
| Andersen, TO; Eilertsen, AL; Mowinckel, MC; Qvigstad, E; Sandset, PM; Sandvik, L | 1 |
| Archer, DF; Ellman, H; Nakajima, ST | 1 |
| Abdallah, MA; Abdullah, HI; Gercel-Taylor, C; Kang, S; Nakajima, ST; Taylor, DD | 1 |
| Bagnoli, VR; Cavalcanti, AL; Fonseca, AM; Paixão, JS; Penteado, SR; Pinotti, JA | 1 |
| Abbamonte, HL; Ferrero, S; Fulcheri, E; Ragni, N; Remorgida, V | 1 |
| Chu, MC; Gentzschein, E; Lobo, RA; Stanczyk, FZ; Zhang, X | 1 |
| Schaudig, K; Thomssen, C | 1 |
| Brosnan, JF; Norris, LA; Sheppard, BL | 1 |
| Godoy-Tundidor, S; Ho, SM; Mukherjee, K; Syed, V | 1 |
| Archer, DF; Gut, R; Lang, E; Panay, N; Ylikorkala, O | 1 |
| Azavedo, E; Hirschberg, AL; Hofling, M; Lundström, E; Svane, G; von Schoultz, B | 1 |
| Azavedo, E; Bygdeson, M; Lundström, E; Svane, G; von Schoultz, B | 1 |
| Karul, A; Kozaci, D; Odabasi, AR; Onur, E; Sezer, SD; Yuksel, H | 1 |
| Blumenthal, JA; Bower, JK; Hinderliter, AL; McFetridge-Durdle, J; Newby, LK; Sherwood, A | 1 |
| Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM | 1 |
| Alexandrou, AP; Bastounis, E; Bramis, J; Christodoulakos, GE; Creatsas, GC; Dalamanga, A; Keramaris, NC; Lambrinoudaki, IV | 1 |
| Divasta, AD; Gordon, CM; Laufer, MR | 1 |
| Bonassi Machado, R; Chada Baracat, E; Eduardo Fernandes, C; Marcelo Lakryc, E; Rodrigues De Lima, G | 1 |
| Franke, HR; Hammar, ML; Nijland, EA; Pornel, B; van de Weijer, P; von Mauw, EM | 1 |
| Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR; Pepe, A; Vacca, F | 1 |
| Alexandrou, AP; Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Vlachou, SA | 1 |
| Archer, DF; Lang, E; Rakov, V; Sturdee, DW | 1 |
| Davis, SR; Helmond, FA; Mulder, RJ; Nathorst-Boös, J; Nijland, EA; Norman, RJ; Palacios, S; Van Lunsen, RH; Weijmar Schultz, WC | 1 |
| Eilertsen, AL; Karssemeijer, N; Qvigstad, E; Sandset, PM; Skaane, P | 1 |
| Casey, CL; Murray, CA | 1 |
| Johansen, OE; Qvigstad, E | 1 |
| Baskan, B; Demir, B; Haberal, A; Kandemir, O; Karabulut, E; Ozturkoglu, E; Solaroglu, A | 1 |
| Menon, S; Phillips, TJ; Symons, J | 1 |
| Love, T; Persad, CC; Smith, YR; Tkaczyk, A; Wang, H; Zubieta, JK | 1 |
| Bruce, D; Frick, A; Robinson, J; Rymer, J; Ylikorkala, O | 1 |
| Angelova, M; Monastirska, M; Tsvetkov, K | 1 |
| Birkhaeuser, MH; Davis, S; Mulder, RJ; Nathorst-Böös, J; Nijland, EA; Palacios, S; Schultz, WC; Stathopoulos, VM; van de Weijer, PW; von Mauw, E | 1 |
| Mishell, DR; Rible, RD; Stanczyk, FZ; Taylor, D; Wilson, ML | 1 |
| Love, T; Persad, CC; Smith, YR; Tkaczyk, A; Zubieta, JK | 1 |
| Altug, T; Aydin, S; Balci, H; Cakatay, U; Coban, I; Karakus, M; Topçuoglu, A; Topçuoglu, D; Uzun, H | 1 |
| Nielsen, LB; Nilas, L; Ottesen, B; Pedersen, NG; Pedersen, SH | 1 |
| Aravantinos, L; Augoulea, A; Christodoulakos, G; Creatsas, G; Kaparos, G; Lambrinoudaki, I; Panoulis, C; Vourtsi, A | 1 |
| Bjørndal, H; Ma, H; Stuedal, A; Ursin, G | 1 |
| Fournier, A; Weiderpass, E | 1 |
| Carlsten, H; d'Elia, HF; Pullerits, R; Tarkowski, A | 1 |
| Barnowski, CE; Burkman, RT; Fisher, AC; LaGuardia, KD; Wan, GJ | 1 |
| Endrikat, J; Fortier, M; Kunz, M; Lukkari-Lax, E; Schmidt, W; Shapiro, H | 1 |
| Bingol, B; Biri, A; Gunenc, Z; Güner, H; Tiras, B; Yilmaz, M | 1 |
| Camerini, G; Ferrero, S; Ragni, N; Remorgida, V; Seracchioli, R; Venturini, PL | 1 |
| Biscaldi, E; Camerini, G; Ferrero, S; Ragni, N; Remorgida, V; Venturini, PL | 1 |
| Dyba, T; Lyytinen, H; Pukkala, E; Ylikorkala, O | 1 |
| Dragojević-Dikić, S; Nikolić, B; Popovac, S; Rakić, S | 1 |
| Hruska, J; Samsioe, G | 1 |
| Brook, RA; Chwalisz, K; Fuldeore, MJ; Marx, SE; Smeeding, JE | 1 |
| Eriksson, K; Naessén, T; Wide, L | 1 |
| Azevedo, LH; Cunha, EP; Fernandes, CE; Ferreira, JA; Peixoto, S; Pompei, LM; Steiner, ML; Strufaldi, R | 1 |
| Jespersen, J; Schwarz, H; Sidelmann, JJ; Skouby, SO; Vitzthum, F | 1 |
| Biscaldi, E; Camerini, G; Ferrero, S; Ragni, N; Remorgida, V; Seracchioli, R; Venturini, PL | 1 |
| Alexandrou, A; Christodoulakos, G; Creatsa, M; Grigoriou, O; Kaparos, G; Karaflou, M; Kouskouni, E; Lambrinoudaki, I; Logothetis, E; Panoulis, C | 1 |
| Christodoulakos, G; Creatsa, M; Kaparos, G; Karaflou, M; Lambrinoudaki, I; Rizos, D | 1 |
| Alhava, E; Härmä, K; Honkanen, R; Jurvelin, J; Kiviniemi, V; Komulainen, M; Kröger, H; Saarikoski, S; Tuppurainen, M | 1 |
| Adamo, EB; Altavilla, D; Bitto, A; D'Anna, R; Giordano, D; Granese, R; Maisano, D; Marini, H; Nicotina, PA; Squadrito, F; Triolo, O; Villari, D | 1 |
| Appelbaum, H | 1 |
| Horttanainen, M; Kovanen, V; Pöllänen, E; Puolakka, J; Ronkainen, PH; Sipilä, S; Suominen, H; Takala, T | 1 |
| Ferrero, S; Remorgida, V | 1 |
| Bernstein, P; Pohost, G | 1 |
| Roman, H | 1 |
| Ferrero, S; Gillott, DJ; Remorgida, V; Venturini, PL | 1 |
| Africander, D; Hapgood, JP; Louw, R; Noeth, D; Verhoog, N | 1 |
| De Geyter, C; De Napoli, G; de Weerd, V; Foekens, JA; Kloosterboer, HJ; Martens, JW; Sieuwerts, AM; van Galen, A; Zhang, H | 1 |
| Hirschberg, AL; Lundström, E; Söderqvist, G | 1 |
| Aravantinos, L; Augoulea, A; Creatsa, M; Kyroudi, A; Lambrinoudaki, I; Panoulis, C; Politi, E; Rizos, D; Sergentanis, TN; Sioulas, VD | 1 |
| Berry, KF; Kaser, DJ; Laufer, MR; Missmer, SA | 1 |
| Chwalisz, K; Stanczyk, FZ; Surrey, E | 1 |
| Koskela-Niska, V; Lyytinen, H; Pukkala, E; Riska, A; Ylikorkala, O | 1 |
| Granat, A; Melamed, A; Mishell, DR; Steward, R | 1 |
| Consonni, D; De Giorgi, O; Fedele, L; Frattaruolo, MP; Somigliana, E; Vercellini, P | 1 |
| Brosnan, JF; Kelly, LA; Norris, LA; O'Leary, JJ; Sheppard, BL | 1 |
| Eiken, P; Jensen, JE; Køber, L; Mosekilde, L; Rejnmark, L; Schierbeck, LL; Stilgren, L; Tofteng, CL | 1 |
| Di Luca, M; Ferrero, S; Leone Roberti Maggiore, U; Remorgida, V; Scala, C; Venturini, PL | 1 |
| Cannegieter, SC; Helmerhorst, FM; Lijfering, WM; Roach, RE; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Andrade, AT; Brandão, M; Castro, IQ; Guerra, Mde O; Polisseni, AF; Polisseni, F; Ribeiro, LC | 1 |
| Fels, H; Granat, A; Melamed, A; Mishell, DR; Stanczyk, FZ; Steward, R | 1 |
| Alberico, D; Consonni, D; Fedele, L; Frattaruolo, MP; Jones, GL; Somigliana, E; Vercellini, P | 1 |
| Africander, D; Hapgood, JP; Louw, R | 1 |
| Stanczyk, FZ; Winer, SA | 1 |
| Butler, R; Cheng, G; Gustafsson, JÅ; Landgren, BM; Warner, M; Wilczek, B | 1 |
| Avenant, C; Du Toit, A; Hapgood, JP; Ray, RM; Tomasicchio, M | 1 |
| Adamson, KA; Chisholm, J; Kilbride, L; Mackay, L | 1 |
| Archer, DF; Ellman, H; Gilbert, RD; Koltun, WD; Nakajima, ST; Sawyer, AT; Trupin, S; Wentworth, J | 1 |
| Chen, FP; Chen, HY; Chien, MH; Huang, TS; Ng, YT | 1 |
| Ferrero, S; Leone Roberti Maggiore, U; Remorgida, V; Venturini, PL | 1 |
| Bestel, E; Gotteland, JP; Pohl, O | 1 |
| Barlow, DH; Bestel, E; Bouchard, P; Donnez, J; Donnez, O; Fauser, BC; Loumaye, E; Nouri, K; Osterloh, I; Palacios, S; Tomaszewski, J; Vázquez, F | 1 |
| Bordi, G; Caserta, D; Mallozzi, M; Matteucci, E; Moscarini, M; Ralli, E | 1 |
| Africander, D; Avenant, C; Govender, Y; Grantham, NJ; Hapgood, JP; Ray, RM; Verhoog, NJ | 1 |
| Africander, DJ; Hapgood, JP; Storbeck, KH | 1 |
| Athanasopoulos, N; Creatsas, G; Deligeoroglou, E; Economou, E; Lambrinoudaki, I; Mastorakos, G; Papamichael, C; Rizos, D; Stamatelopoulos, K; Tsimaris, P | 1 |
| Deenen, R; Fischer, JW; Freudenberger, T; Heim, HK; Köhrer, K; Kretschmer, I; Mayer, P; Seiler, LF; Zimmermann, A | 1 |
| Ferrero, S; Leone Roberti Maggiore, U; Scala, C; Venturini, PL | 1 |
| Fan, P; Jordan, VC; Sweeney, EE | 1 |
| Ferrero, S; Morotti, M; Remorgida, V; Sozzi, F; Venturini, PL | 1 |
| Granqvist, CJ; Ipsen, HE; Kokot-Kierepa, M; Mattsson, LÅ | 1 |
| Pertyńska-Marczewska, M; Pertyński, T; Stachowiak, G | 1 |
| Baracat, EC; Fernandes, CE; Lakryc, EM; Machado, RB; Soares, JM | 1 |
| DiVasta, AD; Feldman, HA; Gordon, CM; Hornstein, MD; Laufer, MR; Sadler Gallagher, J; Stokes, NA | 2 |
| Agarwal, SK; Foster, WG | 1 |
| Al-Jefout, M; Nawaiseh, N | 1 |
| Archer, DF; Nakajima, ST; Pappadakis, J | 1 |
| Buyers, EM; Huguelet, PS; Lange-Liss, JH; Scott, SM | 1 |
| Alberico, D; Bracco, B; Dhouha, D; Mosconi, P; Roberto, A; Somigliana, E; Vercellini, P | 1 |
| Abdel-Raouf, SM; Abdeldayem, HM; Arafa, EM; Atwa, K; Girbash, EF; Nooh, AM | 1 |
| Jach, R; Milewicz, T; Piróg, MM; Undas, A | 1 |
| He, J; Li, H; Li, S; Ma, X; Wang, Q; Xu, K; Yang, H | 1 |
| Bergendal, A; Hirschberg, AL; Kieler, H; Kocoska-Maras, L; Sundström, A | 1 |
| Bonafede, M; Castelli-Haley, J; Farr, AM; Soliman, AM; Winkel, C | 1 |
| Brynhildsen, J | 1 |
| Cook, J; Ganderton, C; Pizzari, T; Semciw, A | 1 |
| Acosta, JI; Andrews, MG; Bimonte-Nelson, HA; Braden, BB; Lavery, C; Mennenga, SE | 1 |
| Bersinger, N; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Nirgianakis, K; Papadia, A | 1 |
| Brady, PC; Laufer, MR; Missmer, SA | 1 |
| Casper, RF | 1 |
| Biscaldi, E; Calanni, L; Ferrero, S; Morotti, M; Racca, A; Stabilini, C; Vellone, VG; Venturini, PL | 1 |
| Bersinger, NA; Facchinetti, F; Grandi, G; McKinnon, BD; Mueller, MD | 1 |
| Buggio, L; Frattaruolo, MP; Ottolini, F; Roberto, A; Somigliana, E; Vercellini, P | 2 |
| Barra, F; Ferrero, S; Leone Roberti Maggiore, U; Scala, C; Venturini, PL | 1 |
| Barra, F; Ferrero, S; Scala, C | 1 |
| Heikinheimo, O; Holopainen, E; Huvinen, E | 1 |
| Cockrum, RH; Cohen, KS; Ham, SA; Snow, SG; Soo, J | 1 |
| Syed, YY | 1 |
| Găman, MA; Mei, H; Prabahar, K; Tang, Z | 1 |
| Badalotti, M; Bonassi Machado, R; Costa-Paiva, LD; Cruz, AM; Del Debbio, SYO; Nahas, EAP; Nahas-Neto, J; Pompei, LM; Wender, MCO | 1 |
| Abdeldayem, HM; Girbash, EF; Radwan, AM; Sherif, HE | 1 |
| Compton, SD; Rager, TL; Rosen, MW; Winfrey, OK | 1 |
| Arjona Ferreira, JC; Johnson, B; Lee, TY; Li, Y; Lukes, A; Migoya, E | 1 |
30 review(s) available for norethindrone and norethindrone acetate
| Article | Year |
|---|---|
Norethisterone and norethisterone acetate.
Topics: Animals; Carcinogens; Chemical Phenomena; Chemistry; Dogs; Female; Haplorhini; Humans; Male; Mice; Mutagens; Norethindrone; Norethindrone Acetate; Pregnancy; Rabbits; Rats; Teratogens | 1979 |
The ovary and the immune function: our experience.
Topics: Autoimmune Diseases; Female; Humans; Immune System; Immune Tolerance; Menstruation Disturbances; Norethindrone; Norethindrone Acetate; Ovary; Pregnancy; Primary Ovarian Insufficiency; Progesterone; Progestins; Thyroid Diseases | 1991 |
Long-acting hormonal contraceptives for women.
Topics: Aniline Compounds; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Ovulation | 1991 |
Progestational agents in the treatment of breast cancer.
Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Norethindrone Acetate; Progestins | 1988 |
Absorption and metabolic effects of different types of estrogens and progestogens.
Topics: Absorption; Administration, Oral; Estradiol Congeners; Estrogens; Female; Humans; Intestinal Absorption; Menopause; Norethindrone; Norethindrone Acetate; Progesterone Congeners | 1987 |
The effects of estrogens and progestogens on the endometrium. Modern approach to treatment.
Topics: Drug Administration Schedule; Endometrium; Estrogens; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Uterine Hemorrhage; Uterine Neoplasms | 1987 |
The menopause.
Topics: Adult; Breast Neoplasms; Calcium; Clinical Trials as Topic; Coronary Disease; Estrogens; Female; Gallbladder Diseases; Humans; Lipid Metabolism; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Thromboembolism; Uterine Neoplasms | 1986 |
Post-menopausal bone loss: effects of oestrogens and progestogens. A review.
Topics: Drug Therapy, Combination; Estradiol; Estrogens; Female; Humans; Norethindrone; Norethindrone Acetate; Osteoporosis; Progestins | 1986 |
Long acting injectable hormonal contraceptives.
Topics: Animals; Breast Neoplasms; Contraceptive Agents; Delayed-Action Preparations; Dogs; Drug Administration Schedule; Female; Fetus; Humans; Infertility, Female; Infusions, Parenteral; Lactation; Macaca mulatta; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Pregnancy; Time Factors; Uterine Neoplasms | 1982 |
Ovulation failure and induction.
Topics: Adolescent; Adult; Anovulation; Bromocriptine; Clomiphene; Female; Gonadotropins; Humans; Hypothalamic Diseases; Infertility, Female; Luteal Phase; Menstruation Disturbances; Norethindrone; Norethindrone Acetate; Ovarian Diseases; Ovulation Detection; Ovulation Induction; Pituitary Diseases; Progesterone; Prolactin; Thyroid Diseases | 1981 |
Oestrogens and hypertension.
Topics: Adolescent; Adult; Age Factors; Angiotensin II; Cardiac Output; Cardiovascular Diseases; Contraceptives, Oral; Estrogens; Female; Humans; Hypertension; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Pituitary-Adrenal System; Progestins; Prospective Studies; Prostaglandins; Renin; Renin-Angiotensin System; Sympathetic Nervous System | 1981 |
Transdermal application of steroid hormones for contraception.
Topics: Absorption; Administration, Cutaneous; Contraceptive Agents, Female; Delayed-Action Preparations; Diffusion; Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Norprogesterones; Skin | 1995 |
Formation-stimulating regimens other than sodium fluoride.
Topics: Anabolic Agents; Calcitriol; Diphosphonates; Growth Hormone; Humans; Insulin-Like Growth Factor I; Norethindrone; Norethindrone Acetate; Osteogenesis; Osteoporosis; Parathyroid Hormone; Peptide Fragments; Progesterone Congeners; Teriparatide | 1993 |
Add-back therapy: extending safety and efficacy of GnRH analogues in the gynecologic patient.
Topics: Endometriosis; Estrogens; Estrogens, Conjugated (USP); Female; Genital Diseases, Female; Gonadotropin-Releasing Hormone; Humans; Norethindrone; Norethindrone Acetate | 1998 |
Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals.
Topics: Animals; Animals, Laboratory; Contraceptives, Oral; Dogs; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Haplorhini; In Vitro Techniques; Mice; Mutagens; Neoplasms; Norethindrone; Norethindrone Acetate; Rats; Species Specificity; Teratogens; Toxicity Tests | 2001 |
Contraceptive vaginal rings.
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estradiol; Estrogens; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norprogesterones; Patient Acceptance of Health Care; Progesterone; Progestins; Vinyl Compounds | 2001 |
[Tibolone].
Topics: Adult; Aged; Animals; Blood Coagulation; Breast; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Hysterectomy; Lipid Metabolism; Lipids; Medrogestone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Placebos; Postmenopause; Progesterone Congeners; Prospective Studies; Rabbits; Rats; Risk Factors; Surveys and Questionnaires; Time Factors | 2002 |
Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review.
Topics: Bone and Bones; Drug Therapy, Combination; Estrogens; Female; Hormone Replacement Therapy; Humans; Norethindrone; Norethindrone Acetate | 2002 |
Hormone replacement therapy and risk of breast cancer: the role of progestins.
Topics: Breast Neoplasms; Drug Administration Schedule; Epidemiologic Studies; Estrogen Replacement Therapy; Europe; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Meta-Analysis as Topic; Middle Aged; Norethindrone; Norethindrone Acetate; Progestins; Risk Factors; United States | 2003 |
Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.
Topics: Bone Density; Endometrial Hyperplasia; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Randomized Controlled Trials as Topic | 2006 |
HT update: spotlight on estradiol/norethindrone acetate combination therapy.
Topics: Bone Density; Breast Neoplasms; Colorectal Neoplasms; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Memory; Norethindrone; Norethindrone Acetate; Risk Assessment; Stroke; Venous Thromboembolism | 2008 |
Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
Topics: Antidepressive Agents; Breast Neoplasms; Cardiovascular Diseases; Clinical Trials as Topic; Diet; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Humans; Menopause; Norethindrone; Norethindrone Acetate | 2008 |
Progesterone, progestins, and the heart.
Topics: Coronary Vessels; Estrogen Replacement Therapy; Humans; Medroxyprogesterone; Myocardial Infarction; Myocardium; Norethindrone; Norethindrone Acetate; Patient Selection; Progesterone; Progestins; Risk Assessment; Risk Factors; Stroke; Women's Health | 2010 |
The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis.
Topics: Bone Density; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Osteoporosis; Pelvic Pain; Progesterone | 2012 |
Hormone replacement therapy for women with type 1 diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol; Estrogen Replacement Therapy; Female; Humans; Norethindrone; Norethindrone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors | 2013 |
Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills.
Topics: Administration, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Endometriosis; Endometrium; Female; Humans; Menstrual Cycle; Nandrolone; Norethindrone; Norethindrone Acetate; Pelvic Pain; Progestins; Treatment Outcome | 2017 |
Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis.
Topics: Administration, Oral; Endometriosis; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pelvic Pain; Progestins; Randomized Controlled Trials as Topic; Receptors, Steroid | 2018 |
Norethisterone and its acetate - what's so special about them?
Topics: Biological Factors; Breast Neoplasms; Contraceptive Agents, Hormonal; Endometrium; Female; Humans; Norethindrone; Norethindrone Acetate; Thrombosis | 2021 |
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids.
Topics: Acetates; Estradiol; Female; Humans; Leiomyoma; Menorrhagia; Norethindrone; Norethindrone Acetate; Uterine Neoplasms | 2022 |
The effect of 17β-estradiol plus norethisterone acetate treatment on lipoprotein (a), atherogenic and anti-atherogenic apolipoproteins levels in postmenopausal women: A meta-analysis of randomized controlled trials.
Topics: Apolipoproteins; Apolipoproteins B; Estradiol; Female; Humans; Lipids; Lipoprotein(a); Norethindrone; Norethindrone Acetate; Postmenopause; Randomized Controlled Trials as Topic | 2023 |
292 trial(s) available for norethindrone and norethindrone acetate
| Article | Year |
|---|---|
Endometrial effects of transdermal estradiol/norethisterone acetate.
Topics: Administration, Cutaneous; Adult; Aged; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Uterine Hemorrhage; Vagina | 1992 |
A multicentre study of coagulation and haemostatic variables during oral contraception: variations with geographical location and ethnicity. Task Force on Oral Contraceptives--WHO Special Programme of Research, Development and Research Training in Human R
Topics: Adult; Blood Coagulation; Brazil; Chile; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Ethnicity; Female; Fibrinolysis; Hemostasis; Humans; Ireland; Levonorgestrel; Norethindrone; Norethindrone Acetate; Singapore | 1991 |
Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Sex Hormone-Binding Globulin | 1991 |
Transdermal administration of oestrogen/progestagen hormone replacement therapy.
Topics: Administration, Cutaneous; Adult; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Surveys and Questionnaires | 1990 |
Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.
Topics: Absorptiometry, Photon; Administration, Cutaneous; Administration, Oral; Bone Density; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Female; Femur Head; Humans; Lumbar Vertebrae; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Osteoporosis; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
Topics: Bone Density; Calcium; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoproteins; Long-Term Care; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies | 1990 |
[Efficacy of an adjuvant norethisterone acetate therapy (NEA) of endometrial carcinoma treated with primary surgery or irradiation].
Topics: Aged; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Uterine Neoplasms | 1990 |
Collagen synthesis in postmenopausal women during therapy with anabolic steroid or female sex hormones.
Topics: Aged; Anabolic Agents; Collagen; Drug Combinations; Estradiol; Female; Humans; Menopause; Middle Aged; Nandrolone; Nandrolone Decanoate; Norethindrone; Norethindrone Acetate; Peptide Fragments; Procollagen | 1990 |
A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement.
Topics: Adult; Biopsy; Bone Density; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Phosphorus | 1990 |
The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study.
Topics: Administration, Cutaneous; Administration, Oral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estradiol; Female; Humans; Menopause; Middle Aged; Multicenter Studies as Topic; Norethindrone; Norethindrone Acetate; Time Factors; United Kingdom | 1990 |
Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures.
Topics: Aged; Bone and Bones; Calcitonin; Calcium; Estradiol; Female; Fractures, Spontaneous; Humans; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Phosphorus; Prospective Studies; Random Allocation; Spinal Injuries; Time Factors | 1989 |
[Prospective perimenopausal estrogen-progestin substitution therapies for the prevention of osteoporosis].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Estriol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Prospective Studies | 1989 |
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes | 1989 |
Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation; Substance Withdrawal Syndrome; Time Factors | 1989 |
[Experience in the treatment of metastatic breast carcinoma with norethisterone acetate in a clinical study].
Topics: Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Menopause; Neoplasm Metastasis; Norethindrone; Norethindrone Acetate; Remission Induction; Time Factors | 1989 |
[Absorption of norethisterone acetate from tablets with normal and coarse particle size].
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Particle Size; Random Allocation; Tablets | 1989 |
The measurement of secretory endometrial protein PP14 in serum from postmenopausal women receiving unopposed estrogen or continuously combined estrogen/progestogen.
Topics: Drug Combinations; Estradiol; Female; Glycodelin; Glycoproteins; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Pregnancy Proteins; Radioimmunoassay; Random Allocation | 1989 |
Anti-androgen treatment in women with acne: a controlled trial.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Random Allocation | 1986 |
Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medical Records; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Norgestrel; Ovulation Detection; Research Design | 1988 |
Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
Topics: Alkaline Phosphatase; Biochemical Phenomena; Biochemistry; Bone and Bones; Calcium; Calcium-Binding Proteins; Clinical Trials as Topic; Creatinine; Double-Blind Method; Drug Combinations; Estradiol; Female; Humans; Hydroxyproline; Menopause; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteocalcin; Osteoporosis; Radionuclide Imaging; Random Allocation | 1988 |
Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints.
Topics: Adult; Aged; Climacteric; Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation | 1988 |
The effect of the contraceptive pill on blood pressure: a randomized controlled trial of three progestogen-oestrogen combinations in Szeged, Hungary.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Structure-Activity Relationship; Time Factors | 1986 |
Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Lipoproteins; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Prospective Studies; Random Allocation; Triglycerides | 1986 |
LHRH agonist and contraception.
Topics: Adolescent; Adult; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Humans; Luteinizing Hormone; Norethindrone; Norethindrone Acetate; Progesterone | 1986 |
A multicentre comparative study of serum lipids and lipoproteins in four groups of oral combined contraceptive users and a control group of IUD users. World Health Organization. Task Force on Oral Contraceptives.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estrogens; Female; Humans; Intrauterine Devices; Lipids; Lipoproteins; Norethindrone; Norethindrone Acetate; Progestins; Prospective Studies; Triglycerides | 1988 |
Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII.
Topics: Adult; Antithrombin III; Dose-Response Relationship, Drug; Ethinyl Estradiol; Factor XII; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Partial Thromboplastin Time; Prospective Studies; Prothrombin; Random Allocation | 1988 |
[Behavior the lipid spectrum following complete ovariectomy and subsequent substitution with estradiol valerate or norethisterone acetate].
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Female; Humans; Hysterectomy; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Ovariectomy; Postoperative Complications; Testosterone; Triglycerides | 1987 |
The menopause.
Topics: Adult; Breast Neoplasms; Calcium; Clinical Trials as Topic; Coronary Disease; Estrogens; Female; Gallbladder Diseases; Humans; Lipid Metabolism; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Thromboembolism; Uterine Neoplasms | 1986 |
Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women.
Topics: Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Estrogens; Female; Hemorrhage; Humans; Lipoproteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Vaginal Diseases | 1987 |
Vaginal administration of a combined oral contraceptive containing norethisterone acetate.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Endometrium; Ethinyl Estradiol; Fatigue; Female; Humans; Norethindrone; Norethindrone Acetate; Ovulation; Progesterone; Vagina | 1985 |
A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Prospective Studies; Stereoisomerism | 1984 |
Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Calcium-Binding Proteins; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Minerals; Norethindrone; Norethindrone Acetate; Osteocalcin | 1984 |
Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions.
Topics: Adult; Blood Pressure; Bone and Bones; Calcium; Cholesterol; Climacteric; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogens; Female; Humans; Menopause; Menstruation; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Random Allocation | 1982 |
Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
Topics: Blood Glucose; Cholesterol; Drug Evaluation; Female; Follicle Stimulating Hormone; Humans; Insulin; Kidney; Liver; Menstruation; Norethindrone; Norethindrone Acetate; Thyroid Gland; Time Factors; Triglycerides | 1981 |
Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
Topics: Bone and Bones; Calcitriol; Calcium; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis; Phosphates; Progestins | 1981 |
A randomized, double-blind study of six combined oral contraceptives.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Menstruation; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Random Allocation | 1982 |
Progestogen effects and their relationship to lipoprotein changes. A report from the Oral Contraception Study of the Royal College of General Practitioners.
Topics: Breast Neoplasms; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Lipoproteins; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Prospective Studies; Thrombosis | 1982 |
Long-term effects of oestrogens in combination with gestagen on plasma prolactin and FSH levels in post-menopausal women.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Prolactin; Radioimmunoassay; Random Allocation; Time Factors | 1982 |
Changes in plasma renin concentration, activity and substrate after twentyeight days' treatment with micronized estrogen, ethinylestradiol and norethisterone-acetate in postmenopausal women.
Topics: Adult; Angiotensinogen; Angiotensins; Estrogens; Ethinyl Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Radioimmunoassay; Renin | 1981 |
Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation.
Topics: Adult; Aged; Biopsy; Clinical Trials as Topic; Drug Combinations; Endometrium; Estradiol; Estriol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation | 1981 |
Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
Topics: Aged; Bone and Bones; Calcitriol; Calcium; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Norethindrone; Norethindrone Acetate; Osteoporosis | 1982 |
Potency of progestogens in oral contraceptives--further delay of menses data.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Synergism; Estradiol Congeners; Ethynodiol Diacetate; Female; Humans; Menstruation; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners | 1982 |
Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Endometriosis; Estradiol; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Laparoscopy; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Prospective Studies | 1995 |
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women.
Topics: Adult; Blood Glucose; C-Peptide; Cholesterol, LDL; Combined Modality Therapy; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypercholesterolemia; Insulin; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Single-Blind Method; Treatment Outcome | 1995 |
The effects of continuous combined transdermal oestrogen-progestogen treatment on bleeding patterns and the endometrium in postmenopausal women.
Topics: Administration, Cutaneous; Climacteric; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menstruation; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 1995 |
Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Cholesterol; Climacteric; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipids; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Triglycerides | 1995 |
A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol.
Topics: Administration, Intravaginal; Adult; Angiotensin II; Cholesterol, HDL; Contraceptive Devices, Female; Delayed-Action Preparations; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Luteal Phase; Menstrual Cycle; Nausea; Norethindrone; Norethindrone Acetate; Sex Hormone-Binding Globulin; Triglycerides | 1994 |
Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol.
Topics: Administration, Intravaginal; Adult; Contraceptive Devices, Female; Delayed-Action Preparations; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Luteal Phase; Menstrual Cycle; Nausea; Norethindrone; Norethindrone Acetate; Ovulation; Sex Hormone-Binding Globulin | 1994 |
Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study.
Topics: Drug Therapy, Combination; Estradiol; Female; Follow-Up Studies; Humans; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Norethindrone; Norethindrone Acetate; Postmenopause | 1995 |
Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
Topics: Breast; Climacteric; Desogestrel; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Flushing; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners | 1994 |
The use of progestins for programming assisted reproductive cycles and gonadotropin-releasing hormone agonist flare-up protocols in older patients.
Topics: Adult; Aging; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leuprolide; Luteinizing Hormone; Middle Aged; Norethindrone; Norethindrone Acetate; Pregnancy; Reproductive Techniques; Retrospective Studies | 1995 |
Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climate.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Climate; Drug Eruptions; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies | 1994 |
Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Breast Neoplasms; Climacteric; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin-Like Growth Factor I; Middle Aged; Norethindrone; Norethindrone Acetate; Risk Factors; Sex Hormone-Binding Globulin | 1994 |
Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
Topics: Cholesterol; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Triglycerides | 1994 |
[Kliogest--the possibility of hormonal substitution in the postmenopause].
Topics: Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Time Factors | 1993 |
Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
Topics: Administration, Cutaneous; Administration, Oral; Alprostadil; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dinoprostone; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Time Factors; Triglycerides | 1994 |
Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment.
Topics: Bone Density; Double-Blind Method; Drug Combinations; Estradiol; Female; Forearm; Humans; Long-Term Care; Lumbar Vertebrae; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Prospective Studies | 1994 |
Postmenopausal bone loss: does HRT always work?
Topics: Administration, Cutaneous; Administration, Oral; Alkaline Phosphatase; Bone Density; Calcium; Creatinine; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hydroxyproline; Longitudinal Studies; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Osteoporosis, Postmenopausal; Phosphates; Progesterone Congeners | 1993 |
Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Biopsy; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 1993 |
A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment.
Topics: Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Sex Hormone-Binding Globulin | 1993 |
Oral versus transdermal hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Blood Glucose; Bone Density; Cardiovascular Diseases; Cholesterol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin; Lipoproteins; Longitudinal Studies; Menopause; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides; White People | 1993 |
Compliance with long-term oral hormonal replacement therapy.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Humans; Long-Term Care; Norethindrone; Norethindrone Acetate; Patient Compliance; Progesterone | 1995 |
Estrogen and progestagen modify the hemodynamic response to mental stress in young women.
Topics: Adult; Blood Pressure; Estradiol; Estrogens; Female; Heart Rate; Hemodynamics; Humans; Norethindrone; Norethindrone Acetate; Placebos; Stress, Psychological | 1996 |
A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin-releasing hormone agonistic response and minimizes cyst formation during ovarian stimulation.
Topics: Adult; Chorionic Gonadotropin; Drug Therapy, Combination; Estradiol; Female; Fertilization in Vitro; Humans; Leuprolide; Menotropins; Norethindrone; Norethindrone Acetate; Ovarian Cysts; Ovulation Induction; Pregnancy; Prospective Studies | 1996 |
A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
Topics: Administration, Oral; Climacteric; Desogestrel; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Physical Fitness; Placebos; Postmenopause; Progesterone Congeners; Sweating; Uterine Hemorrhage | 1996 |
Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
Topics: Administration, Cutaneous; Administration, Oral; Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoprotein(a); Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Risk Factors | 1996 |
Add-back therapy in the treatment of endometriosis: the European experience.
Topics: Administration, Cutaneous; Bone Density; Double-Blind Method; Drug Combinations; Endometriosis; Estradiol; Estrogen Replacement Therapy; Female; Goserelin; Humans; Injections; Luteinizing Hormone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Treatment Outcome | 1996 |
The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor.
Topics: Cholesterol, HDL; Cross-Over Studies; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Luteinizing Hormone; Megestrol; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Postmenopause; Progesterone Congeners; Receptors, Androgen | 1996 |
Different effects of oral and transdermal hormonal replacement on prostacyclin and thromboxane A2.
Topics: Administration, Cutaneous; Administration, Oral; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Thromboxane A2 | 1997 |
Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Apolipoprotein A-I; Apolipoprotein A-II; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Estradiol; Estrogen Replacement Therapy; Female; Glycoproteins; Heparin; Humans; Lipolysis; Lipoprotein(a); Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Triglycerides | 1997 |
Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women.
Topics: Estradiol; Estrogen Replacement Therapy; Female; Humans; Hydroxyindoleacetic Acid; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Serotonin | 1997 |
[A clinical study of the efficacy of and tolerance for the combined transdermal preparation Estracomb TTS (CIBA)].
Topics: Administration, Cutaneous; Drug Combinations; Drug Tolerance; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Ovariectomy; Postmenopause; Premenopause; Syndrome; Time Factors | 1997 |
Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Topics: Administration, Cutaneous; Administration, Oral; Cohort Studies; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Reference Values; Uterine Hemorrhage; Vasomotor System | 1997 |
Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Topics: Administration, Cutaneous; Adult; Biopsy; Cohort Studies; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 1997 |
Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring.
Topics: Adult; Contraceptive Devices, Female; Drug Administration Schedule; Drug Therapy, Combination; Ethinyl Estradiol; Female; Headache; Humans; Nausea; Norethindrone; Norethindrone Acetate; Time Factors; Vomiting | 1997 |
In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women.
Topics: Administration, Oral; Area Under Curve; Biological Availability; Cohort Studies; Cross-Over Studies; Dose-Response Relationship, Drug; Estradiol Congeners; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Time Factors | 1997 |
Effects of hormone replacement therapy on plasma glutathione S-transferase A1-1 concentrations in healthy postmenopausal women.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Glutathione Transferase; Humans; Isoenzymes; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 1998 |
Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Body Weight; Cohort Studies; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Uterine Hemorrhage | 1997 |
The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.
Topics: Administration, Cutaneous; Administration, Oral; Endothelin-1; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nitric Oxide; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Thromboxanes | 1998 |
A prospective randomized controlled study comparing the morphological and biochemical responses of the endometrium to two different forms of 'period-free' hormone replacement therapy.
Topics: CA-125 Antigen; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Menstruation; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Pregnancy Proteins; Prospective Studies | 1998 |
Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow.
Topics: Administration, Cutaneous; Administration, Oral; Carotid Arteries; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Uterus; Vascular Resistance | 1998 |
Ultrasonographic blood flow measurement in the carotid arteries in postmenopausal women.
Topics: Carotid Arteries; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Pulsatile Flow; Time Factors; Ultrasonography; Vascular Resistance | 1999 |
Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
Topics: Aged; Analysis of Variance; Blood Glucose; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin; Insulin Resistance; Insulin Secretion; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Reference Values; Treatment Outcome | 1999 |
Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up.
Topics: Adult; Aged; Endometrial Hyperplasia; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Progestins; Prospective Studies; Time Factors; Triptorelin Pamoate | 1999 |
Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
Topics: Androgens; Contraception; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipids; Menstrual Cycle; Norethindrone; Norethindrone Acetate; Norgestrel; Patient Satisfaction | 1999 |
Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate | 1999 |
Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women.
Topics: Bone Remodeling; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Ilium; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoclasts; Postmenopause; Progesterone Congeners; Prospective Studies | 1999 |
Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.
Topics: Bone Density; Cross-Sectional Studies; Denmark; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hysterectomy; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Longitudinal Studies; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal | 1999 |
Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Endometrium Study Group.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Uterine Hemorrhage | 1999 |
Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
Topics: Aged; Bone Density; Bone Remodeling; Bone Resorption; Calcium; Double-Blind Method; Drug Synergism; Estradiol; Estrogen Replacement Therapy; Female; Fluorides; Humans; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Phosphates; Placebos; Postmenopause; Prospective Studies | 1999 |
A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Female; Humans; Lipoproteins; Lipoproteins, VLDL; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 1999 |
A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
Topics: Adolescent; Adult; Biocompatible Materials; Contraceptive Agents, Female; Contraceptive Devices, Female; Corpus Luteum; Delayed-Action Preparations; Elastomers; Estradiol; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Ovarian Follicle; Ovary; Progesterone; Silicones; Vagina | 1999 |
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group.
Topics: Administration, Cutaneous; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Incidence; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1999 |
Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group.
Topics: Biopsy; Endometrial Hyperplasia; Estradiol; Female; Hormone Replacement Therapy; Humans; Incidence; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors; Time Factors | 1999 |
Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple oral doses to postmenopausal women.
Topics: Administration, Oral; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Radioimmunoassay | 1999 |
Elevated levels of sE-selectin in post-menopausal females are decreased by hormone replacement therapy to levels observed in pre-menopausal females.
Topics: Adult; Aged; Cardiovascular Diseases; Drug Synergism; E-Selectin; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Male; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Premenopause; Risk Factors; Sex Characteristics; Solubility; von Willebrand Factor | 1999 |
Administration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Cutaneous; Blood; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Norethindrone; Norethindrone Acetate; Postmenopause; Progestins; Prospective Studies; Umbilical Veins | 2000 |
Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
Topics: Administration, Cutaneous; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Progesterone Congeners; Sweating | 2000 |
Effect of low-dose oral contraceptives on androgenic markers and acne.
Topics: Acne Vulgaris; Adolescent; Adrenal Glands; Adult; Androgens; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Ovary; Sex Hormone-Binding Globulin; Testosterone; Weight Gain | 1999 |
Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.
Topics: Aged; Blood Coagulation; Cholesterol; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Plasminogen Activator Inhibitor 1; Postmenopause; Triglycerides | 2000 |
Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate.
Topics: Aged; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Glycoproteins; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Triglycerides | 2000 |
Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Topics: Administration, Oral; Cholesterol; Cholesterol, HDL; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Triglycerides | 2000 |
Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; C-Peptide; Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Liver; Middle Aged; Models, Theoretical; Norethindrone; Norethindrone Acetate; Pancreas; Postmenopause | 2000 |
Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study.
Topics: Aged; Blood Coagulation; Blood Coagulation Tests; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Fibrinolysis; Hemostasis; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism | 2000 |
Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators.
Topics: Adult; Aged; Climacteric; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Risk; Uterine Hemorrhage | 2000 |
Norethindrone acetate and estradiol-induced endometrial hyperplasia.
Topics: Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate | 2000 |
Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Topics: Anabolic Agents; Arteries; Estradiol; Female; Humans; Iliac Artery; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Pelvis; Postmenopause; Pulsatile Flow; Ultrasonography, Doppler, Color; Uterus; Vascular Resistance | 2000 |
Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up.
Topics: Adult; Bone Density; Drug Implants; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Goserelin; Hip Joint; Hormone Replacement Therapy; Humans; Longitudinal Studies; Lumbosacral Region; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Spine | 2000 |
Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
Topics: Aged; Apolipoprotein A-I; Blood Coagulation Factors; Blood Glucose; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Glycated Hemoglobin; Humans; Insulin; Lipids; Lipoprotein(a); Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors; Treatment Outcome; Triglycerides | 2000 |
[Influence of hormone replacement therapy on the quality of life in postmenopausal women with hypertension].
Topics: Adipose Tissue; Body Mass Index; Drug Combinations; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Hemodynamics; Humans; Hypertension; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Quality of Life; Surveys and Questionnaires | 2000 |
The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
Topics: Administration, Oral; Adult; Aged; Drug Combinations; Endometrial Hyperplasia; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Prevalence; Progesterone Congeners; Prospective Studies; Treatment Outcome | 2000 |
Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels.
Topics: Administration, Cutaneous; Administration, Oral; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Female; Homocysteine; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies | 2000 |
Negative mood changes during hormone replacement therapy: a comparison between two progestogens.
Topics: Affect; Cross-Over Studies; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Medical Records; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Premenstrual Syndrome; Progesterone Congeners | 2000 |
Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial.
Topics: Biomarkers; Chlormadinone Acetate; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Estrogens; Female; Glucose Intolerance; Hormone Replacement Therapy; Humans; Informed Consent; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 2000 |
Charcoal treatment and risk of escape ovulation in oral contraceptive users.
Topics: Adolescent; Adult; Antidiarrheals; Charcoal; Contraceptives, Oral, Combined; Diarrhea; Drug Administration Schedule; Enterohepatic Circulation; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Norpregnenes; Ovary; Ovulation; Ultrasonography | 2001 |
Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy.
Topics: Bone Density; Calcium; Cholesterol; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Placebos; Pyrrolidines; Receptors, Estrogen; Triglycerides; Ultrasonography | 2001 |
Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement.
Topics: Blood Pressure; Cardiovascular Diseases; Cerebrovascular Circulation; Cross-Over Studies; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Heart; Humans; Magnetic Resonance Angiography; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Stroke Volume; Vascular Resistance | 2001 |
Bioequivalence and relative bioavailability of three estradiol and norethisterone acetate-containing hormone replacement therapy tablets.
Topics: Administration, Oral; Aged; Area Under Curve; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Therapeutic Equivalency | 2001 |
Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Biomarkers; Body Constitution; Body Mass Index; Cholesterol, HDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hyperlipidemias; Hypertension; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Reference Values; Syndrome; Triglycerides | 2000 |
Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms.
Topics: Adult; Aged; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Progestins; Uterine Hemorrhage; Vasomotor System | 2001 |
Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Topics: Androgens; Androstenedione; Dehydroepiandrosterone Sulfate; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone | 2001 |
Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol.
Topics: Adult; Androgens; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Kinetics; Norethindrone; Norethindrone Acetate; Sex Hormone-Binding Globulin; Testosterone | 2001 |
Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
Topics: Aging; Blood Pressure; Double-Blind Method; Drug Combinations; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies | 2001 |
The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
Topics: Biomarkers; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Hemostasis; Hormone Replacement Therapy; Humans; Lipoproteins; Middle Aged; Multivariate Analysis; Norethindrone; Norethindrone Acetate; Recurrence; Thromboembolism; Thrombophilia; Venous Thrombosis | 2001 |
Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy.
Topics: Affect; Climacteric; Cross-Over Studies; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Pregnanolone; Progestins; Saccades | 2001 |
Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Body Mass Index; Climacteric; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 2001 |
Anti-ischemic action of estrogen-progestogen continuous combined hormone replacement therapy in postmenopausal women with established angina pectoris: a randomized, placebo-controlled, double-blind, parallel-group trial.
Topics: Aged; Angina Pectoris; Blood Pressure; China; Double-Blind Method; Drug Combinations; Electrocardiography, Ambulatory; Estradiol; Estrogen Replacement Therapy; Exercise Test; Exercise Tolerance; Female; Humans; Lipids; Middle Aged; Myocardial Ischemia; Norethindrone; Norethindrone Acetate; Placebos | 2001 |
Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: a longitudinal study.
Topics: Aged; Amino Acids; Bone Resorption; Cells, Cultured; Cytokines; Estradiol; Estrogen Replacement Therapy; Female; Humans; Interleukin-1; Interleukin-6; Leukocytes, Mononuclear; Longitudinal Studies; Middle Aged; Norethindrone; Norethindrone Acetate | 2001 |
Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.
Topics: Activated Protein C Resistance; Aged; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Factor V; Female; Follow-Up Studies; Heterozygote; Humans; Middle Aged; Mutation; Norethindrone; Norethindrone Acetate; Recurrence; Thromboembolism | 2001 |
The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris.
Topics: Aged; Angina Pectoris; Brachial Artery; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Endothelium, Vascular; Estradiol; Female; Hemodynamics; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Ultrasonography, Doppler | 2001 |
Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study.
Topics: Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estradiol; Female; France; Germany; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Surveys and Questionnaires; Treatment Outcome; Triglycerides; Uterine Hemorrhage | 2001 |
Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
Topics: Administration, Cutaneous; Administration, Oral; Cardiovascular Diseases; Carotid Artery, Internal; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Prospective Studies; Pulsatile Flow | 2001 |
Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Europe; Female; Fibrinogen; Humans; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triglycerides | 2001 |
Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
Topics: Argentina; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Europe; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Promegestone; Treatment Outcome; Uterine Hemorrhage | 2001 |
[A clinical assessment of a 3 month replacement therapy effectiveness with low norethisterone acetate (Activelle) in postmenopausal women].
Topics: Aged; Body Mass Index; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Treatment Outcome | 2001 |
The efficacy of two dosages of a continuous combined hormone replacement regimen.
Topics: Aged; Alkaline Phosphatase; Amino Acids; Asian People; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Collagen; Collagen Type I; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Estradiol; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Peptides; Postmenopause; Prospective Studies; Singapore; Treatment Outcome; Triglycerides; Uterine Hemorrhage | 2002 |
Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women.
Topics: Analysis of Variance; Brachial Artery; Cell Adhesion Molecules; Double-Blind Method; Drug Combinations; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Statistics, Nonparametric; Vasodilation | 2001 |
Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
Topics: Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Uterine Hemorrhage | 1998 |
Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis.
Topics: Cardiovascular Diseases; Double-Blind Method; Endothelin-1; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nitric Oxide; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2002 |
Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent.
Topics: Age Factors; Bone Density; Cross-Sectional Studies; Estradiol; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteoporosis; Progesterone Congeners | 2002 |
Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
Topics: Biopsy, Needle; Breast; Double-Blind Method; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Humans; Mammography; Norethindrone; Norethindrone Acetate; Norpregnenes; Placebos; Postmenopause; Prospective Studies | 2002 |
Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up.
Topics: Adult; Bone Density; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endometriosis; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Norethindrone; Norethindrone Acetate; Patient Dropouts; Prospective Studies | 2002 |
Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Lipids; Lipoproteins; Luteinizing Hormone; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Triglycerides | 2002 |
Effect of raloxifene on the ovarian circulation in women after menopause.
Topics: Aged; Drug Combinations; Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Ovary; Raloxifene Hydrochloride; Regional Blood Flow; Selective Estrogen Receptor Modulators; Single-Blind Method; Vascular Resistance | 2002 |
Transvaginal sonographic monitoring of the uterine effects of raloxifene and a continuous combined replacement therapy in postmenopausal women.
Topics: Administration, Oral; Adult; Drug Administration Schedule; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome; Ultrasonography; Uterus | 2002 |
Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.
Topics: Administration, Cutaneous; Administration, Oral; Cholesterol, HDL; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin-Like Growth Factor I; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Sex Hormone-Binding Globulin | 2002 |
Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women.
Topics: Analysis of Variance; Bone Density; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Exercise; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 2002 |
Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study.
Topics: Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Norethindrone; Norethindrone Acetate; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Postmenopause | 2002 |
Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Polyps; Postmenopause; Progesterone Congeners; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms | 2002 |
National differences in lipid response to postmenopausal hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Europe; Female; Humans; Lipids; Lipoproteins; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners | 2002 |
Effects of oral continuous and transdermal cyclic 17-beta estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Age Factors; Delayed-Action Preparations; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Platelet Aggregation; Platelet Count; Prospective Studies; Time Factors | 2002 |
Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial.
Topics: Adult; C-Reactive Protein; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Weight Gain | 2002 |
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Topics: Alkaline Phosphatase; Amino Acids; Bone Density; Combined Modality Therapy; Diet, Fat-Restricted; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Femur; Follicle Stimulating Hormone; Genistein; Humans; Isoenzymes; Lumbar Vertebrae; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoblasts; Osteocalcin; Osteoclasts; Osteoporosis, Postmenopausal; Radiography | 2002 |
Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy.
Topics: Estradiol; Female; Hemostasis; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Risk Factors; Time Factors | 2002 |
Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
Topics: Administration, Oral; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Apoprotein(a); Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromatography, High Pressure Liquid; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Fatty Acids; Female; Humans; Lipid Peroxidation; Lipoprotein(a); Malondialdehyde; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Tocopherols; Treatment Outcome; Triglycerides | 2002 |
[Amenorrhea rate after switch from sequential hormone replacement therapy to continuous combined administration of low dose estradiol and norethisterone acetate].
Topics: Amenorrhea; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate | 2002 |
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.
Topics: Cholesterol, LDL; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Progestins; Risk Factors; Thrombosis; Time Factors; Uterus | 2002 |
Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone.
Topics: Adult; Aged; Austria; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Germany; Hot Flashes; Humans; Medrogestone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2002 |
A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women.
Topics: Blood Coagulation; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Fibrinolysis; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Reference Values | 2002 |
Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Topics: Adult; Amenorrhea; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Time Factors; Uterine Hemorrhage | 2003 |
Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women.
Topics: Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2003 |
A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone.
Topics: Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Incidence; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Safety; Severity of Illness Index | 2003 |
Low-dose hormone therapy and carbohydrate metabolism.
Topics: Blood Glucose; Body Mass Index; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause | 2003 |
Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Topics: Aged; Anticholesteremic Agents; Brachial Artery; Cholesterol, HDL; Cholesterol, LDL; Diet, Reducing; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Hypercholesterolemia; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Pravastatin; Progesterone Congeners; Quality of Life; Reference Values; Regional Blood Flow | 2002 |
Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study.
Topics: Biomarkers; Brachial Artery; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Female; Genistein; Humans; Middle Aged; Nitrates; Nitrites; Norethindrone; Norethindrone Acetate; Postmenopause; Time Factors; Vasodilation | 2003 |
The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study.
Topics: Administration, Cutaneous; Cardiac Output; Estradiol; Estrogen Replacement Therapy; Female; Heart Ventricles; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Stroke Volume; Systole; Ultrasonography; Ventricular Function, Left | 2003 |
Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study.
Topics: Adipose Tissue; Alkaline Phosphatase; Body Composition; Bone and Bones; Bone Density; Collagen; Collagen Type I; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteocalcin; Peptides; Prospective Studies; Thinness | 2003 |
Modification of serum IGF-I, IGFBPs and SHBG levels by different HRT regimens.
Topics: Adult; Blood Proteins; Cyproterone; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor I; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Sex Hormone-Binding Globulin | 2003 |
Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women.
Topics: Drug Therapy, Combination; Estrogens; Female; Fibrinolysis; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Postmenopause; Tissue Plasminogen Activator | 2003 |
Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; C-Reactive Protein; Double-Blind Method; Drug Therapy, Combination; E-Selectin; Estradiol; Estrogen Replacement Therapy; Female; Humans; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Sex Hormone-Binding Globulin; Time Factors | 2003 |
The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women.
Topics: Administration, Cutaneous; Cholesterol; Cholesterol, LDL; Climacteric; Estradiol; Female; Humans; Lipids; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Prospective Studies; Spain; Triglycerides | 2003 |
The effects of hormone replacement therapy type on pulmonary functions in postmenopausal women.
Topics: Adult; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Forced Expiratory Volume; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Random Allocation; Vital Capacity | 2003 |
Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Fasting; Female; Homocysteine; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Probability; Reference Values; Sensitivity and Specificity | 2003 |
Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Adult; C-Reactive Protein; Cross-Sectional Studies; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 2003 |
Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes.
Topics: Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors | 2004 |
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women.
Topics: Amino Acids; Bone Density; Bone Remodeling; Bone Resorption; Carrier Proteins; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Femur Neck; Genistein; Glycoproteins; Humans; Membrane Glycoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoprotegerin; Placebos; Postmenopause; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2004 |
Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.
Topics: Adult; Analysis of Variance; Aromatase Inhibitors; Bone Density; Contraceptives, Oral, Synthetic; Endometriosis; Enzyme Inhibitors; Female; Humans; Letrozole; Middle Aged; Nitriles; Norethindrone; Norethindrone Acetate; Pain Measurement; Parity; Pelvic Pain; Pilot Projects; Premenopause; Triazoles | 2004 |
Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.
Topics: Administration, Cutaneous; Adult; Anthropometry; Biomarkers; Blood Glucose; Cardiovascular Diseases; Delayed-Action Preparations; Drug Combinations; Epidemiologic Methods; Estradiol; Estrogen Replacement Therapy; Female; Hemostasis; Humans; Insulin; Lipids; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 2004 |
Uterine effects of estrogen plus progestin therapy and raloxifene: adjudicated results from the EURALOX study.
Topics: Algorithms; Double-Blind Method; Estradiol; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uterus | 2004 |
Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Treatment Outcome; Triglycerides | 2004 |
Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy.
Topics: Breast; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Growth Substances; Hormones; Humans; Mammography; Nandrolone; Norethindrone; Norethindrone Acetate; Sex Hormone-Binding Globulin; Testosterone | 2004 |
Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate therapy regimen.
Topics: Adult; Aged; Biopsy; Climacteric; Contraceptive Agents, Female; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Ultrasonography; Uterine Hemorrhage | 2004 |
A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolon and continuous combined estrogen-progestogen treatment.
Topics: Aged; Antibodies, Monoclonal; Biopsy, Needle; Breast; Cell Division; Contraceptives, Oral, Synthetic; Double-Blind Method; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Ki-67 Antigen; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Prospective Studies | 2004 |
A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen.
Topics: Aged; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Uterine Hemorrhage | 2004 |
Low-dose oral combination of 17beta-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1.
Topics: Administration, Oral; Aged; Antithrombins; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Plasminogen Activator Inhibitor 1; Postmenopause | 2004 |
Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens.
Topics: Breast; Contraceptive Agents, Female; Depression; Double-Blind Method; Edema; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Irritable Mood; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Pain; Postmenopause; Predictive Value of Tests; Prospective Studies; Quality of Life; Sleep Initiation and Maintenance Disorders; Sweating | 2004 |
A comparison of the central effects of different progestins used in hormone replacement therapy.
Topics: Administration, Cutaneous; Anxiety; Body Temperature; Depression; Double-Blind Method; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Placebos; Postmenopause; Progestins; Time Factors | 2004 |
Carotid and uterine vascular resistance in short-term hormone replacement therapy postmenopausal users.
Topics: Analysis of Variance; Brazil; Carotid Arteries; Double-Blind Method; Endometrium; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Outpatients; Placebos; Postmenopause; Time Factors; Ultrasonography, Doppler, Duplex | 2004 |
Measurement of aortic blood flow by magnetic resonance below and above the origin of the coronary arteries in postmenopausal hormone replacement therapy.
Topics: Aorta; Blood Flow Velocity; Contraceptives, Oral, Synthetic; Coronary Circulation; Cross-Over Studies; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Feasibility Studies; Female; Humans; Magnetic Resonance Imaging, Cine; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Regional Blood Flow; Reproducibility of Results | 2004 |
Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Topics: Apoptosis; Biopsy; Cell Proliferation; Endometrium; Estradiol; Estrogen Receptor alpha; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Ki-67 Antigen; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Receptors, Progesterone; Regression Analysis; Sweden; Uterine Hemorrhage | 2004 |
Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being.
Topics: Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Quality of Life; Sweden | 2004 |
Influence of different HRT regimens on mammographic density.
Topics: Adult; Breast; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Mammography; Medrogestone; Middle Aged; Norethindrone; Norethindrone Acetate; Perimenopause; Postmenopause; Prospective Studies | 2005 |
Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women.
Topics: Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; England; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoprotein(a); Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone | 2004 |
The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
Topics: Administration, Oral; Adult; Anxiety; Contraceptives, Oral, Synthetic; Depression; Dizziness; Estradiol; Estrogen Replacement Therapy; Female; Headache; Heart Rate; Hot Flashes; Humans; Latin America; Lipids; Menopause; Middle Aged; Muscle Weakness; Norethindrone; Norethindrone Acetate; Paresthesia; Prospective Studies | 2005 |
A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms.
Topics: Administration, Cutaneous; Aged; Drug Combinations; Estradiol; Female; Hot Flashes; Humans; Hyperhidrosis; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Postmenopause; Quality of Life; Reproductive Control Agents | 2005 |
Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
Topics: Administration, Cutaneous; Blood Coagulation; Cholesterol; Cholesterol, VLDL; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Middle Aged; Netherlands; Norethindrone; Norethindrone Acetate; Postmenopause; Sweden; Treatment Outcome | 2005 |
Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
Topics: Aged; Breast; Estradiol; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Humans; Insulin-Like Growth Factor I; Mammography; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Testosterone | 2005 |
The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
Topics: C-Reactive Protein; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Female; Genistein; Homocysteine; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Phytoestrogens; Postmenopause; Treatment Outcome | 2005 |
[The effect of transdermal hormone replacement therapy on vasomotor symptoms in perimenopausal women].
Topics: Administration, Cutaneous; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Perimenopause; Poland; Severity of Illness Index; Time Factors; Treatment Outcome; Vasomotor System | 2004 |
Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy.
Topics: Breast; Chi-Square Distribution; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Radionuclide Imaging | 2006 |
Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Hemostasis; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Treatment Outcome | 2006 |
Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Hodgkin Disease; Humans; Inhibins; Norethindrone; Norethindrone Acetate; Pilot Projects; Primary Ovarian Insufficiency; Prospective Studies; Treatment Outcome | 2005 |
Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
Topics: Adult; Aged; Blood Coagulation Factors; Blood Glucose; Body Mass Index; Bone Density; Contraceptives, Oral, Synthetic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Obesity; Overweight; Pharmaceutical Preparations; Postmenopause | 2005 |
The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes.
Topics: Aged; Blood Glucose; Body Mass Index; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hyperandrogenism; Lipid Metabolism; Middle Aged; Norethindrone; Norethindrone Acetate; Sex Hormone-Binding Globulin; Statistics, Nonparametric | 2006 |
The effect of low dose hormone therapy on mammographic breast density.
Topics: Adult; Aged; Breast; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 2006 |
Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate.
Topics: Adolescent; Adult; Confidence Intervals; Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Pain Measurement; Progestins; Rectal Diseases; Statistics, Nonparametric; Vaginal Diseases | 2005 |
Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate.
Topics: Administration, Oral; Adult; Affect; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Prospective Studies; Quality of Life; Sweating | 2005 |
A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1 mg 17beta-estradiol and trimegestone compared with a regimen containing 1 mg estradiol valerate and norethisterone over a two-year period.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Prospective Studies; Quality of Life; Sleep Wake Disorders; Sweating; Uterine Hemorrhage | 2005 |
A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women.
Topics: Administration, Oral; Adult; Body Weight; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Prospective Studies; Uterine Hemorrhage | 2005 |
Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Topics: Adult; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Time Factors; Uterine Hemorrhage | 2006 |
Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol/trimegestone versus 1 or 2 mg 17beta-estradiol/norethisterone acetate in postmenopausal women.
Topics: Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Europe; Female; Humans; Israel; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Treatment Outcome; Uterine Hemorrhage | 2005 |
Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
Topics: Body Mass Index; Bone Density; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Random Allocation; Treatment Outcome | 2006 |
Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Gingival Crevicular Fluid; Humans; Longitudinal Studies; Matrix Metalloproteinase 8; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Periodontium; Placebos; Saliva; Secretory Rate | 2006 |
Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study.
Topics: Aged; Body Mass Index; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Hemostasis; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Time Factors | 2007 |
Combined hormone replacement therapy improves lipids but may increase leucocytes.
Topics: Administration, Oral; Adult; Aged; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Cholinergic Antagonists; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leukocytes; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 2006 |
Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation.
Topics: Antineoplastic Agents, Hormonal; Blood Coagulation; Blood Coagulation Tests; Bone Density Conservation Agents; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Thromboembolism | 2006 |
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women.
Topics: Brachial Artery; Drug Combinations; Endothelium, Vascular; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Reference Values; Regional Blood Flow; Vasodilation | 2006 |
Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.
Topics: Adult; Androgens; Atherosclerosis; Biomarkers; Cardiovascular System; Chemokine CCL2; Chemokine CCL5; Chemotaxis; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2007 |
Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
Topics: Administration, Oral; Adult; Aged; Body Composition; Body Mass Index; Body Weight; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Placebos; Postmenopause; Subcutaneous Fat, Abdominal; Waist-Hip Ratio | 2006 |
Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin.
Topics: Administration, Cutaneous; Bilirubin; Bone Density; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Treatment Outcome | 2006 |
Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study.
Topics: Aged; Biomarkers; Blood Coagulation; Coronary Disease; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Estradiol; Factor VII; Feasibility Studies; Female; Fibrinolysis; Hemostasis; Hormone Replacement Therapy; Humans; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Pilot Projects | 2006 |
Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging.
Topics: Brain; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Magnetic Resonance Imaging; Memory; Middle Aged; Models, Biological; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Radiography; Space Perception; Visual Perception | 2006 |
Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects.
Topics: Adult; Body Weight; Cholesterol; Contraceptive Agents, Female; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Triglycerides | 2007 |
Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Risk Assessment; Risk Factors; Treatment Outcome | 2006 |
Effects of intranasal versus oral hormone therapy on asymmetric dimethylarginine in healthy postmenopausal women: a randomized study.
Topics: Administration, Intranasal; Administration, Oral; Aged; Arginine; Chromatography, High Pressure Liquid; Double-Blind Method; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Treatment Outcome | 2007 |
Effects of estradiol alone and combined with norethisterone acetate on pulse-wave velocity in hypertensive postmenopausal women.
Topics: Blood Flow Velocity; Blood Pressure; Carotid Arteries; Double-Blind Method; Drug Combinations; Estradiol; Female; Humans; Hypertension; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Pulse; Vascular Resistance | 2006 |
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.
Topics: Administration, Oral; Aged; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Female; Fibrinolysis; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Retrospective Studies; Time Factors | 2007 |
Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Menstrual Cycle; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Pregnancy; Pregnancy Rate; Risk Assessment; Safety; Time Factors; Treatment Outcome | 2007 |
Monophasic estrogen-progestogen therapy and sexuality in postmenopausal women.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Drug Combinations; Estradiol; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Libido; Middle Aged; Norethindrone; Norethindrone Acetate; Personal Satisfaction; Postmenopause; Progesterone Congeners | 2007 |
Letrozole and norethisterone acetate in rectovaginal endometriosis.
Topics: Administration, Oral; Aromatase Inhibitors; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Female; Humans; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Prospective Studies; Rectal Diseases; Triazoles; Vaginal Diseases | 2007 |
Formation of ethinyl estradiol in women during treatment with norethindrone acetate.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Premenopause | 2007 |
Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?
Topics: Administration, Cutaneous; Administration, Oral; Aged; alpha-2-Antiplasmin; Antigens; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Ireland; Middle Aged; Norethindrone; Norethindrone Acetate; Peptide Fragments; Postmenopause; Prothrombin; Risk Factors; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2007 |
Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.
Topics: Adult; Aged; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Hot Flashes; Humans; Hydrogen-Ion Concentration; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Severity of Illness Index; Vagina | 2007 |
Testosterone addition during menopausal hormone therapy: effects on mammographic breast density.
Topics: Aged; Androgens; Breast; Contraceptives, Oral, Synthetic; Dihydrotestosterone; Double-Blind Method; Estradiol; Female; Hormone Replacement Therapy; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Testosterone | 2007 |
Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.
Topics: Adult; Aged; Breast; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Sweden; Treatment Outcome | 2007 |
Effects of standard and low dose 17beta-estradiol plus norethisterone acetate on body composition and leptin in postmenopausal women at risk of body mass index and waist girth related cardiovascular and metabolic disease.
Topics: Body Composition; Body Mass Index; Cardiovascular Diseases; Estradiol; Female; Hormone Replacement Therapy; Humans; Leptin; Metabolic Diseases; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Single-Blind Method; Waist-Hip Ratio | 2007 |
Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
Topics: Administration, Cutaneous; Age Factors; Aged; Aged, 80 and over; Aging; Blood Flow Velocity; Brachial Artery; Chi-Square Distribution; Coronary Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endothelium, Vascular; Estradiol; Female; Humans; Middle Aged; Multivariate Analysis; Nitroglycerin; Norethindrone; Norethindrone Acetate; Postmenopause; Probability; Reference Values; Risk Factors; Treatment Outcome; Vascular Patency | 2007 |
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis | 2007 |
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Topics: Analysis of Variance; Blood Coagulation; Blood Coagulation Factors; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism; Venous Thrombosis | 2007 |
Effects of estrogen and estrogen-progestogen therapy on homocysteine levels and their correlation with carotid vascular resistance.
Topics: Carotid Artery, Common; Double-Blind Method; Estradiol; Female; Homocysteine; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Prospective Studies; Pulsatile Flow; Ultrasonography; Vascular Resistance | 2007 |
Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
Topics: Aged; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes | 2007 |
Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
Topics: Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Postmenopause; Treatment Outcome | 2008 |
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
Topics: Adult; Body Mass Index; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Estrogens, Conjugated (USP); Fas Ligand Protein; Female; Follicle Stimulating Hormone; Ghrelin; Hormone Replacement Therapy; Humans; Insulin; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin | 2008 |
Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women.
Topics: Adult; Aged; Amenorrhea; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Double-Blind Method; Endometrium; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Ultrasonography; Uterine Hemorrhage | 2008 |
Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
Topics: Administration, Cutaneous; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Libido; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Sexual Dysfunction, Physiological; Stress, Psychological | 2008 |
Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
Topics: Administration, Oral; Aged; Breast; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Organ Size; Postmenopause; Raloxifene Hydrochloride | 2008 |
The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Topics: Blood Glucose; Carbohydrate Metabolism; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin Resistance; Lipid Metabolism; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Obesity; Progesterone Congeners; Prospective Studies | 2008 |
Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild t
Topics: Analysis of Variance; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Self-Assessment; Skin; Skin Aging; Treatment Outcome | 2008 |
Enhanced neuroactivation during verbal memory processing in postmenopausal women receiving short-term hormone therapy.
Topics: Cross-Over Studies; Double-Blind Method; Educational Status; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Judgment; Language; Magnetic Resonance Imaging; Memory; Mental Status Schedule; Middle Aged; Norethindrone; Norethindrone Acetate; Phonetics; Placebos; Postmenopause; Speech | 2009 |
A comparison of hormone therapies on the urinary excretion of prostacyclin and thromboxane A2.
Topics: Cardiovascular Diseases; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Thromboxane A2 | 2008 |
[Using pausogest for hormone replacement therapy--effect on plasma lipoproteins in menopause women].
Topics: Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoproteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Treatment Outcome | 2008 |
Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.
Topics: Administration, Cutaneous; Aged; Breast; Double-Blind Method; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Pain; Postmenopause; Sexual Dysfunction, Physiological; Uterine Hemorrhage | 2009 |
Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Endometrium; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Inhibins; Luteinizing Hormone; Menstruation; Middle Aged; Norethindrone; Norethindrone Acetate; Ovarian Follicle; Progesterone; Ultrasonography; Young Adult | 2009 |
Short-term hormone treatment modulates emotion response circuitry in postmenopausal women.
Topics: Brain; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Emotions; Estrogen Replacement Therapy; Estrogens; Ethinyl Estradiol; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Nerve Net; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Radiography; Time Factors | 2010 |
Progestin may modify the effect of low-dose hormone therapy on mammographic breast density.
Topics: Adult; Androstenes; Breast; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Middle Aged; Mineralocorticoid Receptor Antagonists; Norethindrone; Norethindrone Acetate; Postmenopause | 2009 |
The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.
Topics: Alkaline Phosphatase; Arthritis, Rheumatoid; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Calcium; Cartilage; Cartilage Oligomeric Matrix Protein; Cholecalciferol; Estradiol; Estrogen Replacement Therapy; Extracellular Matrix Proteins; Female; Glycoproteins; Humans; Matrilin Proteins; Middle Aged; Norethindrone; Norethindrone Acetate; Peptide Fragments; Postmenopause; Procollagen; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Statistics, Nonparametric | 2009 |
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Pregnancy, Unplanned; Proportional Hazards Models; Retrospective Studies; Risk; Young Adult | 2009 |
A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.
Topics: Adult; Canada; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norethindrone; Norethindrone Acetate; Prospective Studies; Severity of Illness Index | 2009 |
Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Carbohydrate Metabolism; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Lipid Metabolism; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors | 2010 |
Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis.
Topics: Adult; Analgesics, Non-Narcotic; Aromatase Inhibitors; Drug Therapy, Combination; Dysmenorrhea; Dyspareunia; Endometriosis; Female; Humans; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Pain Measurement; Patient Satisfaction; Pelvic Pain; Prospective Studies; Time Factors; Treatment Outcome; Triazoles; Young Adult | 2009 |
Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.
Topics: Blood Glucose; Blood Pressure; Breast; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Hemostasis; Humans; Insulin-Like Growth Factor I; Lipids; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Sex Hormone-Binding Globulin; Uterine Hemorrhage | 2010 |
Effect of abrupt discontinuation versus gradual dose reduction of postmenopausal hormone therapy on hot flushes.
Topics: Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Time Factors | 2010 |
Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women.
Topics: Adult; Age Factors; Coronary Disease; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Risk Factors; Serine Endopeptidases | 2010 |
The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.
Topics: ADAM Proteins; Adult; Androgen Antagonists; Androstenes; CD40 Ligand; Estradiol; Estrogen Replacement Therapy; Female; Health; Humans; Membrane Proteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone Congeners | 2010 |
Estrogen plus progestin treatment: effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women.
Topics: Androstenes; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Health; Humans; Norethindrone; Norethindrone Acetate; Postmenopause; Progestins | 2010 |
Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
Topics: Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Clodronic Acid; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Femur; Finland; Follow-Up Studies; Humans; Lumbar Vertebrae; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies | 2010 |
Genistein aglycone: a new therapeutic approach to reduce endometrial hyperplasia.
Topics: Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Female; Genistein; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Phytoestrogens; Phytotherapy; Plant Extracts; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Uterine Hemorrhage | 2010 |
Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial.
Topics: Adult; Aromatase Inhibitors; Drug Therapy, Combination; Dyspareunia; Endometriosis; Female; Humans; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Pelvic Pain; Triazoles; Triptorelin Pamoate; Ultrasonography | 2011 |
Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women.
Topics: Breast; Breast Neoplasms; Estradiol; Estrogen Receptor Modulators; Female; Gene Expression Regulation, Neoplastic; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Risk Factors | 2011 |
Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
Topics: Breast; Cimicifuga; Contraceptives, Oral, Synthetic; Densitometry; Double-Blind Method; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Plant Preparations; Postmenopause; Radiographic Image Interpretation, Computer-Assisted; Statistics, Nonparametric | 2011 |
Comparison of cervical mucus of 24/4 vs. 21/7 combined oral contraceptives.
Topics: Adult; Cervix Mucus; Cervix Uteri; Chemical Phenomena; Contraceptives, Oral, Combined; Cross-Over Studies; Cryopreservation; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Male; Menstrual Cycle; Norethindrone; Norethindrone Acetate; Patient Dropouts; Semen Preservation; Single-Blind Method; Sperm Transport; Viscosity; Young Adult | 2012 |
Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction.
Topics: Adult; Body Mass Index; Cohort Studies; Coitus; Dyspareunia; Endometriosis; Female; Humans; Logistic Models; Norethindrone; Norethindrone Acetate; Pain Measurement; Patient Satisfaction | 2012 |
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
Topics: Breast Neoplasms; Contraceptives, Oral, Synthetic; Denmark; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Follow-Up Studies; Heart Failure; Hormone Replacement Therapy; Hospitalization; Humans; Middle Aged; Myocardial Infarction; Neoplasms; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Risk; Stroke; Time Factors; Treatment Outcome; Venous Thrombosis | 2012 |
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies.
Topics: Adult; Aromatase Inhibitors; Calcium; Cholecalciferol; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogen Receptor Modulators; Female; Humans; Image Processing, Computer-Assisted; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Norpregnenes; Prospective Studies; Rectal Diseases; Treatment Outcome; Triazoles; Triptorelin Pamoate; Ultrasonography; Vaginal Diseases; Vitamins | 2013 |
Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
Topics: Affect; Calcium Carbonate; Cholecalciferol; Contraceptives, Oral, Synthetic; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Quality of Life; Sexual Behavior; Statistics, Nonparametric; Surveys and Questionnaires; Vitamins | 2013 |
Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives.
Topics: Adult; Cervix Mucus; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Estradiol; Ethinyl Estradiol; Female; Follicular Phase; Humans; Norethindrone; Norethindrone Acetate; Ovary; Ovulation Inhibition; Patient Dropouts; Pituitary Gland; Progesterone; Single-Blind Method; Tissue Distribution; Young Adult | 2013 |
Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Middle Aged; Norethindrone; Norethindrone Acetate; Pregnancy; Pregnancy Rate; Young Adult | 2013 |
Synergistic effects of E2MATE and norethindrone acetate on steroid sulfatase inhibition: a randomized phase I proof-of-principle clinical study in women of reproductive age.
Topics: Adult; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Endometrium; Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Reproduction; Steryl-Sulfatase; Young Adult | 2014 |
Long-term treatment of uterine fibroids with ulipristal acetate ☆.
Topics: Administration, Oral; Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Drug Administration Schedule; Endometrium; Europe; Female; Humans; Leiomyoma; Menorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Pelvic Pain; Quality of Life; Time Factors; Treatment Outcome; Tumor Burden; Uterine Neoplasms | 2014 |
Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study.
Topics: Adult; Antineoplastic Agents; Blood Loss, Surgical; Chemotherapy, Adjuvant; Cicatrix; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Female; Humans; Laparoscopy; Leiomyoma; Letrozole; Neoadjuvant Therapy; Nitriles; Norethindrone; Norethindrone Acetate; Operative Time; Premenopause; Prospective Studies; Single-Blind Method; Triazoles; Tumor Burden; Ultrasonography; Uterine Neoplasms | 2014 |
Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment.
Topics: Adult; Contraceptives, Oral; Endometriosis; Female; Follow-Up Studies; Humans; Nandrolone; Norethindrone; Norethindrone Acetate; Pain Measurement; Patient Satisfaction; Pelvic Pain; Pilot Projects; Prospective Studies; Quality of Life; Rectal Diseases; Treatment Outcome; Vaginal Diseases | 2014 |
What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?
Topics: Age Factors; Brazil; C-Reactive Protein; Cardiovascular Diseases; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Homocysteine; Humans; Longitudinal Studies; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Dropouts; Postmenopause; Progestins; Prospective Studies | 2015 |
Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Bone Resorption; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endometriosis; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Norethindrone; Norethindrone Acetate; Prospective Studies; Quality of Life; Risk Assessment; Treatment Outcome; Young Adult | 2015 |
Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back.
Topics: Adult; Aromatase Inhibitors; Cohort Studies; Drug Therapy, Combination; Endometriosis; Female; Humans; Letrozole; Longitudinal Studies; Nitriles; Norethindrone; Norethindrone Acetate; Pain Measurement; Pelvic Pain; Progestins; Treatment Outcome; Triazoles; Young Adult | 2015 |
Continuous Norethisterone Acetate versus Cyclical Drospirenone 3 mg/Ethinyl Estradiol 20 μg for the Management of Primary Dysmenorrhea in Young Adult Women.
Topics: Adolescent; Analgesics; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dysmenorrhea; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Jordan; Mineralocorticoid Receptor Antagonists; Norethindrone; Norethindrone Acetate; Pain Measurement; Prospective Studies; Treatment Outcome; Young Adult | 2016 |
Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive.
Topics: Adolescent; Adult; Amenorrhea; Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Obesity; Pregnancy; Pregnancy, Unplanned; Young Adult | 2016 |
Depo-Provera Versus Norethisterone Acetate in Management of Endometrial Hyperplasia Without Atypia.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Disease Management; Endometrial Hyperplasia; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies | 2016 |
Plasma fibrin clot properties in postmenopausal women: effects of hormone therapy.
Topics: Adult; Blood Coagulation; C-Reactive Protein; Case-Control Studies; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrin; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Premenopause | 2016 |
The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial.
Topics: Adolescent; Boston; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Therapy, Combination; Endometriosis; Estrogens; Estrogens, Conjugated (USP); Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Norethindrone; Norethindrone Acetate; Pain; Quality of Life; Treatment Outcome; Young Adult | 2017 |
Does menopausal hormone therapy (MHT), exercise or a combination of both, improve pain and function in post-menopausal women with greater trochanteric pain syndrome (GTPS)? A randomised controlled trial.
Topics: Administration, Topical; Australia; Clinical Protocols; Estradiol; Exercise; Female; Femur; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Pain; Pain Management; Placebos; Postmenopause; Quality of Life; Surveys and Questionnaires | 2016 |
Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia.
Topics: Endometrial Hyperplasia; Endometrium; Estradiol; Female; Humans; Male; Nandrolone; Norethindrone; Norethindrone Acetate | 2023 |
A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women.
Topics: Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Phenylurea Compounds | 2023 |
304 other study(ies) available for norethindrone and norethindrone acetate
| Article | Year |
|---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Plasma levels of norethisterone in women with subcutaneous implants of norethisterone acetate.
Topics: Adult; Drug Implants; Female; Humans; Norethindrone; Norethindrone Acetate | 1979 |
Treatment of advanced breast cancer with norethisterone acetate.
Topics: Age Factors; Aged; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Norethindrone; Norethindrone Acetate | 1979 |
Plasma lipid and lipoprotein effects of transdermal administration of estradiol and estradiol/norethisterone acetate.
Topics: Administration, Cutaneous; Adult; Aged; Cholesterol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners | 1992 |
The effect of combined estrogen/progestogen treatment in women with hyperprolactinemic amenorrhea.
Topics: Adolescent; Adult; Amenorrhea; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperprolactinemia; Norethindrone; Norethindrone Acetate; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1992 |
Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
Topics: Amenorrhea; Atrophy; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Time Factors; Uterine Hemorrhage | 1992 |
A transdermal regimen for continuous combined hormone replacement therapy in the menopause.
Topics: Administration, Cutaneous; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners | 1992 |
Effect of 17 beta-oestradiol and norethisterone acetate on vertebral bone mass and lipid metabolism in early postmenopausal women.
Topics: Bone Density; Estradiol; Female; Humans; Lipids; Lumbar Vertebrae; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteocalcin; Progesterone Congeners; Prospective Studies | 1992 |
Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women.
Topics: Administration, Cutaneous; Affect; Attitude to Health; Climacteric; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Quality of Life | 1992 |
[Programmed stimulation for in vitro fertilization].
Topics: Adult; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteolytic Agents; Menotropins; Norethindrone; Norethindrone Acetate; Ovulation Induction; Pilot Projects; Pregnancy; Triptorelin Pamoate | 1992 |
Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
Topics: Analysis of Variance; Animals; Aorta; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Estradiol; Female; Levonorgestrel; Lipoproteins; Norethindrone; Norethindrone Acetate; Ovariectomy; Progestins; Rabbits; Random Allocation; Triglycerides | 1992 |
Effect of alcohol ingestion on carcinogenesis by synthetic estrogen and progestin in the rat liver.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Cell Nucleus; Cytosol; DNA; Estradiol Congeners; Ethanol; Ethinyl Estradiol; Female; gamma-Glutamyltransferase; Liver; Liver Neoplasms, Experimental; Norethindrone; Norethindrone Acetate; Phosphorus Radioisotopes; Progestins; Rats; Rats, Inbred Strains; Receptors, Estrogen | 1991 |
[The action of Sequostat in comparison to Sequence Ovosiston on selected metabolic parameters].
Topics: Adolescent; Adult; Blood Glucose; Blood Proteins; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Lipids; Mestranol; Metabolism; Norethindrone; Norethindrone Acetate; Norgestrel | 1990 |
Bioavailability of norethindrone and menstrual pattern after insertion of norethindrone acetate implants in rhesus monkeys.
Topics: Amenorrhea; Animals; Biological Availability; Drug Implants; Female; Macaca mulatta; Menstruation; Norethindrone; Norethindrone Acetate; Radioimmunoassay | 1991 |
Pharmacokinetic studies of norethisterone-3-oxime and norethisterone-3-oxime acetate in rhesus monkey.
Topics: Animals; Biological Availability; Chromatography, High Pressure Liquid; Female; Macaca mulatta; Norethindrone; Norethindrone Acetate; Progesterone Congeners | 1991 |
Androgen synthesis in human fetal testis exposed in utero to a combination of norethindrone acetate and ethinyl estradiol.
Topics: Androgens; Androstenedione; Ethinyl Estradiol; Female; Humans; Leydig Cells; Male; Maternal-Fetal Exchange; Microscopy, Electron; Multienzyme Complexes; Norethindrone; Norethindrone Acetate; Pregnancy; Progesterone Reductase; Steroid Isomerases; Testis; Testosterone | 1991 |
[Contraception with cyclic administration of buserelin and gestagens: increase in testosterone and free testosterone serum concentration].
Topics: Administration, Intranasal; Adult; Buserelin; Contraceptives, Oral, Combined; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Protein Binding; Testosterone | 1991 |
Diffuse uterine leiomyomatosis with hemorrhage.
Topics: Adult; Clomiphene; Female; Humans; Immunohistochemistry; Infertility, Female; Leiomyoma; Menorrhagia; Norethindrone; Norethindrone Acetate; Uterine Neoplasms | 1991 |
Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
Topics: Animals; Aorta; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Drug Therapy, Combination; Endometrium; Energy Intake; Estradiol; Estradiol Dehydrogenases; Female; Isocitrate Dehydrogenase; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Ovariectomy; Rabbits | 1991 |
Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.
Topics: Adult; Aged; Breast; Delayed-Action Preparations; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Longitudinal Studies; Mammography; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Retrospective Studies; X-Ray Intensifying Screens | 1990 |
Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal women.
Topics: Animals; Bone and Bones; Calcium; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrus; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteocalcin; Osteogenesis; Time Factors | 1990 |
Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status.
Topics: Adult; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Menopause; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Pregnancy Proteins; Progesterone | 1990 |
Dissolution testing of norethindrone:ethinyl estradiol, norethindrone:mestranol, and norethindrone acetate:ethinyl estradiol combination tablets.
Topics: 1-Propanol; Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Indicators and Reagents; Mestranol; Norethindrone; Norethindrone Acetate; Sodium Dodecyl Sulfate; Solubility; Spectrophotometry, Ultraviolet | 1990 |
Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures.
Topics: Alkaline Phosphatase; Bone and Bones; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Hydroxyproline; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Random Allocation; Spinal Injuries | 1990 |
Cyclic therapy resulted in pregnancy in premature ovarian failure.
Topics: Adult; Chlormadinone Acetate; Drug Administration Schedule; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Menopause, Premature; Norethindrone; Norethindrone Acetate; Pregnancy | 1985 |
[Interdisciplinary diagnosis and therapy concepts in climacteric osteoporosis].
Topics: Adult; Bone and Bones; Calcium; Chlormadinone Acetate; Climacteric; Combined Modality Therapy; Ethinyl Estradiol; Female; Fluorides; Follow-Up Studies; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Physical Therapy Modalities; Radiography | 1989 |
[Therapy of juvenile adenomatous hyperplasia of the endometrium by progesterone stimulation].
Topics: Adenoma; Adolescent; Adult; Chlormadinone Acetate; Drug Administration Schedule; Endometrial Hyperplasia; Female; Humans; Norethindrone; Norethindrone Acetate; Uterine Neoplasms | 1989 |
Use of progestins.
Topics: Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Estradiol; Estradiol Congeners; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Time Factors | 1989 |
Effect of progestins, estradiol, and coenzymes NAD and NADPH on the interconversion of estradiol and estrone in rabbit uterus in vitro.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenosine Triphosphate; Animals; Biotransformation; Estradiol; Estrone; Female; Glucosephosphates; In Vitro Techniques; NAD; NADP; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone; Progestins; Rabbits; Uterus | 1989 |
[Synthetic female hormones-induced liver cancer].
Topics: Animals; Carcinoma, Hepatocellular; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen | 1989 |
Estrogens and progestogens conserve bone in rats deficient in calcitonin and parathyroid hormone.
Topics: Animals; Bone and Bones; Calcitonin; Calcium; Cyclic AMP; Estradiol; Female; Hydroxyproline; Norethindrone; Norethindrone Acetate; Parathyroid Glands; Parathyroid Hormone; Rats; Rats, Inbred Strains; Reference Values; Thyroid Gland; Thyroidectomy; Transplantation, Autologous | 1989 |
[Treatment with danazol of breast adenosis. A comparative note].
Topics: Adolescent; Adult; Danazol; Female; Fibrocystic Breast Disease; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Pregnadienes; Vitamin A; Vitamin E | 1989 |
Norethisterone acetate as secondary endocrine treatment in advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Ovariectomy; Prednisolone; Tamoxifen | 1989 |
Reversible busulfan-induced ovarian failure.
Topics: Adult; Amenorrhea; Busulfan; Estradiol; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Infant, Newborn; Leukemia, Myeloid; Luteinizing Hormone; Menopause, Premature; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Pregnancy Complications, Neoplastic | 1987 |
The effects of long-acting injectable contraceptives on carbohydrate metabolism.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Longitudinal Studies; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pyruvates; Time Factors | 1985 |
Oral contraceptive use and the risk of chlamydial and gonococcal infections.
Topics: Adult; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Contraceptives, Oral; Female; Gonorrhea; Humans; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Cervical Diseases | 1989 |
[Therapy with gestagens in hyperplastic changes of the endometrium].
Topics: Adenocarcinoma; Adenoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norethindrone Acetate; Uterine Neoplasms | 1986 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |
Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
Topics: Administration, Cutaneous; Adult; Contraceptive Agents, Male; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Sperm Count; Spermatogenesis; Testosterone | 1988 |
Surface activity on the periosteal and corticoendosteal envelopes following continuous progestogen supplementation in spayed beagles.
Topics: Animals; Bone and Bones; Bone Resorption; Dogs; Female; Minerals; Norethindrone; Norethindrone Acetate; Osteogenesis; Ovariectomy; Periosteum | 1986 |
Antacid does not reduce the bioavailability of oral contraceptive steroids in women.
Topics: Adult; Antacids; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Time Factors | 1986 |
Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill.
Topics: Clomiphene; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Menotropins; Norethindrone; Norethindrone Acetate; Ovulation Induction | 1987 |
Plasma rifampicin levels during oral contraception.
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Rifampin | 1988 |
[Optimization of high-performance liquid chromatographic separation of progestogens].
Topics: Algorithms; Chromatography, High Pressure Liquid; Microcomputers; Norethindrone; Norethindrone Acetate; Progestins | 1987 |
Effects of natural oestrogen/progestogen substitution therapy on carbohydrate and lipid metabolism in post-menopausal women.
Topics: Adult; Blood Glucose; Cholesterol; Diabetes Mellitus; Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Kinetics; Lipids; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Triglycerides | 1986 |
Embryotoxicity of sex steroidal hormone combinations in nonhuman primates: I. Norethisterone acetate + ethinylestradiol and progesterone + estradiol benzoate (Macaca mulatta, Macaca fascicularis, and Papio cynocephalus).
Topics: Abnormalities, Drug-Induced; Abortion, Veterinary; Animals; Bone and Bones; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Fetal Death; Genitalia; Gestational Age; Macaca fascicularis; Macaca mulatta; Maternal-Fetal Exchange; Norethindrone; Norethindrone Acetate; Papio; Pregnancy; Progesterone | 1987 |
Use of progestogen therapy.
Topics: Breast Neoplasms; Cholesterol, HDL; Drug Therapy, Combination; Estrogens; Female; Humans; Menopause; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Risk; Uterine Neoplasms | 1987 |
[Monogest in clinical practice--hormone studies].
Topics: Adult; Body Temperature; Contraceptives, Oral, Synthetic; Endometrium; Estrogens; Female; Humans; Menstrual Cycle; Norethindrone; Norethindrone Acetate | 1987 |
Comparison of radioimmunoassay and enzyme-linked immunoassay for the measurement of progestogen in equine plasma and milk.
Topics: Animals; Enzyme-Linked Immunosorbent Assay; Estrus; Estrus Detection; Female; Horses; Milk; Norethindrone; Norethindrone Acetate; Ovulation; Ovulation Detection; Pregnancy; Radioimmunoassay | 1987 |
Adolescent contraception.
Topics: Adolescent; Adolescent Behavior; Contraception; Contraceptive Devices; Contraceptives, Oral, Hormonal; Diethylstilbestrol; Female; Humans; Intrauterine Devices; Male; Norethindrone; Norethindrone Acetate | 1987 |
The relative fatty acid composition of serum lecithin and cholesterol ester: influence of an estrogen-progestogen regimen in climacteric women.
Topics: Adult; Cholesterol Esters; Climacteric; Drug Combinations; Estradiol; Estriol; Fatty Acids; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Phosphatidylcholines | 1986 |
Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
Topics: Cholesterol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Estradiol; Estriol; Estrogens; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1986 |
Steroid receptors in human ovarian malignancy. A review of four years tissue collection.
Topics: Adult; Estrogens; Female; Hormones; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone | 1986 |
Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest.
Topics: Atrophy; Climacteric; Drug Combinations; Endometrium; Estradiol; Estriol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1985 |
Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
Topics: Adult; Climacteric; Drug Combinations; Endometrium; Estradiol; Estriol; Female; Humans; Lipids; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1985 |
The influence of a sequential-type oral contraceptive with ethinylestradiol-sulfonate soft gelatin capsules and norethisterone acetate on carbohydrate metabolism during the first twelve months.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral; Contraceptives, Oral, Sequential; Delayed-Action Preparations; Ethinyl Estradiol; Female; Humans; Insulin; Norethindrone; Norethindrone Acetate; Time Factors | 1985 |
Sulpiride and the potentiation of progestogen only contraception.
Topics: Adult; Contraception; Drug Synergism; Female; Humans; Norethindrone; Norethindrone Acetate; Sulpiride | 1985 |
[Effect of ethinyl estradiol sulfonate/norethisterone acetate on gonadotropin secretion in pubertal girls].
Topics: Adolescent; Body Height; Child; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norethindrone; Norethindrone Acetate; Pituitary Hormone-Releasing Hormones; Puberty; Radioimmunoassay | 1985 |
[Effect of ethinyl estradiol sulfonate/norethisterone acetate on PRI secretion in pubertal girls].
Topics: Adolescent; Body Height; Child; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Prolactin; Puberty; Radioimmunoassay; Thyrotropin-Releasing Hormone | 1985 |
[Effect of ethinyl estradiol sulfonate/norethisterone acetate on HGH secretion in pubertal girls].
Topics: Adolescent; Adult; Arginine; Body Height; Chorionic Gonadotropin; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Pituitary Hormone-Releasing Hormones; Puberty; Radioimmunoassay; Thyrotropin-Releasing Hormone | 1985 |
[Effect of ethinyl estradiol sulfonate/norethisterone acetate on TSH, T4, TBC and the FT4 index in pubertal girls].
Topics: Adolescent; Arginine; Body Height; Child; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Pituitary Hormone-Releasing Hormones; Puberty; Thyroid Hormones; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Thyroxine-Binding Proteins | 1985 |
Prediction of response to endocrine therapy in pronounced cyclical mastalgia using dynamic tests of prolactin release.
Topics: Adult; Breast Diseases; Bromocriptine; Danazol; Domperidone; Fatty Acids, Essential; Fatty Acids, Unsaturated; Female; gamma-Linolenic Acid; Humans; Linoleic Acids; Middle Aged; Norethindrone; Norethindrone Acetate; Oenothera biennis; Plant Oils; Prolactin; Secretory Rate; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1985 |
Androgen receptor in human normal and malignant pancreatic tissue and cell lines.
Topics: Adenocarcinoma; Aged; Binding, Competitive; Chromatography, Affinity; Female; Humans; Male; Middle Aged; Norethindrone; Norethindrone Acetate; Pancreas; Pancreatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone | 1986 |
Management of advanced carcinoma of the breast.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Neoplasm Recurrence, Local; Norethindrone; Norethindrone Acetate; Tamoxifen | 1985 |
Cyclic changes in ciliation, cell height, and mitotic activity in human tubal epithelium during reproductive life.
Topics: Cell Cycle; Epithelial Cells; Estrogens; Fallopian Tubes; Female; Follicular Phase; Humans; Leiomyoma; Menstrual Cycle; Mitotic Index; Norethindrone; Norethindrone Acetate; Ovulation; Uterine Neoplasms | 1985 |
Effects of natural and synthetic estrogens and progestins on glycogen deposition in female mice.
Topics: Animals; Estradiol; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Glycogen; Liver; Mice; Muscles; Myocardium; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Uterus | 1985 |
Endometrial responses to transdermal estradiol in postmenopausal women.
Topics: Administration, Topical; Adult; Endometrium; Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Skin; Uterine Hemorrhage | 1985 |
[Influence of some sexual hormones on the binding of uric acid- plasma proteins: ex vivo and in vitro experience].
Topics: Blood Proteins; Colorimetry; Contraceptives, Oral; Cyclofenil; Estradiol; Female; Humans; In Vitro Techniques; Norethindrone; Norethindrone Acetate; Progesterone; Protein Binding; Testosterone; Time Factors; Ultrafiltration; Uric Acid | 1985 |
Sex and hormonal influences on platelet sensitivity and coagulation in the rat.
Topics: Animals; Blood Coagulation; Estradiol; Estrogens; Estrus; Ethinyl Estradiol; Female; Male; Norethindrone; Norethindrone Acetate; Platelet Aggregation; Progestins; Rats; Rats, Inbred Strains; Sex Factors | 1985 |
Endometrial and menstrual response to subcutaneous oestradiol and testosterone implants and continuous oral progestogen therapy in post-menopausal women.
Topics: Administration, Oral; Adult; Drug Implants; Drug Therapy, Combination; Endometrium; Estradiol; Female; Humans; Menopause; Menstruation; Middle Aged; Norethindrone; Norethindrone Acetate; Testosterone | 1985 |
Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women.
Topics: Adult; Aged; Cholesterol; Clonidine; Dydrogesterone; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides | 1982 |
The effect of various oral contraceptive combinations on premenstrual symptoms.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Female; Humans; Menstruation Disturbances; Middle Aged; Norethindrone; Norethindrone Acetate; Premenstrual Syndrome | 1982 |
Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
Topics: Adult; Age Factors; Breast; Breast Neoplasms; Contraceptives, Oral; Drug Combinations; Endometrium; Female; Humans; Mitosis; Norethindrone; Norethindrone Acetate; Ovary; Pregnancy; Risk; Time Factors | 1983 |
Facts about injectable contraceptives: memorandum from a WHO meeting.
Topics: Animals; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pregnancy; World Health Organization | 1982 |
Assay of some endogenous and synthetic sex steroids for tumor-initiating activity in rat liver using the Solt-Farber system.
Topics: Androgen Antagonists; Animals; Carcinogens; Cyproterone; Cyproterone Acetate; Estradiol; Ethinyl Estradiol; Liver Neoplasms; Male; Neoplasms, Experimental; Norethindrone; Norethindrone Acetate; Norethynodrel; Progesterone; Rats; Rats, Inbred F344 | 1983 |
Norethisterone and ethinylestradiol do not inhibit delta 5-3 beta-hydroxysteroid dehydrogenase in rat Leydig cells.
Topics: 3-Hydroxysteroid Dehydrogenases; Androstenedione; Animals; Cyanoketone; Dehydroepiandrosterone; Ethinyl Estradiol; Kinetics; Leydig Cells; Male; Norethindrone; Norethindrone Acetate; Pregnenolone; Rats; Rats, Inbred Strains | 1984 |
Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
Topics: Climacteric; Endometrium; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Norethindrone; Norethindrone Acetate; Prolactin | 1982 |
Androgen and progestogen production in cultured interstitial cells derived from immature rat testis.
Topics: Androgens; Animals; Cells, Cultured; Chorionic Gonadotropin; Cyclic AMP; Gonadotropins; Leydig Cells; Male; Norethindrone; Norethindrone Acetate; Oxidation-Reduction; Progesterone; Rats; Rats, Inbred Strains; Sexual Maturation; Testosterone; Time Factors | 1982 |
Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
Topics: Adult; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Middle Aged; Norethindrone; Norethindrone Acetate; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1983 |
[Primary adenoma of the liver with spontaneous rupture following long-term intake of gestagens. Case report].
Topics: Adenoma; Adult; Female; Humans; Liver Neoplasms; Norethindrone; Norethindrone Acetate; Rupture, Spontaneous | 1983 |
[Effect of sequential preparation with ethinyl estradiol sulfonate soft gelatin capsules and norethindrone acetate on carbohydrate metabolism].
Topics: Adult; Blood Glucose; Capsules; Drug Administration Schedule; Ethinyl Estradiol; Female; Gelatin; Glucose Tolerance Test; Humans; Insulin; Norethindrone; Norethindrone Acetate; Pharmaceutical Vehicles | 1984 |
Urinary estrogen and serum gonadotropin profiles in women ingesting oral contraceptive steroid formulations with variable estrogen content.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norethindrone; Norethindrone Acetate | 1983 |
The effect of 2 mg estradiol-17 beta plus 1 mg estriol, sequentially combined with 1 mg norethisteroneacetate, on LH, FSH, estradiol-17 beta, progesterone, testosterone and prolactin after ovariectomy.
Topics: Adult; Castration; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone; Prolactin; Testosterone | 1984 |
Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
Topics: Adult; Climacteric; Double-Blind Method; Drug Combinations; Drug Evaluation; Endometrium; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Liver; Liver Function Tests; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation | 1984 |
Norethisterone acetate and ethinylestradiol in early human pregnancy.
Topics: 17-alpha-Hydroxyprogesterone; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Kinetics; Norethindrone; Norethindrone Acetate; Pregnancy; Pregnancy Tests; Progesterone; Random Allocation; Ultrasonography; Uterine Hemorrhage | 1984 |
Are there any absolute medical contraindications to the progestogen only oral contraceptive?
Topics: Contraceptives, Oral; Contraceptives, Oral, Hormonal; Female; Humans; Hydatidiform Mole; Norethindrone; Norethindrone Acetate; Pregnancy; Pregnancy, Ectopic; Uterine Neoplasms | 1984 |
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms | 1980 |
Lipid metabolic studies in oophorectomized women: effects of synthetic progestogens on individual serum phospholipids and serum lecithin fatty acid composition.
Topics: Adult; Castration; Fatty Acids; Female; Humans; Levonorgestrel; Liver Function Tests; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Phosphatidylcholines; Phospholipids; Progesterone Congeners | 1982 |
A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
Topics: Adult; Climacteric; Drug Combinations; Estradiol; Estriol; Female; Humans; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Time Factors | 1984 |
Kinetics of chloroquine & contraceptive steroids in oral contraceptive users during concurrent chloroquine prophylaxis.
Topics: Adult; Chloroquine; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Interactions; Ethinyl Estradiol; Female; Humans; Kinetics; Malaria; Norethindrone; Norethindrone Acetate; Progesterone | 1984 |
Distribution of norethisterone and ethinylestradiol in the gravid rat and in the feto-placental unit of rhesus monkeys following intragastric administration of norethisterone acetate in combination with ethinylestradiol. I. Direct determinations.
Topics: Animals; Drug Combinations; Ethinyl Estradiol; Feces; Female; Fetus; Intubation, Gastrointestinal; Macaca mulatta; Maternal-Fetal Exchange; Norethindrone; Norethindrone Acetate; Placenta; Pregnancy; Radioimmunoassay; Rats; Rats, Inbred Strains; Time Factors | 1984 |
[Synthesis of cyclopentylpropionic ester of norethisterone acetate as a long-acting contraceptive].
Topics: Contraceptives, Oral; Female; Humans; Norethindrone; Norethindrone Acetate | 1984 |
Is endocrine status relevant to treatment planning in patients with gynaecological cancer?
Topics: Carcinoma; Female; Humans; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Uterine Neoplasms | 1984 |
Aetiological monitor of congenital abnormalities: a case-control surveillance system.
Topics: Abnormalities, Drug-Induced; Congenital Abnormalities; Data Collection; Employment; Estrogens; Female; Humans; Hungary; Norethindrone; Norethindrone Acetate; Pregnancy; Pregnancy Complications; Registries; Risk | 1983 |
Effects of daily 30 mcg d-norgestrel on growth hormone and cortisol.
Topics: Adult; Asian People; Carbohydrate Metabolism; Female; Growth Hormone; Humans; Norethindrone; Norethindrone Acetate; Norgestrel; Thailand | 1983 |
Does postmenopausal bone loss respond to estrogen replacement therapy independent of bone loss rate?
Topics: Aged; Bone and Bones; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estriol; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis | 1983 |
[Comparative studies of the effect on the in vitro growth of endometrial cancers of hydroxyprogesterone caproate, norethisterone acetate and D-norgestrel].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cells, Cultured; Drug Evaluation, Preclinical; Drug Resistance; Female; Humans; Hydroxyprogesterones; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Neoplasms | 1984 |
Norethisterone acetate in the treatment of advanced breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Humans; Hypophysectomy; Middle Aged; Norethindrone; Norethindrone Acetate; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 1984 |
Norethisterone and ethinyl estradiol kinetics during dapsone therapy.
Topics: Adult; Contraceptives, Oral, Combined; Dapsone; Drug Interactions; Ethinyl Estradiol; Female; Humans; Leprosy; Norethindrone; Norethindrone Acetate | 1984 |
Effects of an intranasally administered low dose progestogen on the pituitary and gonadal functions.
Topics: Administration, Intranasal; Adult; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Kinetics; Luteinizing Hormone; Norethindrone; Norethindrone Acetate; Progesterone | 1980 |
Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
Topics: Drug Implants; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Norethindrone; Norethindrone Acetate; Progesterone; Radioimmunoassay; Time Factors | 1981 |
'Cyclic hepatitis' in a young woman. Case presentation.
Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate | 1981 |
Effects of an intranasally administered low dose progestogen on the gingival epithelium.
Topics: Adult; Epithelium; Estradiol; Female; Follicle Stimulating Hormone; Gingiva; Humans; Luteinizing Hormone; Norethindrone; Norethindrone Acetate; Nose; Ovulation; Progesterone | 1981 |
Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Synthetic; England; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Prospective Studies | 1982 |
The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Lipids; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides | 1982 |
Effects of progestogens on the cardiovascular system.
Topics: Adult; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Coronary Disease; Estrogens; Female; Humans; Hypertension; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins | 1982 |
Blood pressure and contraceptive use.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Hypertension; Norethindrone; Norethindrone Acetate | 1982 |
Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens.
Topics: Adult; Blood Glucose; Castration; Contraceptives, Oral, Combined; Female; Glucose Tolerance Test; Humans; Hysterectomy; Insulin; Levonorgestrel; Lipids; Lipoproteins; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Cervical Neoplasms | 1982 |
Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period.
Topics: Bendroflumethiazide; Climacteric; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Time Factors | 1982 |
[Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
Topics: Adult; Buserelin; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Evaluation; Endometrium; Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Menstruation; Norethindrone; Norethindrone Acetate; Ovulation; Patient Acceptance of Health Care; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1982 |
Unilobar small hepatic vein obstruction: possible role of progestogen given as oral contraceptive.
Topics: Adult; Budd-Chiari Syndrome; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Female; Hepatic Veins; Humans; Norethindrone; Norethindrone Acetate; Phlebography; Tomography, X-Ray Computed | 1983 |
Comparative trials of low-dose combined oral contraceptives.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy | 1983 |
Norethindrone in serum after use of an oral contraceptive containing norethindrone acetate.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Half-Life; Humans; Kinetics; Menstruation; Norethindrone; Norethindrone Acetate | 1983 |
[Therapeutic potentials of treating uterine hemorrhages with norethisterone acetate].
Topics: Adolescent; Adult; Drug Evaluation; Female; Humans; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Uterine Hemorrhage | 1983 |
Fertilization and embryonic survival in ewes synchronized with exogenous hormones during the anestrous and estrous seasons.
Topics: Animals; Estrus; Estrus Synchronization; Female; Fertilization; Gonadotropins, Equine; Male; Norethindrone; Norethindrone Acetate; Ovum; Pregnancy; Seasons; Sheep; Sperm Count; Sperm-Ovum Interactions; Time Factors | 1981 |
Metabolism and pharmacokinetics of aminophenazone in man of different age and under various pathological conditions.
Topics: Adult; Age Factors; Aged; Aminopyrine; Ampyrone; Diabetes Mellitus, Type 1; Drug Interactions; Female; Humans; Kidney Diseases; Kinetics; Male; Middle Aged; Norethindrone; Norethindrone Acetate | 1982 |
Failure of contraceptive steroids to modify human chorionic gonadotrophin secretion by hydatidiform mole tissue and choriocarcinoma cells in culture.
Topics: Cell Division; Cells, Cultured; Choriocarcinoma; Chorionic Gonadotropin; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hydatidiform Mole; Norethindrone; Norethindrone Acetate; Organ Culture Techniques; Pregnancy; Uterine Neoplasms | 1981 |
Effect of castration and oral contraceptives on hepatic ethanol and acetaldehyde metabolizing enzymes in the male rat.
Topics: Alcohol Oxidoreductases; Aldehyde Oxidoreductases; Animals; Castration; Contraceptives, Oral; Cytosol; Ethanol; Ethinyl Estradiol; Liver; Male; Mitochondria, Liver; Norethindrone; Norethindrone Acetate; Rats | 1980 |
Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate.
Topics: Adult; Drug Implants; Female; Half-Life; Humans; Kinetics; Metabolic Clearance Rate; Norethindrone; Norethindrone Acetate; Progesterone | 1982 |
Plasma and erythrocyte membrane fatty acids in oral contraceptive users.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Erythrocyte Membrane; Erythrocytes; Estrogens; Fatty Acids; Female; Humans; Norethindrone; Norethindrone Acetate; Phosphatidylcholines; Phospholipids; Plasma | 1982 |
Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus.
Topics: Adolescent; Adult; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Lupus Erythematosus, Systemic; Norethindrone; Norethindrone Acetate | 1982 |
Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints.
Topics: Climacteric; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Uterine Hemorrhage; Vagina; Vaginal Smears | 1982 |
Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
Topics: Adult; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Synergism; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Menstruation; Norethindrone; Norethindrone Acetate | 1982 |
Psychophysiological stress responses in postmenopausal women before and after hormonal replacement therapy.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Estradiol; Estriol; Female; Heart Rate; Hormones; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Stress, Psychological; Sweating | 1982 |
The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women.
Topics: Adolescent; Adult; Ethambutol; Ethinyl Estradiol; Female; Humans; Isoniazid; Kinetics; Norethindrone; Norethindrone Acetate; Rifampin; Sex Hormone-Binding Globulin; Tuberculosis | 1980 |
Plasma protein binding of norethisterone.
Topics: Adult; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Kinetics; Norethindrone; Norethindrone Acetate; Protein Binding; Serum Albumin; Sex Hormone-Binding Globulin | 1982 |
Effect of implanted progesterone pellets on plasma progestogen concentrations in anoestrous pony mares.
Topics: Anestrus; Animals; Drug Implants; Estrus; Female; Horses; Male; Norethindrone; Norethindrone Acetate; Ovary; Pregnancy; Progesterone | 1982 |
Fluid-filled silastic capsules : a new approach to a more constant steroidal drug delivery system.
Topics: Capsules; Female; Humans; Norethindrone; Norethindrone Acetate; Silicone Elastomers | 1981 |
Bioavailability of norethindrone in rabbits after administration of norethindrone acetate in single, double and quadruple doses released through subcutaneous silastic implants.
Topics: Animals; Biological Availability; Drug Implants; Female; Norethindrone; Norethindrone Acetate; Rabbits; Silicone Elastomers | 1980 |
Dysfunctional uterine bleeding in the adolescent.
Topics: Adolescent; Blood Coagulation Disorders; Diagnosis, Differential; Estrogens; Female; Humans; Menstruation Disturbances; Norethindrone; Norethindrone Acetate | 1981 |
Nuclear progestin receptors in human uterus.
Topics: Cell Nucleus; Cytosol; Female; Humans; Kinetics; Menstruation; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Receptors, Progesterone; Uterus | 1981 |
Effect of oral contraceptives on tryptophan and tyrosine availability: evidence for a possible contribution to mental depression.
Topics: Adult; Brain Chemistry; Contraceptives, Oral; Contraceptives, Oral, Combined; Depressive Disorder; Ethinyl Estradiol; Female; Humans; Kynurenine; Mestranol; Norethindrone; Norethindrone Acetate; Tryptophan; Tyrosine | 1981 |
[Hormonal contraceptives of differentiated composition -- effects on thrombocyte function (author's transl)].
Topics: Blood Platelets; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Norgestrel; Platelet Adhesiveness; Platelet Aggregation; Thrombelastography | 1981 |
[Results obtained from gestagen treatment of patients for endometrial carcinoma, with particular reference to results obtained from in vitro tests before treatment (author's transl)].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Drug Resistance; Female; Humans; Hydroxyprogesterones; Neoplasm Staging; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Neoplasms | 1981 |
Effect of norethindrone acetate on glycogen & phosphorylase of adult rat testes & epididymis.
Topics: Animals; Epididymis; Glycogen; Male; Norethindrone; Norethindrone Acetate; Phosphorylases; Rats; Testis | 1981 |
Synchronization of ewes during anestrus: influence of time of year and interval to onset of estrus on conception rate.
Topics: Animals; Estrus; Estrus Synchronization; Female; Fertility; Gonadotropins, Equine; Litter Size; Norethindrone; Norethindrone Acetate; Ovulation; Pregnancy; Seasons; Sheep; Time Factors | 1981 |
Effects of a long-term treatment with norethisterone (a progestogen-only contraceptive) on the epidermis, the sebaceous glands, the meibomian gland and the Harderian gland in the cycling female rat.
Topics: Animals; Epidermal Cells; Epidermis; Eyelids; Female; Harderian Gland; Lacrimal Apparatus; Meibomian Glands; Norethindrone; Norethindrone Acetate; Rats; Rats, Inbred Strains; Sebaceous Glands | 1981 |
Menstrual behaviour with steroid implant.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Fertility; Humans; Menstruation Disturbances; Norethindrone; Norethindrone Acetate | 1981 |
In vivo production of nucleolar channel system in human endocervical secretory cells.
Topics: Adult; Cell Nucleolus; Cervix Uteri; Contraceptives, Oral; Cytoplasm; Cytoplasmic Granules; Female; Humans; Menstruation; Microscopy, Electron; Norethindrone; Norethindrone Acetate; Ovulation | 1981 |
In vitro hydrolysis of 19-norsteroid esters.
Topics: Adipose Tissue; Animals; Hydrolysis; In Vitro Techniques; Intestine, Small; Kidney; Liver; Lung; Lynestrenol; Muscles; Myocardium; Norethindrone; Norethindrone Acetate; Norgestrel; Norsteroids; Rabbits | 1980 |
Progestin receptors in human uterine cytosol.
Topics: Cytosol; Female; Humans; Kinetics; Menstruation; Norethindrone; Norethindrone Acetate; Progestins; Receptors, Estrogen; Receptors, Progesterone; Uterus | 1980 |
[Serum lipids in treatment with transdermal estradiol and oral norethisterone acetate].
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Climacteric; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Triglycerides | 1995 |
Effects of norethisterone acetate and tamoxifen on serum prolactin levels, uterine growth and on the presence of uterine immunoreactive prolactin in estradiol-treated ovariectomized rats.
Topics: Animals; Estradiol; Female; Norethindrone; Norethindrone Acetate; Ovariectomy; Prolactin; Rats; Rats, Wistar; Tamoxifen; Uterus | 1995 |
Postmenopausal hormone replacement therapy and plasma lipoproteins.
Topics: Aged; Cardiovascular Diseases; Cholesterol, HDL; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Progesterone Congeners; Progestins; Randomized Controlled Trials as Topic; Risk Factors | 1995 |
"Rollerball" ablation of the endometrium.
Topics: Electrocoagulation; Endometrium; Female; Humans; Hysterectomy; Leuprolide; Life Tables; Medroxyprogesterone Acetate; Menorrhagia; Norethindrone; Norethindrone Acetate; Postoperative Complications; Reoperation; Uterine Hemorrhage | 1995 |
Formation of ethinylestradiol in postmenopausal women during continuous treatment with a combination of estradiol, estriol and norethisterone acetate.
Topics: Aged; Estradiol; Estriol; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 1995 |
Transdermal hormonal replacement therapy with transdermal progestin every second month.
Topics: Administration, Cutaneous; Biopsy; Climacteric; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate | 1995 |
Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
Topics: Aged; Aged, 80 and over; Biopsy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Norethindrone; Norethindrone Acetate; Progestins; Retrospective Studies | 1994 |
Alcohol ingestion enhances hepatocarcinogenesis induced by synthetic estrogen and progestin in the rat.
Topics: Alcohol Drinking; Animals; Cell Division; Cytosol; DNA Damage; Ethinyl Estradiol; Female; Hyperplasia; Liver; Liver Neoplasms, Experimental; Male; Neoplasm Proteins; Norethindrone; Norethindrone Acetate; Organ Size; Rats; Rats, Wistar; Receptors, Estrogen; Receptors, Progesterone; Sex Factors | 1994 |
The effect of contraceptive steroids on hepatic cholesterol metabolism in female rats (I).
Topics: Acetoacetates; Acetyl-CoA C-Acetyltransferase; Animals; Cholesterol; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Hydroxymethylglutaryl-CoA Synthase; Levonorgestrel; Liver; Norethindrone; Norethindrone Acetate; Rats | 1993 |
The effects of antibiotics and steroids on the carriage of vaginal bacteria into the uterus during insertion of intra-uterine monofilaments in the guinea-pig.
Topics: Animals; Bacteria; Colony Count, Microbial; Female; Guinea Pigs; Injections, Intraperitoneal; Intrauterine Devices; Norethindrone; Norethindrone Acetate; Oxytetracycline; Progesterone Congeners; Uterus; Vagina | 1993 |
Effect of norethisterone acetate on serum lipid and lipoprotein parameters as well as on blood coagulation in female monkeys (M. fascicularis).
Topics: Animals; Blood Coagulation; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Female; Fibrinolysis; Lipids; Lipoproteins; Macaca fascicularis; Norethindrone; Norethindrone Acetate; Phospholipids; Triglycerides | 1993 |
Progestin effects on prolactin secretion and on immunoreactive prolactin cells in estradiol-treated ovariectomized rats.
Topics: Animals; Estradiol; Female; Immunohistochemistry; Norethindrone; Norethindrone Acetate; Organ Size; Ovariectomy; Pituitary Gland; Prolactin; Rats; Rats, Wistar | 1993 |
[Successful treatment of recurrent lower gastrointestinal hemorrhage in intestinal angiodysplasia with an estrogen-progesterone combination].
Topics: Aged; Aged, 80 and over; Drug Combinations; Ethinyl Estradiol; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Telangiectasia, Hereditary Hemorrhagic | 1993 |
The effect of contraceptive steroids on plasma lipoprotein metabolism in female rats (II).
Topics: Animals; Apolipoproteins; Cholesterol; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Levonorgestrel; Lipids; Lipoproteins; Norethindrone; Norethindrone Acetate; Phospholipids; Rats; Triglycerides | 1993 |
Does low-dose, transdermal, norethisterone acetate reliably cause endometrial transformation in postmenopausal oestrogen-users?
Topics: Administration, Cutaneous; Adult; Endometrium; Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Prospective Studies | 1993 |
High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse.
Topics: Analysis of Variance; Animals; Bone Development; Bone Resorption; Estradiol; Female; Femur; Megestrol; Megestrol Acetate; Mice; Mice, Inbred BALB C; Norethindrone; Norethindrone Acetate; Osteoclasts; Ovariectomy; Progesterone Congeners; Radioimmunoassay; Random Allocation; Spine; Tibia | 1993 |
Steroids 51. An improved synthesis of ORG 2058 and the synthesis of [3H]ORG 2058.
Topics: Isotope Labeling; Molecular Structure; Norethindrone; Norethindrone Acetate; Pregnenediones; Progesterone Congeners; Tritium | 1993 |
Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Buserelin; Calcium; Disease Models, Animal; Estradiol; Estrogens; Female; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Rats | 1993 |
Effect of oestrogen/gestagen replacement therapy on liver enzymes in patients with Ullrich-Turner syndrome.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Body Height; Child; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Liver Function Tests; Norethindrone; Norethindrone Acetate; Sexual Maturation; Turner Syndrome | 1995 |
Growth hormone normalizes vertebral strength in ovariectomized rats.
Topics: Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Disease Models, Animal; Estradiol; Female; Growth Hormone; Lumbar Vertebrae; Norethindrone; Norethindrone Acetate; Ovariectomy; Rats; Rats, Sprague-Dawley; Tensile Strength | 1995 |
Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Implants; Electrophoresis, Agar Gel; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Hydrogen-Ion Concentration; Hysterectomy; Isomerism; Luteinizing Hormone; Middle Aged; Norethindrone; Norethindrone Acetate; Sex Hormone-Binding Globulin; Time Factors | 1996 |
Transdermal estroprogestins versus transdermal estrogen plus oral dihydrogesterone replacement in menopause.
Topics: 20-alpha-Dihydroprogesterone; Administration, Cutaneous; Blood Coagulation; Blood Pressure; Body Mass Index; Bone and Bones; Bone Density; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1996 |
Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women.
Topics: Adult; Aged; Climacteric; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Levonorgestrel; Long-Term Care; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Progestins | 1996 |
Quantitative determination of norethisterone acetate in human plasma by capillary gas chromatography with mass-selective detection.
Topics: Calibration; Circadian Rhythm; Gas Chromatography-Mass Spectrometry; Humans; Norethindrone; Norethindrone Acetate; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Testosterone | 1996 |
Effect of a programmed short-term stimulation protocol on the replacement of cryopreserved embryos.
Topics: Adult; Clinical Protocols; Cryopreservation; Embryo Transfer; Embryo, Mammalian; Female; Fertilization in Vitro; Gamete Intrafallopian Transfer; Humans; Menstrual Cycle; Norethindrone; Norethindrone Acetate; Ovulation Induction | 1996 |
Urinary cGMP excretion after hormone replacement therapy in postmenopausal women.
Topics: Administration, Oral; Cross-Over Studies; Cyclic GMP; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Treatment Outcome | 1996 |
Diagnostic efficacy of push-enteroscopy and long-term follow-up of patients with small bowel angiodysplasias.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiodysplasia; Combined Modality Therapy; Drug Therapy, Combination; Electrocoagulation; Endoscopy, Gastrointestinal; Ethinyl Estradiol; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intestinal Diseases; Intestine, Small; Male; Melena; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone Congeners; Retrospective Studies; Treatment Outcome | 1996 |
The addition of norethindrone acetate to leuprolide acetate for ovarian suppression has no adverse effect on ovarian stimulation.
Topics: Adult; Blastomeres; Drug Therapy, Combination; Female; Fertilization in Vitro; Follicular Phase; Humans; Leuprolide; Menotropins; Norethindrone; Norethindrone Acetate; Oocytes; Ovulation Induction; Pregnancy; Progesterone Congeners; Superovulation | 1997 |
Transdermal progestins in hormone replacement therapy.
Topics: Administration, Cutaneous; Aged; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 1997 |
Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study.
Topics: Drug Therapy, Combination; Endometriosis; Estrogens, Conjugated (USP); Female; Humans; Leuprolide; Norethindrone; Norethindrone Acetate | 1998 |
Norethindrone acetate enhances the antiatherogenic effect of 17beta-estradiol: a secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Drug Synergism; Estradiol; Female; Lipoproteins; Norethindrone; Norethindrone Acetate; Ovariectomy; Rabbits | 1998 |
Research in progress.
Topics: Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Norethindrone; Norethindrone Acetate; Prevalence; Research | 1998 |
The effects of progesterone and progestins on endometrial proliferation.
Topics: Atrophy; Biopsy; Cell Division; Contraceptives, Oral; Cyclins; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Mitosis; Norethindrone; Norethindrone Acetate; Norethynodrel; Postmenopause; Premenopause; Progesterone Congeners; Proliferating Cell Nuclear Antigen; Stromal Cells | 1998 |
Estradiol inhibits LDL oxidation: do the progestins medroxyprogesterone acetate and norethisterone acetate influence this effect?
Topics: Drug Interactions; Estradiol; Female; Hormone Replacement Therapy; Humans; Lipoproteins, LDL; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Oxidation-Reduction; Progesterone Congeners | 1998 |
The influence of norethisterone acetate on urinary urodilatin excretion in postmenopausal women.
Topics: Atrial Natriuretic Factor; Diuretics; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Peptide Fragments; Postmenopause | 1998 |
Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects.
Topics: Adult; Androstenes; Cells, Cultured; Collagenases; Contraceptive Agents, Female; Endometrium; Female; Humans; Levonorgestrel; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pregnenediones; Progesterone; Progesterone Congeners; Stromal Cells; Tissue Inhibitor of Metalloproteinase-1 | 1999 |
Endometrial cancer after combined hormone replacement therapy.
Topics: Adenocarcinoma; Endometrial Neoplasms; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors; Time Factors | 1999 |
The usefulness of biochemical bone markers in predicting the response of hormone replacement therapy in perimenopausal cigarette smoking healthy women.
Topics: Alkaline Phosphatase; Biomarkers; Calcium; Collagen; Collagen Type I; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments; Peptides; Procollagen; Smoking | 1999 |
Female sex hormone replacement therapy increases serum free 1,25-dihydroxyvitamin D3: a 1-year prospective study.
Topics: Calcitriol; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Postmenopause | 1999 |
Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Corpus Luteum; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norethindrone; Norethindrone Acetate; Ovarian Follicle; Ovary; Time Factors | 1999 |
Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study.
Topics: Aged; Aged, 80 and over; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Gastric Antral Vascular Ectasia; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Middle Aged; Norethindrone; Norethindrone Acetate; Pilot Projects; Progesterone Congeners; Recurrence | 1999 |
Hormone replacement therapy after uterine leiomyosarcoma treatment. Case reports.
Topics: Adult; Climacteric; Disease Progression; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyosarcoma; Middle Aged; Norethindrone; Norethindrone Acetate; Sigmoid Neoplasms; Uterine Neoplasms | 1999 |
Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy.
Topics: Aged; Cross-Sectional Studies; Endothelial Growth Factors; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Levonorgestrel; Lymphokines; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
[Severe gastrointestinal hemorrhage secondary to diffuse angiodysplasia: efficacy of estrogen-progesterone treatment].
Topics: Aged; Angiodysplasia; Blood Transfusion; Estradiol Congeners; Ethinyl Estradiol; Gastrointestinal Hemorrhage; Humans; Male; Norethindrone; Norethindrone Acetate; Progesterone; Risk Factors | 2000 |
Effects of ethinylestradiol-norethisterone acetate combinations on the ultrastructure of liver, kidney, ovary and endometrium cells.
Topics: Animals; Contraceptives, Oral, Combined; Endometrium; Energy Metabolism; Ethinyl Estradiol; Female; Kidney; Liver; Microscopy, Electron; Norethindrone; Norethindrone Acetate; Ovary; Protein Biosynthesis; Rats; Rats, Wistar | 1998 |
Effect of sequential estrogen/progestin treatment on biochemical vasoactive markers in postmenopausal women comparing oral and transdermal application.
Topics: Administration, Cutaneous; Administration, Oral; Biomarkers; Cyclic GMP; Estradiol; Estrogen Replacement Therapy; Female; Humans; Kidney; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Vasodilation | 2000 |
100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives.
Topics: Adult; Aspirin; Blood Viscosity; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Erythrocyte Aggregation; Erythrocyte Deformability; Ethinyl Estradiol; Female; Fibrinolytic Agents; Hemorheology; Humans; Norethindrone; Norethindrone Acetate; Norgestrel; Thrombophilia | 2000 |
Visualization of percutaneous 3H-estradiol and 3H-norethindrone acetate transport across human epidermis as a function of time.
Topics: Administration, Cutaneous; Autoradiography; Biological Transport; Epidermis; Estradiol; Extracellular Space; Female; Humans; Lipid Metabolism; Middle Aged; Norethindrone; Norethindrone Acetate; Permeability; Progesterone Congeners; Radiopharmaceuticals; Skin Absorption; Time Factors; Tritium | 2000 |
High-performance liquid chromatographic optimization study for the separation of natural and synthetic anabolic steroids. Application to urine and pharmaceutical samples.
Topics: Anabolic Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Hydrolysis; Norethindrone; Norethindrone Acetate; Pharmaceutical Preparations; Reproducibility of Results; Salts; Sensitivity and Specificity; Temperature | 2000 |
Effects of norethisterone acetate addition to estradiol in long term HRT.
Topics: Administration, Cutaneous; Administration, Oral; Cohort Studies; Drug Administration Schedule; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Quality of Life; Surveys and Questionnaires | 2000 |
An unusual multiplex cause of severe gastrointestinal bleeding in a haemodialysed patient.
Topics: Aged; Biopsy; Colonic Diseases; Drug Therapy, Combination; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Norethindrone; Norethindrone Acetate; Progesterone; Renal Dialysis; Stomach Diseases | 2000 |
Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK.
Topics: Anabolic Agents; Drug Costs; Estradiol; Female; Hormone Replacement Therapy; Humans; Markov Chains; Models, Economic; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; United Kingdom | 2000 |
[Activelle - modern low-dose hormone replacement therapy for postmenopausal women].
Topics: Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Norethindrone; Norethindrone Acetate | 2000 |
Allergic contact dermatitis from estradiol and norethisterone acetate in a transdermal hormonal patch.
Topics: Administration, Cutaneous; Dermatitis, Allergic Contact; Drug Hypersensitivity; Drug Therapy, Combination; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Patch Tests | 2001 |
Additive antioxidative effect of hormone replacement therapy combined with a statin.
Topics: Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipid Peroxidation; Lipoproteins, LDL; Norethindrone; Norethindrone Acetate; Postmenopause | 2000 |
Mammographic density changes during different postmenopausal hormone replacement therapies.
Topics: Cyproterone Acetate; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Progesterone Congeners; Retrospective Studies; Time Factors | 2001 |
Estimation of hormone replacement therapy influence on serum galanin level in postmenopausal women.
Topics: Adult; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Galanin; Humans; Levonorgestrel; Middle Aged; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause | 2001 |
The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
Topics: Adult; Contraceptives, Oral; Estradiol; Estrogen Replacement Therapy; Estrogens, Catechol; Ethinyl Estradiol; Female; Humans; Hydroxyestrones; Middle Aged; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause | 2001 |
Effect of norethindrone acetate on hormone levels and markers of bone turnover in estrogen-treated postmenopausal women.
Topics: Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Remodeling; Cholesterol; Cholesterol, HDL; Collagen; Collagen Type I; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Hormones; Humans; Isoenzymes; Luteinizing Hormone; Norethindrone; Norethindrone Acetate; Osteocalcin; Peptides; Postmenopause; Sex Hormone-Binding Globulin; Triglycerides | 2001 |
Norethindrone acetate (NA) and ethinyl estradiol (EE) related oxidative transformation products in stability samples of formulated drug product: synthesis of authentic references.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Ethinyl Estradiol; Hydroxylation; Ketosteroids; Norethindrone; Norethindrone Acetate; Oxidation-Reduction; Pharmaceutical Preparations; Reference Standards | 2002 |
Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
Topics: Adult; C-Reactive Protein; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Osmolar Concentration; Postmenopause; Progesterone Congeners; Progestins; Reference Values | 2002 |
Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
Topics: Administration, Oral; Adult; Aged; Contraceptives, Oral, Combined; Endometrial Hyperplasia; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Long-Term Care; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies | 2002 |
Wnt-7a is upregulated by norethisterone in human endometrial epithelial cells: a possible mechanism by which progestogens reduce the risk of estrogen-induced endometrial neoplasia.
Topics: Cells, Cultured; Endometrial Neoplasms; Endometrium; Epithelial Cells; Estradiol; Female; Gene Expression Regulation; Humans; Norethindrone; Norethindrone Acetate; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins; RNA, Messenger; Up-Regulation; Wnt Proteins | 2002 |
The values of urinary NTx in postmenopausal women undergoing HRT; the role of additional alendronate therapy.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Alendronate; Bone Density; Collagen; Collagen Type I; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Peptides; Postmenopause; Prospective Studies | 2002 |
Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins.
Topics: Arteriosclerosis; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Levonorgestrel; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Receptors, Androgen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 2002 |
Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women.
Topics: Biomarkers; C-Reactive Protein; Cholesterol, HDL; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Female; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Norethindrone; Norethindrone Acetate; P-Selectin; Postmenopause; Progesterone Congeners; Serum Amyloid A Protein; Triglycerides; Vascular Cell Adhesion Molecule-1 | 2002 |
Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1beta and IL-6.
Topics: Adolescent; Adult; Aged; Bone Resorption; Cells, Cultured; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Glycoproteins; Humans; Interleukin-1; Interleukin-6; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2003 |
Impact of hormone replacement therapy on endogenous estradiol metabolism in postmenopausal women.
Topics: Estradiol; Female; Humans; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause | 2002 |
Sensitivity and specificity of bioassay of estrogenicity on mammary gland and uterus of female mice.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Estradiol; Female; Gonadal Steroid Hormones; Hydrocortisone; Mammary Glands, Animal; Mice; Mice, Inbred C3H; Norethindrone; Norethindrone Acetate; Organ Size; Ovariectomy; Progesterone; Testosterone; Uterus | 2002 |
Cyclic estrogen-progestin hormone therapy as a new therapeutic approach in the treatment of functional alterations of the hypothalamus-pituitary-ovary axis: case reports.
Topics: Adenoma; Adult; Amenorrhea; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Feedback; Female; Humans; Hypogonadism; Hypothalamus; Norethindrone; Norethindrone Acetate; Ovary; Pituitary Gland; Pituitary Neoplasms; Polycystic Ovary Syndrome | 2002 |
The effects of hormonal therapy on aortic stiffness and left ventricular diastolic function.
Topics: Aorta; Blood Pressure; Diastole; Echocardiography, Doppler; Elasticity; Estradiol; Estrogen Replacement Therapy; Female; Heart Rate; Humans; Mitral Valve; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Ventricular Function, Left | 2003 |
Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
Topics: Animals; Aorta; Cardiotonic Agents; Cardiovascular System; Cholesterol; Coronary Angiography; Coronary Vessels; Dobutamine; Drug Combinations; Electroencephalography; Endometrium; Epithelium; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Lipids; Macaca fascicularis; Mammary Glands, Animal; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Uterus; Vasoconstriction | 2003 |
Bioassay of steroid hormone agonist and antagonist activities of anti-androgens on mammary gland, seminal vesicles and spleen of male mice.
Topics: Androgen Antagonists; Anilides; Animals; Animals, Outbred Strains; Biological Assay; Chlormadinone Acetate; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Flutamide; Male; Mammary Glands, Animal; Mice; Mice, Inbred C3H; Nitriles; Norethindrone; Norethindrone Acetate; Orchiectomy; Progesterone; Seminal Vesicles; Spleen; Steroids; Tosyl Compounds | 2003 |
Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
Topics: Adult; Antineoplastic Agents, Hormonal; Biopsy; Cell Division; Cells, Cultured; Endometrium; Female; Glycogen; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Progesterone Congeners; Progestins; Receptors, Estradiol; Receptors, Progesterone; Time Factors | 2003 |
Clinical experience with norethisterone and norethisterone acetate.
Topics: Gynecology; Norethindrone; Norethindrone Acetate; Progesterone | 1960 |
Jaundice associated with norethindrone acetate therapy.
Topics: Female; Humans; Jaundice; Jaundice, Obstructive; Norethindrone; Norethindrone Acetate | 1962 |
Hydrolysis of norethindrone acetate by fetal and placental tissue.
Topics: Female; Fetus; Humans; Hydrolysis; Norethindrone; Norethindrone Acetate; Placenta; Pregnancy | 1963 |
MASCULINIZATION OF FEMALE INFANTS ASSOCIATED WITH NORETHINDRONE ACETATE.
Topics: Female; Humans; Infant, Newborn; Norethindrone; Norethindrone Acetate; Pregnancy; Pregnancy Complications; Toxicology; Virilism | 1963 |
THE VALUE OF NORETHISTERONE ACETATE IN THE TREATMENT OF ADVANCED CARCINOMA OF THE BREAST.
Topics: Adrenalectomy; Breast; Breast Neoplasms; Carcinoma; Geriatrics; Humans; Hypophysectomy; Neoplasm Metastasis; Norethindrone; Norethindrone Acetate; Toxicology | 1963 |
[EFFECTS OF NORETHISTERONE ACETATE ON THE RENAL EXCRETION OF SODIUM, POTASSIUM AND WATER IN NORMAL INDIVIDUALS].
Topics: Diuresis; Humans; Hypertension; Hypertension, Renal; Kidney; Kidney Function Tests; Natriuresis; Norethindrone; Norethindrone Acetate; Potassium; Pyelonephritis; Renal Elimination; Sodium; Urine; Water; Water-Electrolyte Balance | 1963 |
ACUTE HEMORRHAGIC DEGENERATION OF A LEIOMYOMA FOLLOWING NORETHINDRONE ACETATE: REPORT OF A CASE.
Topics: Female; Humans; Leiomyoma; Neoplasms; Norethindrone; Norethindrone Acetate; Pathology; Surgical Procedures, Operative; Toxicology; Uterine Neoplasms | 1964 |
[ACTION OF NORETHISTERONE ACETATE ON THE HYPOPHYSIS OF THE MALE RAT].
Topics: Castration; Humans; Male; Norethindrone; Norethindrone Acetate; Orchiectomy; Pathology; Pharmacology; Pituitary Gland; Rats; Research; Testis; Toxicology | 1963 |
[EARLY CHANGES IN BASOPHIL CELLS OF THE PITUITARY, IN THE WHITE RAT, INDUCED BY NORETHISTERONE ACETATE].
Topics: Basophils; Cell Biology; Endocrine Cells; Norethindrone; Norethindrone Acetate; Pharmacology; Pituitary Diseases; Pituitary Gland; Rats; Research | 1964 |
EFFECT OF NORETHINDRONE ACETATE UPON GONADOTROPIN-INDUCED OVARIAN FUNCTION.
Topics: Amenorrhea; Chorionic Gonadotropin; Drug Therapy; Endometrial Hyperplasia; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins; Gonadotropins, Pituitary; Humans; Norethindrone; Norethindrone Acetate; Ovulation; Pharmacology; Pituitary Gland; Pregnanediol; Progesterone; Urine | 1965 |
CLINICAL EVALUATION OF NORETHINDRONE ACETATE IN FERTILITY CONTROL.
Topics: Contraception; Contraceptive Agents; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Toxicology | 1965 |
[Clinical experience with norethisterone acetate].
Topics: Amenorrhea; Breast Diseases; Dysmenorrhea; Female; Humans; Norethindrone; Norethindrone Acetate; Premenstrual Syndrome; Progesterone | 1961 |
Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women.
Topics: alpha-Fetoproteins; Biomarkers, Tumor; CA-125 Antigen; CA-19-9 Antigen; Carcinoembryonic Antigen; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medical Records; Medroxyprogesterone Acetate; Middle Aged; Mucin-1; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone; Prospective Studies; Retrospective Studies; Turkey | 2003 |
Differential effects of progestogens on breast cancer cell lines.
Topics: Apoptosis; Breast Neoplasms; Cell Division; Contraceptives, Oral, Synthetic; Estradiol; Humans; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Tumor Cells, Cultured | 2003 |
Effect on endometrium of combined oestrogen-progestogen replacement therapy of 1 mg 17beta-estradiol and 0.5 mg norethisterone acetate.
Topics: Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Ultrasonography | 2004 |
Determination of the physical state of norethindrone acetate containing transdermal drug delivery systems by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.
Topics: Administration, Cutaneous; Calorimetry; Drug Delivery Systems; Microscopy, Polarization; Norethindrone; Norethindrone Acetate; X-Ray Diffraction | 2004 |
Use of isothermal heat conduction microcalorimetry, X-ray diffraction, and optical microscopy for characterisation of crystals grown in steroid combination-containing transdermal drug delivery systems.
Topics: Administration, Cutaneous; Calorimetry; Crystallization; Drug Combinations; Drug Delivery Systems; Estradiol; Hot Temperature; Microscopy, Polarization; Norethindrone; Norethindrone Acetate; X-Ray Diffraction | 2004 |
Different cerebrovascular effects of medroxyprogesterone acetate and norethisterone acetate in the New Zealand White rabbit.
Topics: Acetylcholine; Animals; Calcium; Cerebral Arteries; Constriction, Pathologic; Contraceptive Agents, Female; Endometrium; Endothelin-1; Enzyme Inhibitors; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Medroxyprogesterone Acetate; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroprusside; Norethindrone; Norethindrone Acetate; Ovariectomy; Potassium; Rabbits; Random Allocation; Vasodilator Agents | 2004 |
Effect of previous hormone replacement therapy on endometrial polyps during menopause.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Case-Control Studies; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Immunohistochemistry; Ki-67 Antigen; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Polyps; Proto-Oncogene Proteins c-bcl-2; Receptor, ErbB-2; Retrospective Studies | 2004 |
Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
Topics: Acetylcholine; Animals; Arteries; Calcium; Coronary Vessels; Disease Models, Animal; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Medroxyprogesterone Acetate; Menopause; NG-Nitroarginine Methyl Ester; Nitroprusside; Norethindrone; Norethindrone Acetate; Ovariectomy; Potassium; Progestins; Rabbits; Vasoconstriction; Vasodilation | 2004 |
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone | 2005 |
Oral contraceptives as substrates and inhibitors for human cytosolic SULTs.
Topics: Arylsulfotransferase; Carcinoma, Hepatocellular; Cell Line, Tumor; Contraceptives, Oral; Cytosol; Estradiol; Ethynodiol Diacetate; Humans; Kinetics; Mifepristone; Norethindrone; Norethindrone Acetate | 2005 |
Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
Topics: Androstenes; Animals; Antithrombins; Blood Coagulation; Cholesterol; Estrogens; Ethinyl Estradiol; Female; Humans; Lipoproteins; Models, Animal; Norethindrone; Norethindrone Acetate; Norethynodrel; Ovariectomy; Progestins; Promegestone; Rats; Rats, Sprague-Dawley | 2005 |
The effects of hormone replacement on the biomechanical properties of the uterosacral and round ligaments in the monkey model.
Topics: Animals; Biomechanical Phenomena; Drug Synergism; Elasticity; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Ligaments; Macaca fascicularis; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Ovariectomy; Round Ligament of Uterus; Tensile Strength; Uterus | 2005 |
A comparison of two progestins on myocardial ischemia-reperfusion injury in ovariectomized monkeys receiving estrogen therapy.
Topics: Animals; Biomarkers; Blood Flow Velocity; Blood Pressure; Body Weight; Contraceptive Agents, Female; Coronary Circulation; Disease Models, Animal; Drug Interactions; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Haplorhini; Heart Rate; Lipids; Medroxyprogesterone Acetate; Myocardial Reperfusion Injury; Neovascularization, Physiologic; Norethindrone; Norethindrone Acetate; Ovariectomy; Peroxidase; Progestins; Research Design; Stroke Volume; Vascular Resistance | 2005 |
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Topics: Administration, Cutaneous; Adrenal Glands; Aging; Dehydroepiandrosterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hydrocortisone; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Ovariectomy; Postmenopause; Pregnanolone; Progesterone; Progestins | 2005 |
Synthetic progestins used in HRT have different glucocorticoid agonist properties.
Topics: Animals; Cell Line; Genes, Reporter; Glucocorticoids; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Phosphorylation; Progesterone Congeners; Rats; Receptors, Glucocorticoid; Transcriptional Activation; Transfection; Trypsin | 2005 |
A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Analysis of Variance; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nitric Oxide; Norethindrone; Norethindrone Acetate; Postmenopause; Treatment Outcome | 2006 |
Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study.
Topics: Aged; Breast Neoplasms; Cohort Studies; Coronary Disease; Estradiol; Estrogen Replacement Therapy; Female; Finland; Humans; Levonorgestrel; Middle Aged; Multivariate Analysis; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies | 2006 |
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured | 2005 |
The effect of oestradiol and neta on immunohistochemical staining of iNOS and eNOS in coronary arteries of ovariectomized rats.
Topics: Animals; Atherosclerosis; Connective Tissue; Coronary Vessels; Down-Regulation; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Immunohistochemistry; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norethindrone; Norethindrone Acetate; Ovariectomy; Rats; Rats, Wistar | 2006 |
Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study.
Topics: Breast Neoplasms; Cell Line, Tumor; Equilin; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone | 2007 |
Hormonal therapy with patch or pill: how much does it matter?
Topics: Administration, Cutaneous; Administration, Oral; Blood Coagulation; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Fibrinolysis; Humans; Norethindrone; Norethindrone Acetate; Postmenopause; Pulmonary Embolism; Research Design; Risk Assessment; Risk Factors; Thromboembolism; Treatment Outcome; Venous Thrombosis | 2007 |
Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.
Topics: Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspases; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Female; GPI-Linked Proteins; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Progesterone; Progestins; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor, Member 10c; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor Decoy Receptors | 2007 |
Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis.
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone Density; Cohort Studies; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hip; Humans; Leuprolide; Lumbar Vertebrae; Norethindrone; Norethindrone Acetate | 2007 |
Effects of estrogens on oxidative protein damage in plasma and tissues in ovariectomised rats.
Topics: Animals; Contraceptives, Oral, Synthetic; Estradiol; Estrogens; Female; Glutathione; Malondialdehyde; Norethindrone; Norethindrone Acetate; Ovariectomy; Oxidative Stress; Protein Carbonylation; Proteins; Rats; Rats, Sprague-Dawley | 2009 |
Hormone therapy modulates ET(A) mRNA expression in the aorta of ovariectomised New Zealand White rabbits.
Topics: Animals; Aorta; Drug Combinations; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gene Expression Regulation; Norethindrone; Norethindrone Acetate; Ovariectomy; Rabbits; RNA, Messenger | 2009 |
Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
Topics: Breast; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Norway; Postmenopause | 2009 |
Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women.
Topics: Adult; Cohort Studies; Estradiol; Estrogen Replacement Therapy; Female; Humans; Life Style; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Sweden; Women's Health | 2009 |
Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study.
Topics: Adult; Colonic Diseases; Endometriosis; Female; Humans; Norethindrone; Norethindrone Acetate; Pain; Pilot Projects; Prospective Studies; Rectal Diseases | 2010 |
Do the dose or route of administration of norethisterone acetate as a part of hormone therapy play a role in risk of breast cancer: national-wide case-control study from Finland.
Topics: Breast Neoplasms; Case-Control Studies; Estrogen Replacement Therapy; Female; Finland; Humans; Middle Aged; Multivariate Analysis; Norethindrone; Norethindrone Acetate; Registries | 2010 |
Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure.
Topics: Adult; Cesarean Section; Estradiol; Female; Follicle Stimulating Hormone; Hormone Replacement Therapy; Humans; Luteinizing Hormone; Norethindrone; Norethindrone Acetate; Pregnancy; Primary Ovarian Insufficiency; Ultrasonography, Prenatal | 2009 |
Add-back therapy use and its impact on LA persistence in patients with endometriosis.
Topics: Adult; Contraceptives, Oral, Synthetic; Databases, Factual; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Progesterone Congeners; Retrospective Studies | 2010 |
Effects of 17beta-oestradiol and norethisterone acetate on sulfonation and sialylation of gonadotrophins in post-menopausal women.
Topics: Aged; Drug Implants; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Middle Aged; N-Acetylneuraminic Acid; Norethindrone; Norethindrone Acetate; Postmenopause; Sulfones | 2010 |
Letrozole and norethisterone acetate in colorectal endometriosis.
Topics: Abdominal Pain; Aromatase Inhibitors; Colonic Diseases; Diarrhea; Drug Therapy, Combination; Dyspareunia; Endometriosis; Female; Humans; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Pain Measurement; Patient Satisfaction; Pelvic Pain; Pilot Projects; Prospective Studies; Rectal Diseases; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Triazoles | 2010 |
Membranous dysmenorrhea: a complication of treatment for endometriosis.
Topics: Adolescent; Dysmenorrhea; Endometrium; Female; Humans; Norethindrone; Norethindrone Acetate; Progestins | 2010 |
Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle.
Topics: Estradiol; Estrogen Replacement Therapy; Female; Forkhead Box Protein O1; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Insulin-Like Growth Factor I; Middle Aged; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Norethindrone; Norethindrone Acetate; Protein Isoforms; Proto-Oncogene Proteins c-akt; Randomized Controlled Trials as Topic; Receptor, IGF Type 1; Receptors, Androgen; Receptors, Estrogen; SKP Cullin F-Box Protein Ligases; Testosterone; TOR Serine-Threonine Kinases; Transcription, Genetic | 2010 |
Endometriosis presenting with hemorrhagic ascites.
Topics: Ascites; CA-125 Antigen; Contraceptives, Oral, Synthetic; Diagnostic Imaging; Endometriosis; Female; Hemoperitoneum; Humans; Norethindrone; Norethindrone Acetate; Peritoneal Diseases; Postoperative Care | 2011 |
Oral contraceptives and endometriosis.
Topics: Contraceptives, Oral; Endometriosis; Female; Humans; Norethindrone; Norethindrone Acetate; Recurrence | 2011 |
Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract.
Topics: Blotting, Western; Cell Line; Cervix Uteri; Contraceptive Agents, Female; Cytokines; DNA Primers; Female; Gene Expression Regulation; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Vagina | 2011 |
Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells?
Topics: Aged; Androstenedione; Cervix Uteri; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Epithelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Female; Humans; Metaplasia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Papanicolaou Test; Postmenopause; Raloxifene Hydrochloride; Statistics, Nonparametric; Vaginal Smears; Vascular Endothelial Growth Factor A | 2012 |
Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Endometriosis; Female; Humans; Metrorrhagia; Norethindrone; Norethindrone Acetate; Pelvic Pain; Retrospective Studies; Weight Gain; Young Adult | 2012 |
Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study.
Topics: Aged; Aged, 80 and over; Confidence Intervals; Estradiol; Estrogen Replacement Therapy; Female; Finland; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Postmenopause; Progestins; Risk Assessment; Time Factors | 2013 |
Norethisterone acetate alters coagulation gene expression in vitro in human cell culture.
Topics: Blood Coagulation; Cells, Cultured; Contraceptives, Oral, Synthetic; Estradiol; Estrone; Factor VII; Fibrinogen; Gene Expression Regulation; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins; Norethindrone; Norethindrone Acetate; Plasminogen Activator Inhibitor 1; Prothrombin; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Time Factors; Tissue Plasminogen Activator | 2013 |
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Topics: Administration, Cutaneous; Age Factors; Aged; Case-Control Studies; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Norethindrone; Norethindrone Acetate; Odds Ratio; Postmenopause; Progestins; Risk Assessment; Risk Factors; Sex Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life.
Topics: Adolescent; Adult; Cohort Studies; Depression; Dyspareunia; Endometriosis; Female; Humans; Laparoscopy; Norethindrone; Norethindrone Acetate; Patient Preference; Progestins; Quality of Life; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2013 |
Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Line; Chlorocebus aethiops; Contraceptives, Oral, Synthetic; COS Cells; Gene Expression Regulation; Genes, Reporter; Humans; Luciferases; Medroxyprogesterone Acetate; Myocytes, Cardiac; Norethindrone; Norethindrone Acetate; Orosomucoid; Plasmids; Plasminogen Activator Inhibitor 1; Rats; Receptors, Mineralocorticoid; Response Elements; Signal Transduction; Transcription, Genetic; Transfection | 2013 |
Effect of hormone therapy on breast epithelial cell proliferation.
Topics: Breast; Contraceptives, Oral, Synthetic; Estradiol; Estrogens; Female; Humans; Norethindrone; Norethindrone Acetate; Postmenopause | 2013 |
Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women.
Topics: Aged; Breast; Cell Proliferation; Cholesterol, HDL; Cholesterol, LDL; Collagen; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Hot Flashes; Humans; Ki-67 Antigen; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Receptors, Androgen; Receptors, Progesterone; Sweating | 2013 |
The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.
Topics: Amino Acid Sequence; Apoptosis; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cells, Cultured; Contraceptive Agents, Female; Dexamethasone; Gene Expression Regulation; Gene Products, vpr; HIV-1; Humans; Hydrocortisone; Medroxyprogesterone Acetate; Mifepristone; Molecular Sequence Data; Norethindrone; Norethindrone Acetate; Progesterone; Receptors, Estrogen; Receptors, Glucocorticoid; Signal Transduction | 2013 |
Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Topics: Apoptosis; Breast Neoplasms; Caspase 3; Cell Proliferation; Cell Transformation, Neoplastic; Cyproterone Acetate; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Receptors, Progesterone | 2013 |
Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study.
Topics: Adult; Aromatase Inhibitors; Drug Therapy, Combination; Dysmenorrhea; Dyspareunia; Endometriosis; Female; Humans; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Ovarian Cysts; Treatment Outcome; Triazoles | 2014 |
A 29-year-old woman with complex atypical hyperplasia and polycystic ovary syndrome: a challenging issue.
Topics: Adult; Endometrial Hyperplasia; Female; Fertility Preservation; Humans; Norethindrone; Norethindrone Acetate; Polycystic Ovary Syndrome | 2014 |
The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.
Topics: Cells, Cultured; Cervix Uteri; Contraceptive Agents; Epithelial Cells; Female; HeLa Cells; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Receptors, Glucocorticoid | 2014 |
A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).
Topics: Androgens; Animals; Antineoplastic Agents, Hormonal; Blotting, Western; Chlorocebus aethiops; Contraceptives, Oral, Synthetic; COS Cells; Humans; Luciferases; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Receptors, Androgen; Two-Hybrid System Techniques | 2014 |
The effect of hormone therapy on biochemical and ultrasound parameters associated with atherosclerosis in 46,XY DSD individuals with female phenotype.
Topics: Adolescent; Adult; Androgen-Insensitivity Syndrome; Atherosclerosis; Drug Combinations; Endothelium, Vascular; Estradiol; Estrogens; Female; Gonadal Dysgenesis, 46,XY; Humans; Male; Norethindrone; Norethindrone Acetate; Progestins; Treatment Outcome; Ultrasonography; Young Adult | 2014 |
Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient mice.
Topics: Animals; Aorta; Apolipoproteins E; Carotid Artery Thrombosis; Cells, Cultured; Contraceptive Agents, Female; Coronary Vessels; Endothelial Cells; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Medroxyprogesterone Acetate; Mice, Knockout; Myocytes, Smooth Muscle; Norethindrone; Norethindrone Acetate; Oligonucleotide Array Sequence Analysis; Ovariectomy; Polymerase Chain Reaction | 2014 |
Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study.
Topics: Apoptosis; Breast Neoplasms; Dexamethasone; Estrogens; Female; Glucocorticoids; Hormone Replacement Therapy; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Mifepristone; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Receptors, Estrogen; Receptors, Glucocorticoid; Risk; Women's Health | 2014 |
Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy.
Topics: Contraceptives, Oral, Synthetic; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norway; Prospective Studies; Quality of Life; Surveys and Questionnaires; Sweden; Treatment Outcome; Uterine Hemorrhage | 2015 |
Effect of transdermal hormone therapy on platelet haemostasis in menopausal women.
Topics: Administration, Cutaneous; Aspirin; Blood Platelets; Estradiol; Estrogen Replacement Therapy; Female; Hemostasis; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Poland | 2015 |
Treatment of Acute Abnormal Uterine Bleeding in Adolescents: What Are Providers Doing in Various Specialties?
Topics: Adolescent; Adolescent Medicine; Child; Contraceptives, Oral, Combined; Emergency Treatment; Female; Gynecology; Humans; Menorrhagia; Menstruation Disturbances; Norethindrone; Norethindrone Acetate; Pediatrics; Retrospective Studies; Uterine Hemorrhage; Young Adult | 2016 |
Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study.
Topics: Adult; Cost-Benefit Analysis; Drug Costs; Drug Substitution; Endometriosis; Female; Humans; Nandrolone; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Progestins; Quality of Life; Treatment Outcome | 2016 |
Probing the binding of two 19-nortestosterone derivatives to human serum albumin: insights into the interactions of steroid hormone drugs with functional biomacromolecule.
Topics: Binding Sites; Circular Dichroism; Humans; Hydrogen Bonding; Models, Molecular; Molecular Docking Simulation; Norethindrone; Norethindrone Acetate; Protein Binding; Protein Domains; Serum Albumin, Human; Spectrometry, Fluorescence; Thermodynamics | 2016 |
Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Topics: Administration, Cutaneous; Administration, Oral; Case-Control Studies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Logistic Models; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Odds Ratio; Perimenopause; Postmenopause; Progestins; Risk Factors; Sweden; Vagina; Venous Thromboembolism | 2016 |
Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy.
Topics: Adult; Bone Density; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; International Classification of Diseases; Leuprolide; Medication Adherence; Norethindrone; Norethindrone Acetate; Retrospective Studies | 2016 |
[Withdraw the warning for Primolut-Nor (noretisteronacetat)].
Topics: Contraceptives, Oral, Synthetic; Evidence-Based Medicine; Female; Humans; Norethindrone; Norethindrone Acetate | 2016 |
A comparison of progestins within three classes: Differential effects on learning and memory in the aging surgically menopausal rat.
Topics: Aging; Animals; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Learning; Levonorgestrel; Medroxyprogesterone Acetate; Memory; Models, Animal; Norethindrone; Norethindrone Acetate; Ovariectomy; Progestins; Psychological Tests; Random Allocation; Rats, Inbred F344 | 2017 |
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells.
Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Cellular Microenvironment; Cytokines; Endometriosis; Endometrium; Estrogens; Female; Humans; Immunosuppression Therapy; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Stromal Cells; Tumor Necrosis Factor-alpha | 2016 |
Hepatic Adenomas in Adolescents and Young Women with Endometriosis Treated with Norethindrone Acetate.
Topics: Adenoma; Adolescent; Adult; Contraceptives, Oral, Hormonal; Endometriosis; Ethinyl Estradiol; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Norethindrone; Norethindrone Acetate; Young Adult | 2017 |
Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis.
Topics: Adult; Cohort Studies; Dyspareunia; Endometriosis; Female; Humans; Norethindrone; Norethindrone Acetate; Pain Measurement; Patient Satisfaction; Pelvic Pain; Rectal Diseases; Retrospective Studies; Treatment Outcome; Vaginal Diseases | 2017 |
The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
Topics: Adult; Cytokines; Endometriosis; Endometrium; Female; Humans; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid; Stromal Cells; Tumor Necrosis Factor-alpha | 2017 |
Is Shifting to a Progestin Worthwhile When Estrogen-Progestins Are Inefficacious for Endometriosis-Associated Pain?
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Pelvic Pain; Progestins; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2018 |
Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique
Topics: Adult; Contraceptives, Oral, Synthetic; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Incidence; Intention to Treat Analysis; Intestinal Diseases; Italy; Levonorgestrel; Metrorrhagia; Norethindrone; Norethindrone Acetate; Ovarian Diseases; Pain Measurement; Patient Dropouts; Patient Preference; Pelvic Pain; Prospective Studies; Vaginal Diseases | 2018 |
Shifting from Oral Contraceptives to Norethisterone Acetate, or Vice Versa, because of Drug Intolerance: Does the Change Benefit Women with Endometriosis?
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Hypersensitivity; Drug Substitution; Endometriosis; Female; Humans; Norethindrone; Norethindrone Acetate; Pain Measurement; Quality of Life; Treatment Outcome | 2018 |
Relugolix, Estradiol, and Norethindrone Acetate.
Topics: Estradiol; Humans; Norethindrone; Norethindrone Acetate; Phenylurea Compounds; Pyrimidinones | 2021 |
Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
Topics: Adult; Case-Control Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Venous Thromboembolism | 2022 |
Efficacy and safety of ultra-low-dose estradiol and norethisterone in postmenopausal Brazilian women.
Topics: Amenorrhea; Brazil; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 2023 |
Norethindrone dosing for adequate menstrual suppression in adolescents.
Topics: Adolescent; Female; Humans; Menorrhagia; Norethindrone; Norethindrone Acetate; Obesity; Retrospective Studies | 2023 |